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Biotin protein ligase (BPL, EC: 6.3.4.15) catalyzes the formation of biotinyl-
5'-AMP from biotin and ATP, and the succeeding biotinylation of the biotin 
carboxyl carrier protein (BCCP). The gene encoding the BPL from the 
hyperthermophyle Aqufex  aeolicus were overexpressed in Escherichia co/i and the 
recombinant protein AaBPL was purified to homogeneity. AaBPL was proven to be 
catalytically active and to biotinylate specifically the C-terminal biotinyl domain of 
BCCP (BCCPA67). The isolation and characterisation of a chemically cross-linked 
AaBPL:BCCPA67 complex is described here. Isothermal titration calorimetry 
experiments revealed that in the class I AaBPL, the presence of biotin is not required 
for ATP binding in the absence of Mg 2 ions and the binding of biotin and ATP has 
been determined to occur via a random but cooperative process. The residues 
involved in substrate binding were further investigated by X-ray crystallography and 
we report the structures at 2.3 A resolution of AaBPL in the apo-form and bound to 
biotin and ATP. This is the first crystal structure of a BPL in complex with biotin and 
ATP but also of an ATP-bound BPL. The Arg40 residue from the conserved 
GXGRXG motif is shown to play a key role in stabilizing the two ligands within the 
active site. The structures of the mutant AaBPL R40G both in the apo- and biotin-
bound forms reveal significant conformational differences in the catalytic domain of 
the enzyme and ITC measurements indicate that binding of ATP to AaBPL R40G is 
very weak in the absence or presence of biotin. AaBPL R40G remains catalytically 
active but shows poor substrate specificity. 
IV 
Abstract 
In a separate study, the assembly states of the full-length E. coli BCCP 
(EcBCCP) and biotin carboxylase (BC) subunits of acetyl-CoA carboxylase (ACC) 
have been investigated by mass spectrometry in collaboration with Prof. Carol 
Robinson (University of Cambridge). The accB and accC genes were overexpressed 
in E. coli and analysis of the purified recombinant EcBCCP and BC proteins 
indicated that while BC is dimeric, EcBCCP forms decamers and other oligomers in 
solution. Cloning of the C-terminal fragment BCCP87 and of the BC:EcBCCP 
complex were also carried out for further understanding of the exact stoichiometry of 




aaRS - Aminoacyl tRNA synthetase 
ACC - Acetyl-CoA carboxylase 
AMP - Adenosine 5'-monophosphate 
ATP - Adenosine 5'-triphosphate 
BC - Biotin Carboxylase 
BCCP - Biotin carboxyl carrier protein 
Bp - Base pair(s) 
BPL - Biotin protein ligase 
CSD - Charge state distribution 
CID - Collision induced dissociation 
CoA - Coenzyme A 
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Chapter 1: Biotinylation 
1.1 The Vitamin Biotin 
1 .1.1 The Vitamin B 7 : Biotin 
Vitamins are ubiquitous organic compounds required by all kinds of life that 
act as co-enzymes in essential metabolic reactions.1 2  A common feature of the 
vitamins is that their biosynthesis does not occur in mammals but does in other 
organisms. Humans are believed to have lost the ability to biosynthesize these 
components and have developed instead mechanisms of uptake and absorption.' The 
significance of eating certain foods in order to maintain health was recognized long 
before vitamins were identified in the nutritional diet and several mysterious and fatal 
diseases resulting from vitamin deficiency were still prevalent in the past century. 45 
In the late 19th  century, Eijkman, who was awarded the 1929 Nobel Prize in 
Physiology or Medicine with Hopkins for their discovery of several vitamins, and the 
Russian surgeon Lunin suggested the existence of nutrients other than minerals, fatty-
acids, carbohydrates or amino-acids essential in small amounts for the metabolism in 
living organisms.6  In 1912, Funk proposed that the diseases beriberi, pellagra, 
rickets and scurvy resulted from the lack of four different vital nutrients and was first 
to isolate a water-soluble complex of micronutrients which he proposed to be named 
"Vitamine", standing for vital and amine. 8  Those accessory growth factors were 
divided in 1915 by McCollum and Davis into the fat-soluble (A) and the water-
soluble (B) vitamins. 9  Ten years latter, Jansen successfully isolated a small amount of 
thiamine and in 1933, Williams purified the crystalline compound from rice 
polishings which allowed the characterisation and the synthesis of the vitamin. 10 
Over time, more compounds were identified as vitamins in both the fat-soluble (A, D, 
E, K) and water-soluble (B 1 -B 12, C) families, many of whom were latter shown not to 
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be essential and withdrawn from the list. 3 It is not yet known if all vitamins have been 
discovered but it has been shown that rats can survive on an almost completely 
synthetic diet. 12  Because vitamins are required by all organisms, their biosynthesis in 
microorganisms and their functions remain of considerable interest.' 3 ; 14 
Biotin is the water-soluble B 7 vitamin, also named vitamin H or co-enzyme R, 
and was first discovered in the laboratory of Karl Folker at Merck in 1935 while 
searching for the anti-pernicious anemia factor. The vitamin was isolated the same 
year by Kogl and Tönnis, who purified 1.1 mg of the crystalline compound as its 
methyl ester form from more than 250 kg of egg yolk. 15-17  The structure of biotin was 
subsequently deduced by Du Vigneaud et al. in 1942.18; 19 Biotin has the chemical 
formula C 10H 16N203 S and contains three chiral centres. Of the eight stereoisomers, 
only the dextrorotatory D-(+)-biotin is biologically active (Fig. 1.1). The structure 
reveals an ureido (tetrahydroimidazolidone) group fused to a tetrahydrothiophene ring 
attached to a valeric acid. 
HNI
K2 




/5 	- -- - 
COOH 
10 
7 	 9 
Figure 1.1 - Structure of the biologically active isoform D-(+)-biotin. The atoms 
are numbered and the (*) indicate the chiral centres of biotin. 
Biotin is produced in small quantities by microorganisms and plants while 
mammals rely on dietary intake to satisfy their biotin requirements (human RDA: 
30.0 g).20 The vitamin is synthesized from pimeloyl-CoA and the enzymes involved 
3 
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in the biosynthetic pathway have been studied in details in organisms including 
Escherichia coli, Bacillus subtilis and Saccharomyces cerevisae. 224 The well 
characterised E. coli biotin biosynthetic operon bioABFCD is composed of five 
closely linked genes which encode respectively the enzymes 7,8-diaminononanoate 
synthetase (DANS), biotin synthase, 8-amino-7-oxononanoate synthase (AONS), 
BioC and dethiobiotin synthase (DTBS). 22 AONS catalyses the conversion of 
pimeloyl-CoA and alanine to 8-amino-7-oxononanoate and the subsequent transfer of 
the amino group from S-adenosine-L-methionine resulting in 7,8-diaminononanoate 
is catalysed by DANS. DTBS catalyses the formation of the ureido ring in the 
presence of carbon dioxide and MgATP and the final step catalysed by biotin 
synthase consists of the insertion of the sulfur atom. 2526 
1.1.2 Biotin-Dependant Carboxylation 
Biotin plays key roles in essential carboxylation reactions involved in the 
metabolism of glucose, fatty-acids and amino-acids. Enzymatic carboxylation 
reactions within the cell are divided in four categories: the first category is formed by 
the three enzymes that carboxylate the substrate phosphoenolpyruvate (PEP) leading 
to the formation of oxaloacetate (PEP carboxylase, PEP carboxykinase and PEP 
carboxytransphosphorylase) while the second category contains the enzymes that 
require biotin as a co-factor. 2729 The third is represented by the enzyme ribulose- 1,5-
diphosphate carboxylase, a well characterised carboxylase in photosynthetic plants 
and microorganisms, and the fourth category constitutes the still poorly understood 
enzymes responsible for the carboxylation of glutamyl residues in glycoproteins 
4 
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which require as a co-factor vitamin K, a fascinating coagulant discovered in the late 
1920s by Danish scientist Henrik Dam. 30-32 
While carbon dioxide 	is 	the 	natural 	substrate for the enzymes PEP 
carboxykinase, PEP carboxytransphosphorylase, ribulose-1,5-disphosphate 
carboxylase, as well as the vitamin K-dependent carboxylases, all the biotin-
dependant enzymes and PEP carboxylase use hydrogen carbonate and ATP as cc-
substrates. 33  At physiological pH and temperature, the concentration of dissolved 
carbon dioxide in equilibrium with the atmosphere is only 10 .tM, whereas that of 
bicarbonate ion is 200 gM. 34 Therefore, although it is preferable for an enzyme to use 
the small proportion of electrophilic carbon dioxide, effective ways of fixing the more 
abundant bicarbonate occur in biotin-dependant enzymes. 
There are six well-characterised biotin-dependant carboxylases which have in 
common a requirement for bicarbonate and ATP .27 28  Pyruvate (a-keto propanoic 
acid) carboxylase and urea carboxylase which lead to the formation of oxaloacetate 
and N-carboxyurea respectively. Other biotin enzymes include acetyl-CoA 
carboxylase, propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase and 
geranyl-CoA carboxylase. The specific substrates acetyl-CoA and propionyl-CoA are 
carboxylated on their cc-carbon resulting in the formation of the essential metabolites 
malonyl-CoA and methylmalonyl-CoA (Fig. 1.2). Carboxylation of 3-
methylcrotonyl-CoA and geranyl-CoA occur on their y-carbon which is activated by 
the double bond between the a- and 3- carbons generating -methylglucanoyl-CoA 
and isohexenyl-glutaconyl-CoA respectively. 27  In mammals, biotin serves in the 
carboxylation catalysed by pyruvate carboxylase, acetyl-CoA carboxylase (ACC), 
5 
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propionyl-00A carboxylase and 3-methylcrotonyl-CoA carboxylase while in bacteria 
only ACC requires biotin as a co-factor. 35 
)LcoA 
Ace1-CoA Carbolase 	 CoA 
AceoA 	 COOH r_I__.'aIonyIoA 
HCO3 	ADP 
ATP Pi 
Figure 1.2 - The biotin-dependant carboxylation of acetyl-CoA. The reaction is 
catalysed by ACC in presence of bicarbonate and ATP and results in the formation of 
malonyl-CoA. 
Biotin acts as a transporter molecule for carbon dioxide when covalently 
bound to the dependant carboxylases. 27 ' 28 The first step of the carboxylation reaction 
involves the ATP-dependent fixation of CO2 derived from bicarbonate by biotin to 
form a carboxybiotin complex followed by decarboxylation of carboxybiotin and 
CO2 transfer to different acceptor substrates. 33  In 1959, Lynen et al. showed that 
incubation of purified f-methylcrotonyl-CoA carboxylase in presence of ATP and 
radioactive bicarbonate generated labelled [ 14C]carboxybiotin and the release of ADP 
and inorganic phosphate (Pi). 36 While he argued that the structure of biotin suggested 
that the bicarbonate could reversibly be incorporated at position N3, stabilisation of 
the labile [ 14C]carboxybiotin by esterification with diazomethane showed that the 
resulting dimethyl ester form was identical to synthetic N I -methoxycarbonylbiotin 
methylester. Further, limited proteolysis allowed the characterisation of the N 1 -
carboxybiotin. 36 The localization of the carbon dioxide at the sterically less hindered 
N 1 was proven by X-ray analysis of the bis(p-bromoanilide) derivative of 
carboxybiotin by Bonnemere et al. in 1965. 37 
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Within the cell, the biotin prosthetic group is covalently linked via an amide 
bond with the valerate carboxyl group and the E-amino group of specific lysine 
residues of the biotin dependant-enzymes, resulting in a flexible aliphatic chain, also 
called a "swinging arm" by some authors. 38;  This was first demonstrated by the 
isolation of N-biotinyl-lysine, or biocytin, from an autolysate of growing yeast. 40 
The flexible arm of approximatively 1.6 nm allows the translocation of biotin and 
carboxylated biotin between the different active sites of the carboxy1ase. 33393 
A biotin-dependant carboxylase which does not uses ATP or bicarbonate is 
the transcarboxylase methylmalonyl-CoA carboxyltransferase.' Three 
decarboxylases, methylmalonyl-CoA decarboxylase, glutaconyl-CoA decarboxylase 
and oxaloacetate decarboxylase have also been shown to require biotin as a carboxyl 
carrier. In these three enzymes the CO2 unit is transferred from either an acyl 
derivative or keto-ester to the enzyme before being transferred to either an acceptor or 
released as free CO2. To date, biotin-dependant decarboxylases have been found only 
in anaerobic bacteria which employ the free energy of decarboxylation to pump Na 
across a membrane. The resulting Na gradient is then used for the synthesis of 
ATP.46  47 
1.1.3 The Biological Roles of Biotin 
In addition to its role as a carboxyl carrier, the vitamin biotin has been shown 
to possess other functions within the cell .48 ; 49 Recent characterisations of histones 
covalently bound to biotin suggest roles for the vitamin beyond its attachment to 
carboxylases and so far, at least seven biotinylation sites have been identified in 
7 
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human histones. 5°  Biotin has also been shown to be involved in the regulation of gene 
expression and signal transduction. Cell signaling molecules such as biotinyl-5'-
AMP, Spi and Sp3, nuclear factor —KB and receptor tyrosine kinase depend on biotin 
supply and more than 2000 biotin-dependant genes have been found in various human 
tissues. 51 ; 52 The mechanisms involved in these other functions are still unclear but it 
seems that biotin may have been selected during evolution to play many different 
roles in the metabolism and gene expression of higher organisms. 51 
Biotin is only required in trace amounts and thus, deficiency in the nutritional 
diet is generally rare and mild and can be treated successfully by dietary 
supplements. Seborrheic dermatitis, a disease characterised by scaly skin changes, 
may be related to the poor ability of the patients to use biotin. 53  People with type 2 
diabetes often have low levels of biotin and it has been suggested that the vitamin 
may be involved in the synthesis and release of insulin. 54 ' 55 Deficiency in the vitamin 
has also been proven teratogenic in animals and to be the cause of several 
neurological diseases.56' 57  Biotin deficiency disorders also occur due to genetic 
lesions. Biotin-responsive multiple carboxylase deficiency (MCD) is a rare 
autosomal recessive disorder of biotin utilization associated with reduced activity of 
all four biotin-dependent carboxylases. The MCD disease may be caused by a 
primary deficiency of holocarboxylase synthetase (HCS), required for the biotin-
dependent activation of apo-carboxylases, or of biotinidase, which functions in the 
recovery of biotin from degraded carboxylases. MCD, which can be reversed 
successfully by treatment with additional pharmacological dose of biotin, is 
characterized by metabolic ketoacidosis and organic acidemia accompanied by 
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developmental delay, hypotonia, and erythematous rashes followed by coma and 
death if left untreated .49 
Nowadays, biotin is commonly used in biotechnology due to its extremely 
high affmity for the proteins avidin (from egg white) and streptavidin (from 
Streptomyces avidinii) which are among the strongest protein-ligand associations 
characterised (KD=10'5 M and M respectively) . 58 Therefore, biotin is 
used in a wide range of biochemical applications. The most common remain the 
purification and the detection of biotin-tagged biomolecules from complex mixtures 
by avidin I streptavidin chromatography and the use of streptavidin-biotin complexes 
in western-blots. 356° Biotinylated antibodies are captured by avidin or streptavidin in 
both the ELISPOT and ELISA techniques for the study of protein-protein interactions 
and related biochemical phenomena. 61 
1.2 Acetyl-00A Carboxylase 
1.2.1 The Biological Roles of Acetyl-CoA Carboxylase 
Acetyl-CoA carboxylase catalyses the first committed and rate-determining 
step of fatty acid biosynthesis which is the biotin-dependant conversion of acetyl-
CoA to malonyl-CoA,. 6263 The malonyl-CoA product of the ACC-catalysed reaction 
is used as a building block in the cyclic stepwise condensation reactions catalysed by 
fatty acid synthase (FAS) and is the source of the two carbons units employed in the 
elongation of fatty acids. 64-66  Fatty acids are important constituents of biological 
membranes, energy storage compounds and messenger substances and, therefore, 
ACC is essential in many organisms. 67  In addition to fatty acid production, the 
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malonyl-CoA produced by bacterial ACCs is also the building block for a variety of 
natural products including the vitamins biotin and lipoic acid as well as polyketide 
antibiotics. 68-70  Moreover, malonyl-CoA has been shown recently to play a major 
role in regulating the expression of the transcription factor FapR involved in fatty 
acid and phospholipid metabolism. 7172 
In mammals, two isoforms of acetyl-CoA carboxylase, ACC1 and ACC2, 
encoded by different genes have been characterized. 73 ACC1 is a cytosolic enzyme 
which regulates fatty acid biosynthesis in lipogenic tissues, whereas ACC2 is mainly 
located in the heart and skeletal muscle and is associated with the mitochondrial 
membrane. 74  ACC2 controls the rate of lipid oxidation as its product malonyl-CoA is 
a potent inhibitor of camitine palmitoyltransferase, an enzyme which allows the 
transfer of long chain acyl-CoA into the mitochondria. 75 Since ACC plays critical 
roles in the synthesis and regulation of fatty acid biosynthesis in humans, the enzyme 
has become an attractive target for drug discovery. 76  ACC has been validated for the 
development of novel therapeutics treatments against obesity, type 2 diabetes, and 
other manifestations of the metabolic syndrome. 77-79  However, only a few small 
molecule inhibitor of mammalian ACC are currently known. Animal testing has 
shown that compound CP-640 186 (a Pfizer product) reduces tissue malonyl-CoA 
levels, inhibits fatty acid biosynthesis, stimulates fatty acid oxidation and reduces 
body fat and weight (Fig 1.3, A). 798° 
Bacterial ACCs also constitute an attractive target for the development of 
novel antibiotics. Until now, most inhibitors have been directed against the FAS-
dependent enzyme complex and very few inhibitors of bacterial ACCs are known. 81;  
82  Since the fatty-acid composition of bacteria varies significantly between species, 
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ACC, which is a broadly conserved enzyme among prokaryotes and, with the 
exceptions of some actinobacterias, does not possess any other isoform, has become 
a new antibiotic target area. Pyrrolidinedione derivatives, particularly moiramide B, 
have been shown recently to inhibit the bacterial ACC while having little effect on 
eukaryotic enzyme activity (Fig 1.3, B).83 84  in plants, ACC is also a proven target 
for drug action. Two classes of compounds, aryloxyphenoxypropionate (FOP) and 
cyclohexanedione (DIM), which kill sensitive plants by inhibiting their fatty acid 
biosynthesis, have been used commercially as herbicides for more than 20 years (Fig 
1.3, Q. These herbicides are reversible inhibitors of grass plastid ACC and weak 
inhibitors of mammalian and yeast ACCs 85-87  Soraphen A, a macrocyclic polyketide 
natural product secreted by the soil-dwelling myxobacterium, Sorangium cellulosum, 
is a potent inhibitor of eukaryotic ACC and has been tested for agricultural 
applications (Fig 1.3, D). 88 
B 
I 	 0 Ii  
'OH 
Figure 1.3 - Chemical structures of representative ACC inhibitors. A: CP-
640 186. B: Moiramide B. C: Haloxyfop (FOP compound). D: Soraphen A. 
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1.2.2 The Biological Properties of Acetyl-CoA Carboxylase 
Two physically distinct types of ACC are found in nature.M  The first ACCs 
studied were those from mammals and yeast in which the reaction is catalysed by a 
single large multifunctional polypeptide forming a homodimer. In contrast, bacterial 
ACCs are heterodimeric multi-subunit proteins. 61 ; 89 E. co/i acetyl-CoA carboxylase 
constitutes a paradigm of multi-subunit ACC and is constituted by four subunits: the 
biotin carboxyl carrier protein (BCCP), biotin carboxylase (BC) and 
carboxyltransferase (CTçt and CT) (Table 1. l)Y° The predicted oligomeric states of 
the BC, CT and BCCP subunits would form an enzyme with an overall mass of 200 
kDa. Isolation of such complex has not yet been achieved and the exact 
stoichiometry of the subunits within the ACC complex remains unclear. Until 
recently, the overall activity of E. co/i ACC could be measured only when all four 
subunits were present at high concentrations, although both partial reactions 
catalysed by the subunits BC and CT (x/p can be measured in dilute protein 
solutions.9193 In 2006, Soriano et a/. established a robust assay which monitors the 
overall ACC activity by measuring the phosphate production at physiologically 







Biotin Carboxyl Carrier Protein (BCCP) accB 16.7 Tetramer 
Biotin Carboxylase (BC) accC 49.4 Dimer 
Carboxyltransferase, a subunit (CTa) accA 35.1 Dimer plus dimer of CT 
Carboxyltransferase, 0 subunit (CT) accD 33.2 Dimer plus dimer of CTa 
Table 1.1: The four subunit constituents of E. coil ACC. 
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Although the four subunits of E. co/i ACC were purified to homogeneity 
more than 50 years ago, the four genes accB, accC and accAlD of acetyl-CoA 
carboxylase encoding the different subunits were discovered only in the early 1990s 
(Table 1. 1).92  The accB gene which encodes the biotin carboxyl carrier protein had 
been described previously by groups working on other projects and Li and Cronan 
characterized the gene by a reverse genetic approach. 9597 Cronan subsequently 
showed that the BC ORF (accC) was located immediately downstream of accB. 98 In 
the same period, Kondo et al. independently isolated the accA gene encoding CT-ct 
by reverse genetics leading directly to the identification of the accD gene encoding 
the -subunit.99 100  Citrate, which promotes polymerization of ACC, and long-chains 
acyl-CoAs, which promote the dissociation of the ACC polymers when bound to the 
enzyme, together regulate the enzymatic activity of mammalian acetyl-CoA 
carboxylase. 76 
The identification of the E. coli acc genes has greatly facilitated the study of 
the ACC proteins from different organisms. Until their discovery, a long-standing 
controversy had remained in the field of plant lipid biosynthesis and contradictory 
studies reported the presence of multi-functional as well as multi-subunit ACC 
proteins. 101 ; 102 It has now been established that the multi-subunit ACCs of plants are 
expressed in the plastid and are used in de novo fatty acid biosynthesis while multi-
functional ACC are expressed in the plant cytosol.' °3 The multi-functional enzyme is 
required for the biosynthesis of several secondary metabolites including flavonoids 
and anthocyanins as well as the formation of long acyl chains which are essential 
components of plant waxes. CT-P is mostly encoded by the plastid genome while the 
rest of the subunits are encoded by the nuclear genome and imported into the plastid. 
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However, the locations of the genes can vary within lineages reflecting the 
complexity of lipid biosynthesis in plants.' ° 
1.2.3 The Biotin-Dependant Carboxylation Catalysed by ACC 
In the functional ACC complex, biotin acts as a carboxyl carrier in a two-step 
carboxylation reaction of acetyl-CoA (Fig. 1.4)33; 38; 105 The biotin prosthetic group 
is covalently linked via an amide linkage between its carboxyl group and a specific 
lysine residue on the biotin carboxyl carrier protein BCCP. Biotin carboxylase 
catalyses the first step of the ACC reaction which is the carboxylation of biotinylated 
BCCP (holo-BCCP) at the N 1 atom of the biotin co-factor in the presence of 
bicarbonate and ATP. By means of the flexible arm, the biotin and subsequent 
carboxybiotin groups are presumably able to move between the different active sites 
of biotin carboxylase and carboxyltransferase. 39 
ATP +HCO3 	ADP +P 1 
Biotin Carboxylase [BC (accC)] 
HN 	NH 	 HN 
Biotin Carboxyl Carrier Protein [BCCP (accB)] 
Carboxyl transferase (CTa (accA) and CTD (accD)] 
Malonyl-00A 	 Acetyl-CoA 
COOH 
Figure 1.4 - The two-step reaction mechanism of ACC. The biotin prosthetic group 
is covalently bound to BCCP and acts as a carrier of CO2 by shuttling the carboxylate 
moiety between the BC and CT subunits. 
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The last step of the ACC reaction is catalysed by carboxyltransferase and 
involves the transfer of the carboxyl group from carboxybiotin to the substrate 
acetyl-CoA to form malonyl-CoA (Fig. 1.4). Therefore, ACC catalyses the formation 
of a new carbon-carbon bond and the energy required for this new linkage is derived 
from the hydrolysis of ATP .33  This two-step carboxylation reaction mechanism and 
the structural organization of the ACC multi-enzyme into distinct BCCP, BC and CT 
components is shared among the other members of the biotin-dependent enzyme 
family, including pyruvate carboxylase, propionyl-CoA carboxylase, methyicrotonyl-
CoA carboxylase, transcarboxylase and glutaconyl-CoA decarboxylase. 45 
1.2.4 The Biotin Carboxyl Carrier Protein BCCP 
1.2.4.1 Intact and Truncated Forms of BCCP 
The BCCP domain of acetyl-CoA carboxylase was first characterized by 
Albert and Vagelos who, by treatment of cell-free extract of E. coli ACC with avidin, 
demonstrated that a biotinylated protein, subsequently called biotin carboxyl carrier 
protein (BCCP), was involved in the ACC catalysed-reaction. 38  However, protein 
chemistry quickly showed that the initial BCCP preparations were heterogeneous due 
to cleavage by an unknown protease. Amino-acid sequence analyses indicated that 
the preparations consisted of a short C-terminal protease-resistant biotinyl domain as 
well as N-terminal segments of various lengths. Further purification to homogeneity 
of the full-length 156 amino acids BCCP showed that the protein aggregated and 
formed large oligomers. 106108 Subtilisin cleavage was proven to convert the 
recalcitrant BCCP in a more stable form and consequently most studies have been 
carried out using an 87 amino acid C-terminal fragment containing the biotinylated 
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lysine (BCCP87). 1081° In vivo activities with [3H]biotin performed on C-terminal 
fragments of BCCP expressed as fusion proteins with -galactosidase showed that 
only 80 amino acids are necessary for biotinylation and sequence analysis of the 
truncated BCCPs indicated that the prosthetic group is covalently linked to the 
lys 122 of a highly conserved MKM motif.97 " A high degree of sequence homology 
is also observed among other biotinyl domains and studies carried out by Cronan et 
al. on the biotin carrier subunit 13S of the transcarboxylase from Propionibacterium 
she rmanii indicated that only a 75 amino acid sequence is required for 
biotinylation. 35 
Those results suggest that the N-terminal domain is somehow independent of 
the rest of the BCCP protein. The N-terminus of BCCP, rich in alanine and proline 
residues, is thought to act as flexible linker and to interact with the other subunits of 
ACC. 97 The structure of this upstream linker segment could not be determined due to 
the high degree of mobility and only the structure of the C-terminal 72 amino acids 
of the BCCP-like P. shermanii 13S transcarboxylase subunit has been solved by 
NMR spectroscopy. 1 12;113  Although the biotinyl domain BCCP87 is not 
physiologically relevant, the short form of BCCP provides a valuable tool for 
structural analysis and studies on the mechanism of biotinylation of BCCP. Apo-
BCCP87 is readily modified by sullhydryl reagents and is thought to be a disulfide-
linked dimer in solution. In contrast, the biotinylated form of BCCP87 (holo-
BCCP87) remains monomeric, indicating conformational changes within the biotinyl 
domain which alter the reactivity of the sole Cysi 16 upon biotin attachment.' 14 
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1.2.4.2 Structure of Truncated Apo- and HoIo-BCCP 
The first structure of the biotinyl domain was determined by X-ray 
crystallography at a resolution of 1.8 A by Athappilly et al. for the C-terminal 80 
amino acids of biotinylated E. coli BCCP (BCCP80). 115 Despite low sequence 
conservation, the biotinyl domain of BCCP shows striking structural similarities with 
the lipoyl binding domains of pyruvate dehydrogenase." 6 The crystal structure of 
holo-BCCP80 consists of two sets of antiparallel 13-sheets with a 2-fold axis of quasi-
symmetry that form a flattened 13-barrel with the N- and C-termini close together on 
one side (Fig. 1.5, b).us  The biotin cofactor is located at the other end of the 
molecule and is covalently attached to the side chain of Lys 122 exposed on a tight 13-
turn which connects the two [3-sheets. Biotinylated BCCP80 is stabilized by a core of 
hydrophobic residues in which the reactive Cys 116 is buried. The ureido ring of the 
biotin moiety interacts with a non-symmetric "thumb-like" protrusion segment 
comprising residues 94-101. 
Further heteronuclear multidimensional NMR studies of the two forms, apo- 
and holo-, of BCCP87 have confirmed the symmetrical nature of BCCP80 (Fig. 1.5, 
118 The core of apo-BCCP87 is shown to have a less favourable side-chain 
packing than holo-BCCP87 and this change in dynamics explains the reactivity of 
Cys 116 in the apo-form towards thiol reagents as well as the susceptibility of apo- 
BCCP87 to limited proteolysis.1 14; 119 In the initial crystal structure, Tbr94 was 
reported to form hydrogen bonds with the carbonyl and N 1 protons of the biotin 
uriedo ring. Free biotin acts as a poorer substrate than covalently attached biotin in 
the BC-catalysed carboxylation reaction suggesting that the biotin N1 atom of holo- 
BCCP87 is freely accessible. 120  NMR studies have also shown that the rates of 
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deuterium exchange of the uriedo N I , and N 3 amide protons of BCCP87 are similar 




Eh urn b 
Figure 1.5 - The structures of E. coli (a) apo-BCCP87 and (b) holo-BCCP80. The 
NMR structure of E. co/i apo-BCCP87 and X-ray structure of holo-BCCP80 reveal 
that the biotinyl-domain consists of a 13-barrel with the biotin moiety, drawn in sticks 
with blue carbons, exposed on a tight 13-turn and interacting with the characteristic 
thumb region. (PBD codes IA6X and IBDO). 
Although the NMR data argue against strong hydrogen bonds linking the 
biotin moiety with Thr94, other NMR results indicate that the biotin rings do interact 
weakly with residues located on the thumb.1 18; 119 The amide protons of residues 
Thr94 and Ser96 show slower solvent exchange rates in the biotinylated form and the 
proton chemical shifts of the thumb residues differ in apo- and holo-BCCP87. The 
thumb of holo-BCCP87 is less mobile than the thumb of the apo-form due mainly to 
biotin—thumb interactions. Analyses of mutants lacking the thumb region indicated 
an increased sensitivity to proteolysis even in the presence of bound biotin. 12  The 
structure of holo-BCCP87 is a dynamic picture in which the biotin rings are not 
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completely immobilized and therefore, although the interactions have not been fully 
characterized as they cannot be restricted to a specific geometry, virtually, all of the 
residues from the thumb appear to interact with the relatively flexible biotin 
moiety. 118 ; 119 
Despite high sequence similarities between the biotinyl domains of biotin-
dependent carboxylases and decarboxylases, the thumb insertion is only found 
among ACC enzymes of bacteria and plant plastids that synthesize fatty acids. 33 The 
thumb was proven to be essential for the ACC reaction as expression of two different 
"thumbless" BCCP mutants failed to complement growth of a temperature-sensitive 
E. coil accB strain. 122  However, thumbless BCCP mutants expressed in E. coil were 
also shown to be efficiently biotinylated and there is no evidence that the protruding 
region is involved in biotinylation. 6° Therefore, without having an essential role in 
either protein biotinylation or protein stability, the thumb was suggested to act as a 
mobile lid for either the biotin carboxylase or carboxyltransferase active sites.121 122 
Single-site mutations within the thumb region of E. coii BCCP have been shown to 
have strong effects on the functions of BCCP and ACC indicating that the rather 
mobile protruding segment must have a defined structure to be effective. 122 
1.2.5 Biotin Carboxylase (BC) 
1.2.5.1 BC Mechanism 
The first half of the ACC reaction is catalysed by biotin carboxylase (BC) and 
constitutes the most interesting and still incompletely understood mechanistic aspect 
of the overall ACC reaction. Biotin carboxylase catalyses the carboxylation of the 
biotin prosthetic group covalently attached to BCCP at the N, position in a two-step 
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reaction. 33 91; 105 During the initial step, BC catalyses the dehydratation of the poor 
electrophilic HCO3 by using ATP. Nucleophilic attack of HCO3 on the y-phosphate 
of ATP results in the formation of carboxyphosphate and release of ADP (Fig. 
1.6). 123;  124 Bicarbonate is the source of CO2 for all biotin-dependant carboxylase and 
BC dehydrates the poor electrophilic HCO 3 by using ATP.33 The intermediate 
carboxyphosphate has not been trapped but tracer experiments showed that when 
labelled [ 180]bicarbonate was used as substrate in the propionyl-CoA carboxylase 
catalysed reaction, two 180  atoms ended up in the new carboxyl group of 
methylmalonyl-CoA while the third was found in the released inorganic phosphate 
moiety. '23 125  Moreover, BC is able to catalyse, in a reverse reaction, the transfer of a 
phospho group to ADP from carbamoyl phosphate, an analogue of carboxyphosphate 
(Fig. 1.6). 124  A slow bicarbonate-dependant ATPase activity has also been observed 
in ACC in absence of biotin and dramatically increased in the presence of biotin or 
holo-BCCP.120 126  Therefore, hydrolysis of ATP has been suggested to be synergistic 
with biotin binding. 127 ;  128 It appears that the role of biotin is to mediate the cleavage 
of the co-substrate ATP in an exergonic reaction. 33 
BC 
Ho _< Mg-ATP 	 HO 	 + Mg-ADP 
o 	 o—P03• 
Bicarbonate Carboxyphosphate 
BC 
H2 N 	 + Mg-ADP + 	 Mg-ATP + CO2 + N}1 
o-P03- 
Carbamoyl phosphate 
Figure 1.6 - Reactions catalysed by BC. Formation of carboxyphosphate from 
hydrogen carbonate and ATP and transfer of inorganic phosphate from carbamoyl 
phosphate to MgADP catalysed by BC. 
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The second BC-catalysed reaction involves the carboxylation of the biotin co- 
factor from carboxyphosphate. 33 Several mechanistic pathways have been proposed 
which seek in different ways to overcome the fact that biotin is a poor nucleophile 
and bicarbonate a poor electrophile. Each of these pathways accommodates the 
important fmding that one of the three bicarbonate oxygen atoms ends up in the 
inorganic phosphate product. 123  One possible mechanistic pathway involves the 
transfer of the y-phosphate group of ATP onto the ureido oxygen of biotin, leading to 
the formation of an enol phosphate. Cleavage of the phosphoanhydride bond by 
attack of HCO3 to form carboxyphosphate would simultaneously create a 
nucleophilic centre at the N, atom of biotin. 129 ; 130 However, this mechanism remain 
in contradiction with the ATPase activity observed in the absence of biotin. 126 
Another alternative remains the elimination of Pi from the intermediate 
carboxyphosphate and the release of the more electrophilic carbon dioxide. 12' The 
eliminated basic anion P043 could remove the proton from the N, atom of biotin, 
generating a biotin ureido anion which reacts with CO 2 .' 3 ' However, no bicarbonate- 
dependent ATP/ADP isotopic exchange in the absence of biotin could be observed. 33 
Analyses carried out with carbamoylphosphate synthetase have shown that the 
rate of ADP production is equal to the rate of proton release which is consistent with 
the notion that there is direct attack on carbamoyl phosphate.' 32  Other enzymes of the 
ATP-grasp superfamily such as D-Ala:D-Ala ligase and glutathione synthetase which 
catalyse similar bicarbonate-dependent ATPase reactions also indicate a model in 
which there is direct attack on the carbon of the acyl-phosphate intermediate. 90 BC 
could presumably first catalyses the dehydrogenation of the N,' hydrogen of biotin to 
form an ureido anion and the simplest mechanism remains the nucleophilic attack of 
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the N 1 atom of biotin onto the carboxyl group of the carboxyphosphate.' 33 This 
mechanism is supported by steady-state kinetics of BC carried out by Tipton and 
Cleland which showed that acid-base reactions are involved in the tautomerization of 
biotin which enhances the nucleophilicity of N 1 toward the poor electrophilic 
bicarbonate.' 24 
1.2.5.2 BC Structure 
The crystal structures of the E. coli BC subunit and its mutant Glu288Lys in 
complex with ATP have been determined by X-ray crystallography.' 14; 135 BC shows 
high structural homology to carbamoylphosphate synthetase, D-Ala:D-Ala ligase and 
glutathione synthetase and both the structural and mechanistic similarities of these 
enzymes indicate that they belong to the ATP-grasp fold superfamily. 136 The 
structure of the free BC subunit is cylindrical and consists of three distinct domains. 
The N-terminal (A-domain) forms a dinucleotide binding motif consisting of a 
parallel n-sheet flanked on either side by ct-helices (Fig 1.7). The B-domain, formed 
by two a-helices and three n-strands, extends from the main body of BC and the two 
domains are connected with an AB-linker region. The C-terminal forms the C-
domain and contains an eight-stranded and a smaller four-stranded antiparallel 13-
sheet and seven cc-helices. Together with the AB linker, the A and C domains form 
the cylindrical core of the enzyme.' 34 
The bacterial BC subunit is a dimer in solution and is also in the crystal 
structure. 11 ; 134 In the structure, the monomers are associated through their C-domains 
and the active sites are located away from the dimer interface, at the top of the 
cylinder between the B and C domains (Fig 1.7). In the mutant BC complexed with 
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ATP, the adenine ring and the phosphates are stabilised via hydrogen bonds with the 
two domains as well as to the AB-linker. 135  The B-domain acts as a lid to the active 
site and is shown to undergo large conformational changes upon ATP binding. In the 
structure of unbound BC, the B-domain is more disordered and positioned away from 
the core in an open conformation. In the structure of the complex, the domain rotates 
by approximately 45° in order to cover the active site.' 34  Modelling studies of BC 
have revealed the relative orientation of the two ligands within the active site and 
show that the y-phosphate of ATP lies adjacent to the N,• atom of biotin.' 35 
C-Domain 
(b 
Figure 1.7 - Crystal structures of (a) E. coli BC and (b) mutant BC E288K 
complexed with ATP. (a): Apo-biotin carboxyalse (PBD code 1DV1). BC is 
dimeric and each monomer contains 3 domains. One monomer is shaded grey, while 
the second monomer is coloured to highlight the 3 distinct domains. The N-terminal 
(A-domain) is shaded green, the B-domain is shaded dark blue, the AB-linker is 
shaded cyan, and the C-terminal (C-domain) is shaded pink. (b): BC mutant (E288K) 
in complex with ATP (PBD code 1DV2). ATP is drawn in spheres with white 
carbons. The B-domain has rotated by approximately 45 ° to cover the ATP-bound 
active site. 
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More recently the monomeric structure of the eukaryotic yeast BC domain 
was solved, both in the unbound state and in complex with the potent natural product 
inhibitor soraphen A (See figure 1.3, D).' 37 The overall structures of yeast and E. 
coli BC are similar although, interestingly, the B-domain of yeast biotin carboxylase 
adopts a closed conformation even in absence of ATP in the active site. 137  While the 
active site of BC is located at the top of the cylinder formed by the A and C domains, 
Soraphen A is bound in an allosteric site at the bottom of the cylinder. Structural 
comparison with the bacterial BC dimer suggests that soraphen A may be located in 
the interface of the putative dimer of yeast BC. 138 
1.2.6 Carboxyltransferase (CT) 
1.2.6.1 CT Mechanism 
In contrast to biotin carboxylase BC, little is known about the catalytic 
mechanism of carboxyltransferase (CT). It could be presumed that, once formed, the 
carboxybiotin head group could swing to the carboxyltransferase active site where 
transfer of the carboxyl group to form malonyl-CoA takes place.90 91; 105 The 
recombinant forms of the CT(x/P enzymes have been subjected to rigorous steady-
state kinetic analysis and the activity of CT was assayed in the non-physiological 
direction, in which malonyl-CoA reacts with biotin to form acetyl-CoA and 
carboxybiotin. 139  Initial velocity patterns as well as inhibition studies have revealed 
an ordered kinetic mechanism of carboxyltransferase with malonyl-CoA binding 
before biocytin (c-biotinyl lysine). 140  As is the case for pyruvate carboxylase, 
carboxylation of the thioester substrates in ACC by the carboxyltransferase subunit 
requires abstraction of a proton from the methyl group to form an enolate anion 
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intermediate inducing the subsequent nucleophilic attack on the carbonyl carbon of 
carboxybiotin (Fig 1.8).141 
0 	 0 
HO 	 _ 




0 	 o_ 





Figure 1.8 - Carboxylation of acetyl-CoA catalysed by CT. Nucleophilic attack of 
the enolate anion of acetyl-CoA on the carbonyl of carboxybiotin results in the 
formation of malonyl-CoA. 
The chemical mechanism of carboxyltransferase was originally probed by 
determining the pH rate profile of the reverse reaction. 139  Acid-base catalysis is 
required in this process because the proton on the N 1 atom of biotin must be 
removed in order to allow the carboxyl transfer from malonyl-CoA. The study 
demonstrated that a single ionising group on the enzyme, with a pKa of 7.5, must be 
unprotonated for catalysis to occur. It was postulated that this group was a cysteine 
residue which acts as the base to remove the proton from the Ni , of biotin since CT 
was found to be susceptible to inactivation by the sulfhydryl-modifying reagent N-
ethy1maleimide. 139 
Recent structural evidence and mutational analysis of the active site have 
revealed that no residue acts as a base in the catalytic mechanism of CT.87 142 
Therefore, it has been suggested that like in propionyl-CoA carboxylase (PCC), the 
N1 ' atom of biotin itself functions as the general base. 11 ; 87 This is in direct contrast 
with the crotonase superfamily of enzymes which are characterized by reactions of 
CoA thioesters in which the enolate intermediate is stabilized by polar interactions 
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with basic side chain residues and the oxyanion and where an acidic side chain in the 
enzyme is required for catalysis. 143 ; 144 Carboxyl transfer from carboxybiotin to 
acetyl-CoA can occur via either a stepwise mechanism in which proton abstraction 
from the methyl group of acetyl-CoA occurs before carboxyl transfer or via a 
concerted mechanism in which proton removal is concurrent with carboxyl transfer. 
Studies to distinguish between these two possibilities have not been carried out in 
ACC, although a stepwise mechanism of carboxyl transfer has been proposed for the 
CT subunit of pyruvate carboxylase.' 45 
1.2.6.2 CT Structure 
The crystal structures of the bacterial CT subunits from E. coli and 
Staphylococcus aureus were determined last year at 3.2 and 2.0 A resolution 
respectively. 142  The overall structures of the two bacterial CT subunits are very 
similar and have the a2P2  heterotetrameric assembly proposed on the basis of gel 
filtration and sedimentation equilibrium analysis experiments with the E. coli 
enzyme. 92  The tetramer has a rectangular shape and the dimer of dimers is related by 
a 2-fold axis running through a central cavity which gradually narrows from an 
opening of 13 A diameter to a solvent-inaccessible surface within a 23 A depth (Fig 
1. 9, a). 142 The wedge-shaped monomers CTct and CTP are structurally very 
homologous and the active site is located at the c4 interface suggesting duplication 
and divergence of a single ancestral carboxyltransferase subunit gene. CTct and CT3 
both possess a spiral core composed of a long and twisted 7-stranded mixed n-sheet 
flanked by helical regions and orthogonal to a short 2-stranded parallel n-platform as 
well as a 3-helix bundle located at the edge of the rectangular tetramer. 142 A 
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surprising and novel feature of the bacterial CT subunits is the presence of a Zn 2 
binding domain composed of a tetrahedral cluster of cysteine residues that terminate 
the CT13 dimers.' 42 








Figure 1.9 - Crystal structures of (a) the S. aureus CT subunit and (b) the yeast 
CT domain in complex with HSCoA of ACC. (a): The SaCT U2P2  heterotetramer 
has a rectangular shape. The a and 13 monomers are coloured in magenta and cyan 
respectively. (b): each monomer of the yeast CT dimer is divided into two distinct 
subdomains. One CT monomer is shaded in green, while the other monomer is 
shaded magenta and cyan to highlight the N-terminal (CT13 -cyan) and C-terminal 
(CTa - magenta) subdomains. The binding pocket is highlighted by the presence of 
HSCoA drawn in spheres with white carbons (PBD codes 2F91 and 10132). 
This dimeric structural arrangement as well as the 13-13-a superhelix fold is 
also observed in the structures of the CT domain of yeast ACC solved by Tong et al. 
(Fig. 1.9, b).87 146; 147 Yeast CT is a dimer and each monomer contains two 
subdomains, the N- and C- domains, which are equivalent to the CT13 and CTa 
subunits of bacterial carboxyltransferases respectively. The two monomers are 
arranged in a head-to-tail fashion in the dimer, such that the N-domain of one 
monomer is in contact with the C-domain of the other monomer. 87  The 13-13-
a superhelix fold of bacterial and yeast carboxyl transferases is characteristic of the 
crotonase/CIpP superfamily and is found in the structures of the CT subunit of 
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glutaconyl-CoA decarboxylase and the 3 subunit of propionyl-CoA carboxylase 
(PCC).1"; 148; 149 
Comparison of the complexes of the CT domains from yeast ACC with 
HSCoA and the CTJ3 subunit from Streptomyces coelicolor PCC with propionyl-CoA 
and biotin have allowed the modelling of the active site of the CT subunit of bacterial 
ACCs!42 149  The acyl-CoA and the biotin binding pocket are both located at the 
interface between the CTa of one monomer and the CTP of its dimeric partner. In 
the structure of yeast CT in complex with HSCoA, most of the ligand is associated 
with the N-domain while the thiol group of CoA is located at the dimer interface 
suggesting that the biotin carboxyl approaches the active site from the C-domain of 
the other monomer. 87  This is supported by the fact that biotin binds predominantly to 
the alternate domain from the dimeric partner of the acyl-CoA domain in PCC and 
both ligands interact at the dimer interface. 149 
The structure of the CT domain of yeast ACC has also been determined in 
complex with two FOP herbicides (haloxyfop and diclofop) and the inhibitor CP-
640186 (See figure 1.3, A & p146; 147 The FOP compounds are bound at the dimer 
interface in a pocket near the active site region and kinetic studies indicated that 
haloxyfop is a competitive inhibitor of malonyl-CoA for yeast CT .17 ; 150 The inhibitor 
of mammalian ACC CP-640 186 is a moderate inhibitor of the yeast CT domain and 
more potent against the CT domain of human ACC 1. 76 However, the CT domains of 
yeast ACC and human ACC  are both dimers in solution and thus, the yeast structure 
has been suggested as a good model to study the human enzyme. CP-640186 is 
thought to bind in the putative biotin-binding site and is a non-competitive inhibitor 
with acyl-CoA substrates for yeast CT. 147; 151 Interestingly, there is little structural 
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overlap between the bound HSCoA, haloxyfop and CP-640186, suggesting the 
presence of several distinct regions for inhibitor binding in the active site of the CT 
domain. 
1.2.7 Towards a Working Model of ACC 
E. coli multi-subunit ACC has been shown to be a markedly unstable enzyme 
which readily dissociates into complexes and sub-complexes.63 91 Therefore, despite 
extensive studies on the individual subunits of ACC, their exact stoichiometry and 
respective arrangement within the ACC complex remain unclear. In multi-subunits 
and multi-functional enzymes, the metabolites must be efficiently transferred 
between the active sites through tunnels and channels or through the use of prosthetic 
groups in order to avoid the energetic penalty associated with their loss to diffusion, 
degradation, or competing side-reactions.' 52 The biotin prosthetic group is attached 
to a carrier domain and in E. coli ACC, the lack of interaction of isolated biotinyl 
domains BCCPs in vitro suggests a model similar to that of another swinging domain 
enzyme, pyruvate dehydrogenase.39 153 The biotinyl and lipoyl binding domains of 
these enzymes are structurally highly homologous and mutational analyses have 
shown that modified BCCP were able to switch substrate specificity and be 
efficiently lipoylated.6 154  In lipoyl domains, the sequence rich in proline and 
alanine of the N-terminal linker region results in a flexible structure and allows the 
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Deletion of 30 linker residues located adjacent to the biotinyl domain resulted 
in inactive BCCP species in vivo although it was efficiently biotinylated.' 55 
Expression of this BCCP species failed to restore normal growth and fatty acid 
synthesis to an E. co/i accB mutant strain which encodes a temperature-sensitive 
BCCP (BCCPG133S) that rapidly degrades at 37 °C. Replacement of the deleted 
BCCP linker with a linker derived from E. coli pyruvate dehydrogenase gave a 
chimeric BCCP species shown to restore activity in vivo and this may suggests that 
these two carrier proteins share a common evolutionary origin.' 55 Expression of 
BCCPs having deletions of various segments of the linker region showed that the 
inactive BCCPs all lacked an APAAAAA sequence located adjacent to the tightly 
folded biotinyl domain, whereas deletions that removed only upstream linker 
sequences had little or no effect on the activity of the proteins.' 16 155 
The full-length BCCP has been shown to be a recalcitrant protein due to its 
strong tendency to aggregate, however, the exact stoichiometry of the C-terminal 
biotinyl domain (BCCP87) missing the linker region also remains unclear.108 109 
Sedimentation equilibrium experiments have indicated that BCCP87 is monomeric 
even at the high concentrations used in the NIVIR analyses108 117; 118 Apo-BCCP87 
was also shown to form disulfide linked dimers, although, based on the NMR data, 
the proposed BCCP pairing interactions appear relatively weak.' 4 Furthermore, 
expression of a mutant BCCP lacking the biotinylated lysine residue was able to 
partially restore growth and fatty-acid synthesis to the temperature-sensitive E. co/i 
accB strain. ' 22 It was proposed that the properly folded, albeit inactive, mutant 
stabilized the biotinylated temperature-sensitive unfolded BCCP G1335 implying 
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that dimerization of BCCP is required for the ACC reaction and that the biotinyl 
domains are located close to one another. 122 
The accB and accC genes encoding BCCP and BC respectively lie in the 
same operon in the genomes of very diverse bacteria and have a different pattern of 
regulation than that of the unlinked accA and accD genes. 98  Co-expression of the E. 
coli BCCP and BC proteins from the accBC operon has been previously reported but 
the stoichiometry of the complex was not determined.' 07; 108 Recent studies of the E. 
coli BC:BCCP complex by Cronan et al. have revealed that the ratio of BC per 
BCCP molecule is 1:2.156  Although the active sites of the E. coli BC dimer are 
located on the monomer faces opposite those used in the dimer interface and are 
therefore relatively far apart (62 A), dimerization of BC was initially thought to be 
required for activity.' 34 ; 135; 157 Hybrid BC dimers in which one monomer was native 
and the other carried an inactivating mutation were found to be catalytically 
inactive. 158  Despite recent evidence that monomeric E. coli BC mutants retain 
significant catalytic activity, it is still believed that there is communication between 
the active sites of the BC dimer.' 59 A model has been proposed in which the two 
subunits of BC are mechanistically linked in a fixed cycle and can not catalyse 
carboxylation simultaneously.' 58  The two subunits alternate catalytic reactions, with 
one site performing catalysis while the second is releasing product and this requires 
the two BCCP molecules to be well separated from each other, as each would 
interact with a different BC active site. The flat and hydrophobic bottom formed by 
the N- and C- termini has been suggested as a possible interface for the BCCP dimer 
which would position the two biotin moieties about 60 A apart, a spacing similar to 
that of the BC active sites. 122 
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The complex BC2 :BCCP4 should be aligned in order to interact with the 
active sites of the CT component and multi-subunit ACCs may have parallel arrays 
of active sites. CT is a dimer in solution and in the crystal structure, and it appears 
likely to remain dimeric in the multi-subunit ACCs.87 90; 160 Interestingly, the 
distance between the two active sites of the CT dimer is about the same as that of the 
BC dimer suggesting direct interactions with the BC subunits which would allow the 
positioning of the different active sites in close proximity. 90 The fact that the 
complex has two BCCPs per BC molecule (BC 2 :BCCP4) removes the conflict 
between the two BCCP dimer models discussed above. Each pair of the BC and CT 
active sites may be in contact with two BCCP subunits in the ACC complex. '22 156; 
158 
1.3 Biotin Protein Ligase 
1.3.1 The Biotinylation Reaction Catalysed by BPL 
Biotin protein ligase (BPL, EC: 6.3.4.15) catalyses the covalent attachment of 
biotin to the specific target lysine residues of the different biotin-dependant 
enzymes. 161 BPL is also known as holocarboxylase synthetase (HCS, EC 
6.3.4.10), which is somehow misleading since some biotin enzymes are 
decarboxylases and transcarboxylases. The enzymatic biotinylation reaction 
catalysed by BPL is Mg 2+  and ATP-dependant and occurs in two steps (Fig 1.10).162 
163 In the first step, biotin reacts with ATP in presence of Mg 2 generating the 
reactive intermediate biotinyl-5'-AMP with release of Pi. In the second step, the c- 
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amino group of the target lysine of BCCP reacts with the activated carboxyl group of 
biotin to form the amide linkage of holo-BCCP and the AMP moiety is eliminated. 
The reaction catalysed by BPL is mechanistically homologous to that 
catalysed by lipoyl protein ligase and aminoacyl-tRNA synthetases. The three 
different types of enzymes activate their specific substrate through an adenylate 
intermediate in presence of ATP before post-translational attachment to their 
respective acceptor. 164 ' 67 Most organisms contain fewer than five different biotin-
dependant enzymes and in E. co/i and most bacteria, only the BCCP subunit of 
acetyl-CoA carboxylase is biotinylated.' 68 Thus, the biotinylation reaction catalysed 
by BPL is a remarkably specific post-translational modification as only one of the 












Figure 1.10 - Biotinylation reaction catalysed by Biotin Protein Ligase. The 
reaction occurs in two-steps with intermediary of biotinyl-5'-AMP. 
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The functional interactions between BPLs and biotin-dependant enzymes are 
highly conserved throughout Nature. Biotin-accepting enzymes can be recognised 
and biotinylated by BPLs derived from widely divergent species and the biotin 
protein ligase from E. co/i, BirA, has been shown to biotinylate in vivo biotin carriers 
from other bacteria, yeast and mammals. 35 ;  169; 170 Genetic analyses in 
microorganisms and humans have revealed that almost all organism contains a single 
BPL-encoding gene responsible for processing each biotin-dependant enzyme. 161 
Mutational analysis within the birA gene of E. co/i showed that BPL is required for 
cell growth and mutations within the human HCS gene are known to lead to multiple 
carboxylase deficiency disease.49 171; 172 Only Buchnera species, Borrelia 
burgdorferi, Aeropyrum pernix, thermoplasmas, and mycoplasmas have neither the 
BPL nor the biotin biosynthetic genes, which is consistent with the absence of genes 
for biotin-dependent carboxylases in the genomes of these microorganisms. 173 
BPLs have been classified into four sub-classes according to their size, 
domain structure and ability to control biotin metabolism (Fig. 1.11).17'  All the 
BPL/HCS enzymes share a highly conserved central catalytic domain but differ in 
sequence at their amino termini. Class I and II BPLs are derived from bacteria and 
both possess a small C-terminal domain of unknown function. 174  BPL enzymes from 
class II, including E. co/i BirA and Bacillus subtilis BPL, display an additional N-
terminal DNA binding domain. 171 ;  176 Class II BPLs are bifunctional proteins that act 
as ligases and as transcriptional repressors of biotin biosynthesis. 177  The class I BPL 
genes from microorganisms such as Aqufex  aeolicus and Pyrococcus horikoshii lack 
the DNA-binding domain indicating that class I BPLs are monofunctional enzymes 
that act solely as biotin ligases.'78 179 
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Eukaryotic BPLs are larger than the prokaryotic enzymes and fall into classes 
III and IV.  174 They often have long N-terminal domains which have little or no 
sequence similarity with bacterial enzymes. None of the eukaryotic proteins contain 
sequences that would suggest any DNA-binding activity. The role of the N-termini in 
class III and class IV BPLs remains unclear but an N-terminally truncated BPL from 
yeast Saccharo,nyces cerevisiae showed a dramatic reduction in enzyme activity. 
The N-terminal domain of the yeast enzyme has been speculated to play a role in 
enzymatic activity and acceptor-substrate recognition. 1 70 
Class Example 
NH2- 	 '-COOH 	I 	A. aeolicus 
DNA Binding 	 231 a 
N1­12- 	 ii~ -.-COOH 	II 	E. coil 
Organelle Targeting 	 321 aa  
N1­12-11 	 --COOH 	Ill 	A. thaliana 
367 aa 
NH2- 	 Ca ta lvti c 	 'COOH 	IV 	H. saoiens 
726 aa 
Figure 1.11 - Biotin Protein Ligase classification. BPL enzymes can be divided 
into four separate classes based on there tertiary structure. Bacterial BPLs are 
members of classes I and II, whereas classes III and IV are eukaryotic BPLs. 
1.3.2 E. co/i Biotin Protein Ligase: BirA 
1.3.2.1 The Bifunctional Nature of BirA 
E. co/i BPL, BirA, is a 35.3 kDa enzyme that functions both as a biotin ligase 
and as a repressor of biotin biosynthesis. 116 ; 180; 181 The biotin regulatory system in E. 
co/i, first discovered in the 1970s, constitutes a paradigm of biotin-sensing 
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processes.' 77  The repressor function of BirA is triggered by the formation of biotinyl-
5' -AMP which acts as an essential intermediate in the biotin transfer reaction but 
also serves as a positive allosteric effector for site-specific DNA binding. 182; 183 The  
intermediate biotinyl-5'-AMP promotes DNA binding by enhancing dimerization of 
BirA.' 77 Thermodynamic and kinetic analysis of DNA binding to BirA have shown 
that only the BirA:biotinyl-5'-AMP dimer binds to the 40 base pair biotin operator 
sequence bioO located in between bioA and bloB. 184-186  In this system, the DNA-
binding domains of the two BirA:biotinyl-5'-AMP monomers (holo-BirA) interact 
with the 12 base pair sequences at each terminus of the bidirectional bioO 
operator.1 84; 187; 188 Structural and mutational studies of BirA have shown that 
residues important for catalytic activity are located at the dimer interface.' 87-189 
Biotinyl-5'-AMP binding has been suggested to promote binding to the bioO 
sequence by increasing the stability of the homodimer interface. 186 
Thermodynamic analysis of this model has indicated that the total 
enhancement in the free energy for assembly of the protein-DNA complex closely 
matches the enhancement of dimerization affected by binding of biotinyl-5'-AMP. 186 
These results are consistent with the homodimer interface serving as a major 
mediator for transduction of the allosteric signal. The functional switch in which 
BirA is depleted of its function as a ligase reflects competing homodimer and 
heterodimer interactions. 190 BirA can be selectively targeted towards its enzymatic 
function simply by increasing the kinetic probability of heterodimerisation with apo-
BCCP.' 91 Initial kinetic measurements showed that at sufficiently high 
concentrations, apo-BCCP87 preferentially sequesters the BirA:biotinyl-5 '-AMP 
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monomer in a heterodimeric complex, thereby reducing the availability of holo-BirA 
for homodimerization and bioO binding. 191 
However, these protein-protein interactions remain weak, particularly those 
involved in homodimerization of holo-BirA.185 186  In this system, a preequilibrium 
between the holo-repressor monomer and dimer is assumed to exist. At relatively 
high repressor concentrations, the dimer rapidly forms a very stable complex with 
bioO characterized by a half-life of approximately 7.5 min which is not affected by 
the presence of apo-BCCP. 19 ' The kinetic stability of the final complex ensures 
effective transcription repression of the biotin operon when biotin requirements are 
poor resulting in very low concentrations of both free biotin and unligated BirA 
within the cell. 191 Intracellular biotin levels are intimately linked to gene expression 
due to the ordered sequential addition of substrates to BirA, as biotin binds prior to 
ATP during the formation of the co-repressor biotinyl-5'-AMP.'92 193  However, 
repression of bioO by BirA and biotin biosynthesis are directly controlled by the 
level of acceptor protein apo-BCCP in vivo. 
Studies of another class II BPL from the bacterium Bacillus subtillis have 
revealed a similar role for BPL in regulating biotin biosynthesis .21 ; 175 B. subtilis BPL 
also functions as a dual-purpose protein in that it acts as a repressor of the B. subtilis 
biotin operon and has ligase activity.' 75  Orthologs of birA and biotin biosynthetic 
genes from E. coli and B. subtilis have been identified in the available bacterial 
genomes by similarity search. 173  The BPL gene is widely distributed in eubacteria 
and archaea and is more widespread than the biotin biosynthetic genes among all 
complete genomes. Comparative genomics suggests that the existence of class II 
BPL within a genome strictly correlates with the presence of putative BPL-binding 
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sites upstream of the biotin operon. Interestingly, comparative genomics showed that 
the microorganisms Clostridium acetobutylicum, Lactococcus lactis, Pyrococcus 
furiosus and Pyrococcus abyssii contain the two BPL paralogues, with and without 
regulatory domains.' 73 
1.3.2.2 The Crystal Structure of BirA 
The crystal structures of E. co/i BirA in the ligand-free form (apo-BirA) was 
solved at 2.3 A resolution in 1992 by Wilson et al., followed in 2001 by the structure 
of the BirA:biotin complex (Fig. 1. 12, a).'87' 194  More recently, the X-ray structure of 
BirA was also solved bound to the biotinyl-5'-AMP analogue biotinol-5'-AMP (Fig. 
1.12, b & c)."' ;'95 The structure of apo-BirA is monomeric and shows three distinct 
domains: an N-terminal DNA-binding domain, a central catalytic domain and a small 
C-terminal domain. 194  The N-terminal domain which is used for bioO binding adopts 
a helix-turn-helix fold characteristic of major DNA-binding proteins. 
The central domain of BirA consists of five cc-helices and a mixed n-sheet of 
seven strands. In apo-BirA, four surface loops located in the central domain are 
disordered and cannot be visualized in the electron density (loops 110-128, 140-146, 
193-199 and 212-234). 194  The biotin binding site was determined by exposing the 
apo-BirA crystal to biocytin (-biotinyl lysine) which is a mimic of the final product 
from the biotin transfer reaction and the structure was refined at 2.8 A resolution.' 94 
The biotin moiety of biocytin interacts with parts of three strands from the n-sheet, 
the a5-helix and main-chain atoms of residues 114-118. 1  Residues 116-118 are 
disordered in the structure of apo-BirA and become localized upon biocytin binding, 
partially burying the ligand in the active site. The loop 116-124 contains the glycine- 
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rich motif 115GRGRRG120, identified as a consensus sequence (GXGXXG). This 
glycine-rich sequence has been previously characterized as an ATP and GTP binding 
Motif 
' 96  Because ATP and biotin must be spatially close to permit the formation of 
biotinyl-5'-adenylate, in BirA, the motif was initially associated with nucleotide 
binding.' 94 
The C-terminal domain comprises an anti-parallel 3-sheet sandwich and 
adopts a Src-homology 3 (SH3) fold. SH3 domains are protein modules of 50-70 
amino acids long found in a variety of proteins involved in signal transduction. 197199  
However, since direct interactions with the substrates have yet to be observed by 
crystallography, the exact role of the C-terminus in BirA remains unclear.' 87; 188 
Evidence of protection by biotinyl-5'-AMP against hydroxyl radical cleavage of the 
BirA backbone at several sites within the C-terminal domain implies a possible role 
in the enzymatic reaction. 200  Single-site mutation studies on both BirA and the 
acceptor apo-BCCP87 also suggest that the small SH3-like domain may be involved 
in substrate recognition and ATP binding. 201 
In contrast to biocytin which interacts only weakly with BirA, the crystal of 
apo-BirA was destroyed on soaking with free biotin, suggesting that conformational 
changes had occurred upon binding.' 94  However, co-crystallization of BirA with 
biotin has allowed the characterization of the structure of the BirA:biotin complex at 
a resolution of 2.4 A. 187 The main differences between apo-BirA and the BirA:biotin 
complex are localized in the regions of the surface loops 110-128, 140-146, and 
193-199. In the apo-BirA structure, residues within these loops ranged from partially 
to completely disordered. In contrast, in the BirA:biotin complex, all of the residues 
within the three loops are visible (Fig. 1. 12, a).' 87 
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The hydrogen-bonding interactions between BirA and biocytin described by 
Wilson et al. are also observed in the structure of the enzyme bound to biotin. 181 
However, in the structure of the BirA:biotin complex, the complete loop 
encompassing residues 110-128 is ordered and forms the biotin binding loop. Unlike 
the monomeric apo-repressor, the complex of BirA with biotin is dimeric. 187 
Although biotin is not the physiological corepressor, the free co-factor has been 
shown to act as a weak allosteric activator of BirA binding to bioO. 186 In the dimer 
structure, the 13-sheets in the central domain of each monomer are arranged side by 
side forming a single, seamless 13-sheet. At the region of contact, residues 188-195 of 
one subunit form an extended 13-sheet strand that is hydrogen-bonded to the same 
residues in the neighbouring monomer.' 87  The two loops 140-146 and 193-199 which 
are partially disordered in the structure of apo-BirA are located at the dimerization 
interface. Only the loop composed of residues 212-234 remains disordered in the co-
crystal structure.' 87 
Functional studies indicated that the dimerization and DNA-binding 
properties exhibited by BirA in complex with the analogue biotinol-5'-AMP closely 
resemble those of the functional biotinyl-5'-AMP repressor complex.' 95 The X-ray 
structure revealed that the BirA:biotinol-5'-AMP complex is dimeric and is related to 
the BirA:biotin dimer (Fig. 1. 12, 88  However, several conformational differences 
are observed between the two BirA complexes including the ordering of residues 
212-223 which form the adenylate binding loop upon biotinol-5'-AMP binding.' 95;  
202 Furthermore, the BirA:biotinol-5'-AMP complex forms a much tighter dimer than 
BirA bound to biotin, consistent with previous equilibrium sedimentation studies. In 
the structure of BirA bound to biotinol-5'-AMP, the "hinge angle" between the 
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catalytic domains has bent by 12 O  increasing significantly the buried surface area of 
the dimer. Concomitant with those changes, the C-terminal domains are shifted and 
lie closer together resulting in new interactions at the dimer interface. 195 The 
organization of the structure of BirA upon ligand binding suggests that the allostenc 
activator function reflects its ability to induce disorder-to-order transitions in 
multiple segments of BirA. These folding events are prerequisites for tight binding of 
the holo-BirA dimer to bioO.' 85 ' 8820° 
In contrast to biotin binding, there is no preformed binding site for the 
adenylate in apo-BirA.' 88 Only after biotin is bound and the biotin binding loop is 
ordered, is the full adenylate binding site formed. This is consistent with the 
sequential substrate addition in BirA with biotin binding prior to ATP. The binding 
mode for adenylate was unanticipated and although the glycine-rich motif is 
important for phosphate binding in BirA, it conserves neither the structure nor 
phosphate interactions characteristic of the canonical GXGXXG nucleotide-binding 
motif (Fig. 1. 12, b).188' 196  The 115GRGRRG 120 motif is located at the turn of the 
biotin binding loop and in the structure of BirA bound to biotin, the backbone 
nitrogen of Argi 18 interacts with the carboxyl group of biotin. 187 Additionally, the 
backbone nitrogen and carbonyl of Arg 116 interact with the carbonyl and the ureido 
nitrogen of biotin respectively. In the structure of BirA in complex with biotinol-5'-
AMP, Argi 18 and the adjacent Argl2l make the critical phosphate binding 
interactions. 188 
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Figure 1.12 - The crystal structure of E. co/i BirA. The N-terminal, the central, 
and the C-terminal domains are shaded green, violet and blue slate respectively and 
the disordered loops are highlighted in black (a): Monomeric BirA in complex with 
biotin. The four disordered loops in the apo-structure of BirA are coloured in black. 
Biotin is drawn in spheres whith white carbons. (b): Close up view of BirA active 
site with biotinol-5'-AMP bound. The residue Glyl 15, Argll8 and Argll9 on the 
biotin binding loop are labelled and drawn in sticks with black carbons. Biotin is 
drawn in sticks whith white carbons. (C): BirA dimer in complex with biotinol-5'-
AMP bound at each active site. Monomer B is shaded yellow. The adenylate binding 
loop coloued blak is ordered and highlighted. Biotinol-5'-AMP is drawn in spheres 
with white carbons. (PDB codes 1 HXD for (a) and 2E" for (b) and (c)) 
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1.3.2.3 The Glycine-Rich Motif of BirA 
Early biochemical assays had shown the importance of the glycme-rich motif 
115GRGRRG 120 in BirA catalytic activity, dimerization and repressor function. 
Hydroxyl radical cleavage of BirA with [Fe-EDTA] - was performed to determine the 
ligand-induced changes in the reactivity of the peptide backbone of BirA and the 
regions most affected upon binding of biotin were shown to be residues 115-120 and 
the biotin binding loop.200 The DNA-binding and assembly properties were analysed 
for the three mutants BirA G1 15S, R1 18G and R119W of the glycine motif and 
revealed that both RI 18G and RI 19W mutants were defective in dimerization and 
bioO binding while BirA G1 15 S  bound to the biotin operator with the same affinity 
as wild-type holo-BirA. 189 
Although structural perturbations to apo-BirA induced by the mutations 
should be minor, isothermal titration calorimetry experiments carried out to 
determine the thermodynamic profile of ligand binding to the mutants indicated that 
the structural consequence of amino acid replacement was the disruption of 
hydrogen-bonding interactions and acquisition of the local disorder which 
characterizes apo-BirA. 203 . Kinetic analysis of the three BirA mutants indicated that 
BirA GI 15S and RI 18G were defective in binding both biotin and biotinyl-5'- 
AMP . 204 The crystal structure of BirA shows that the side chain of Arg 119 is largely 
solvent-exposed and therefore, the third mutation RI 19W did not affect the affinity 
for the substrates (Fig. 1. 12, b). 188 However, the three mutant-biotin complexes were 
shown to remain competent for ATP binding and subsequent synthesis of biotinyl-5'- 
AMP.204 . 
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The dissociation constant of BirA G1 15S and R1 18G for biotinyl-5'-AMP 
are 3000 and 400-fold greater than for wild-type BirA respectively. 204 Biotinyl-5'- 
AMP is a good biotinylation reagent and the possibility of the mutants acting as a 
promiscuous biotinylating agents was tested by streptavidin western blotting. 
205 
Analysis of the extract from BirA G1 15S, R1 18G and R1 19W indicated that, in 
contrast to wild-type BirA, the two mutants were self-biotinylated in vivo. This 
observation has been suggested to arises as a result of dissociation of the biotinyl-5'-
AMP-mutants binary complexes to give free adenylate which reacts with exposed 
lysine residues. When the R1 18G protein was expressed in an E. co/i biotin 
auxotroph in the presence of [ 14C]-labeled biotin, the molar ratio of covalently 
attached biotin to the mutant was 0.4 suggesting significant protein modification 
during expression. 205  Additionally, the Ri 1 8G mutant was also shown by western 
blot to biotinylate a wide range of non-cognate cellular proteins. Surprisingly, the 
mutant G1 15S showed no labelling of proteins apart the specific target BCCP. 
Binding of biotin and biotinyl-5'-AMP to the three mutants were determined with the 
loss of the increase in intrinsic fluorescence and thus, the high dissociation constants 
measured for BirA G1 15S are mainly attributed to a shift in the position of the 
ligands within the active site. 20 ' 205 
Western blotting studies indicated that both BSA and RNAse A were readily 
biotinylated in vitro by the RI 18G mutant in a much greater extent than with wild- 
type BirA. 205  Because biotinyl-5'-AMP is a readily hydrolysable mixed anhydride, 
the ability of the mutant to modify distant proteins was studied by analysing the 
extent of biotinylation of a histidine antibody bound either to the C-terminal of BirA 
Ri 18G or to a His-tagged acceptor protein. The chemical biotinylation reaction 
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catalysed by BirA RI 18G was shown to be more efficient when the antibody was 
bound to the mutant and thus it was suggested that BirA RI 18G could be 
manipulated to generate active biotinyl-5 '-AMP and biotinylate target peptides and 
proteins in a proximity dependant process when studying protein-protein interactions 
within the cell .205 ; 206 Furthermore, the mechanistic importance of this residue is 
underscored by the observation that mutation of the corresponding arginine by a 
tryptophan in the conserved 505GKGRGG510 glycine motif of human BPL (R508W) 
is the most recurrent mutations in the HCS gene. The mutation was shown to alter 
the affinity of human BPL for biotin and gives rise to multiple carboxylase 
deficiency syndrome. 172; 207 
1.3.2.4 Structural Homologs 
The core of the catalytic domain of BirA can be described as a circular 
permutation where the N- and C-termini permit folding of the RNA recognition motif 
(the RRM or ferrodoxin-like fold) which is a mixed a13  fold containing two ct-helices 
packed against a four-stranded, antiparallel 13-sheet .208 209  The RRM fold of BirA 
contains several insertions including the biotin and adenylate binding loops and thus, 
BirA belongs to the circular permutation Cyc2. 188 BPL, lipoate-protein ligase A 
(LpIA) and aminoacyl-tRNA synthetases belong mechanistically to the adenylating-
class of enzyme. 165 ; 167 The similarities between the three families of enzyme extend 
in some cases to the structure. 
Despite low sequence identities, the closest structural homologs to BirA are 
members of the bacterial Lp1A families, another example of the Cyc2 permutation of 
the RRM-like fold.' 11 ; 210 BirA and LpIA bind similar substrates in equivalent 
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positions and catalyse essentially the same chemical reactions suggesting that they 
are evolutionarily closely related. 188 210; 211 However, the substrate binding loops of 
bacterial LpIA indicate that the two enzymes have undergone substantial 
divergence.212 In Lp1A, the insertion that corresponds to the biotin binding loop of 
BirA is a small a3 domain that interacts with the lipoate moiety and is ordered in the 
apo-enzyme of E. co/i and Thermophilus acidophilum. 210212 This loop contains 
residues that are conserved in all lipoate protein ligases and plays an important role 
for the binding of the substrate and the stabilization of the three-dimensional 
structure. The loop sequence has been suggested to play a role in substrate specificity 
by preventing biotin entering the active site of LpIA.2' 1; 212 Lp1A also has an insertion 
similar to the adenylate binding loop in BirA, but it is larger and does not undergo a 
disorder-to-order transition. The absence of a DNA binding domain in the LpIA 
structure may be related to the finding that Lp1A metabolizes lipoic acid that is 
exogenously supplied rather than synthesized endogenously in E. coli. 167; 210;213  
BirA also belongs to the same structural family as class II aminoacyl tRNA 
synthetases (aaRS) which are associated with, Ala, Asn, Asp, Gly, His, Lys, Phe, 
Pro, Ser and Thr substrate amino, acids. 199 214; 215 Active sites of class II aaRS are 
built around an antiparallel n-sheet flanked by alpha helices corresponding to a 
Rossmann fold .216  Initial comparison of the structures of BirA and seryl-tRNA 
synthetase revealed striking similarities between their catalytic domains suggesting 
the possibility of a remote evolutionary relationship. 214  Investigation of the structure 
of phenylalanyl-tRNA synthetase (PheRS) showed, that although the catalytic 
domain of the synthetase represents a Cyci circular permutation of the RRM-like 
fold, the DNA-binding domain containing the helix-turn-helix motif and the SH3- 
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fold barrel-like domain of BirA are conserved. ' 99 Despite the fact that there is no 
clear homology between the structure-derived sequence alignment of BirA and 
PheRS, all three domains of BirA appeared to have counterparts in the tRNA 
synthetase structure, supporting the concept of a common ancestor for the two 
enzymes. However, comparisons of the structure of BirAILpIA and class II tRNA 
synthetases show poor conservation of the adenylate binding sites. 188  Furthermore, 
ATP and amino-acyl binding has been proven to be random in class II tRNA 
synthetase which indicate significant mechanistic divergence within the adenylating 
enzymes family. 217  Thus, it has been suggested that the primary function of this 
group of enzymes was to scavenge co-factors or amino-acyls raising the question 
wether the adenylating property appeared before or after selection of their respective 
substrates.' 88 
1.3.3 The BPL:BCCP Complex 
Following the binding of biotin and ATP and the subsequent formation of 
biotinyl-5'-AMP, the BPL ligase must catalyse the transfer of the biotin moiety onto 
the specific lysine of BCCP.' 6 ' Concomitant with the specificity of the biotinylation 
reaction of BCCP, and with the complication of the competitive homo- and 
heterodimerization observed with BirA, a BPL:BCCP complex must be formed to 
allow nucleophilic attack from the c-amino group of the correct lysine of BCCP onto 
the phospho-anhydride bond of biotinyl-5'-AMP.185 190; 191 The complex formed 
between the class I BPL and the C-terminal fragment BCCPA67 of the 
hyperthermophilic bacteria Aqufex aeolicus has been characterised by chemical 
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cross-linking. SDS-PAGE as well as gel-filtration analysis indicated a heterodimer of 
1:1 ratio. 178 
The elucidation of the three-dimensional structures of E. co/i BirA and 
BCCP87 has allowed Weaver et al. to construct a model of the BirA:BCCP 
complex.218 Because of the conformational differences observed upon biotin binding 
to apo-BirA, the BirA:biotin complex was used for modelling the heterologous 
protein-protein interaction with BCCP.' 94 In the proposed model, BCCP is aligned 
with BirA such that the -NH 2 of the target Lys 122 is brought close to the carboxyl 
group of the biotin moiety. The n-strand 122-128 of BCCP can be readily modelled 
so that it forms an extended parallel n-sheet with the same 3-strand 188-195 which is 
involved in homodimerization of BirA. 218 
The protein interactions between BirA and BCCP described in this system are 
supported by previous structural and biochemical studies. Heteronuclear NMR 
spectroscopy studies have shown that the chemical shifts associated with the two 
regions of the BCCP sequence (residues 119-128, 87-90 and 145) which are the 
most perturbed in the presence of BirA correspond precisely to the regions of BCCP 
that have the most extensive contacts with BirA in the model . 219 The BirA:BCCP 
model is also consistent with the results of mutagenesis studies of BCCP in which 
the residues of BirA Glul 19 (close to the target Lys 122 of BCCP) and G1u147 (close 
to Pro 145 of BCCP) were shown to be critical for the biotin transfer reaction . 20 ' The 
model interaction between BirA and BCCP presents Va188, G1y89, and Pro145 of 
BCCP to residues 294-297 of the C-terminal domain of BirA. Thus, the SH3 module 
appears to make a modest favourable contribution to the binding of BCCP and 
possibly to its correct orientation on BirA.201218 
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1.3.4 Pyrococcus horikoshii 0T3 BPL 
The first structure of a class I BPL from the hyperthermophilic bacterium 
Pyrococcus horikoshii 0T3 (PhBPL) was determined at 1.6 A resolution in 2005 by 
Bagautdinov et al. 119; 220 The structure of PhBPL was solved in its apo-form and in 
complex with biotin, ADP and biotinyl-5 '-AMP (Fig. 1.13). 179  Because PhBPL is 
mono-functional, it would seem that this is simpler model with which to study the 
botinylation reaction than BirA. The structure of P/iBPL reveals a constitutive 
homodimer associated through an inter-subunit n-sheet formed by the ,-strands. 
The polypeptide chain shares strong structural homologies with BirA and comprises 
of a large N-terminal catalytic domain and a smaller C-terminal domain. In the 
structure of apo-PhBPL, only the biotin binding loop is disordered and this becomes 
structured upon biotin or ADP binding. ADP binds at a site adjacent to the biotin 
binding pocket and is largely stabilized by the biotin binding loop (Fig. 1.13). 
Therefore, only minor conformational changes to the structure are induced during the 
formation of biotinyl-5'-AMP. The conserved Lysi 11 from the p7-strand has been 
proposed to play a role in the formation of biotinyl-5'-AMP by stabilising the 
pentacoordinate transition state of the cc-phosphate before formation of the 
phosphoanhydride bond of biotinyl-5 'p 179 
In 2006, after initiation of the work described in this thesis, several new BPL 
structures were deposited in the Protein Data Bank including the structures of PhBPL 
in complex with ATP by Bagaudtinov et al. and the BPL from Mycobacterium 
tuberculosis by Ma et al. (PDB entries 1XO1 and 2CGH respectively). In 2007, the 
structures of the complex formed by PhBPL and biotin and ATP as well as the apo- 
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form of A. aeolicus BPL became available on the PDB (entries 2DTO and 2EAY 
respectively). Preliminary crystallographic studies of the P. horikoshii single and 
double mutant complexes BPL R48A:BCCPN76 and BPL R48A-
Kl 1 1A:BCCPNi76 have also been recently reported but no structure is yet available 
in the databank. 221 
N 
Figure 1.13 - Crystal structure of Pyrococcus horikoshii BPL in complex with 
ATP. The disordered biotin binding loop in the apo-structure is shaded black. The 
Arg48 (equivalent to the Argl 18 of E. coli BirA) and ATP are shown in sticks with 
black and white carbons respectively. (PBD code 1XOI) 
1.4 Analysis of Non-Covalent Protein Complexes by Mass 
Spectrometry 
The recent introduction of soft ionisation techniques such as electrospray 
ionisation (ESI) and matrix-assisted laser desorption/ionisation (MALDI) has had a 
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tremendous impact in the field of protein mass spectrometry. In 2002, Fenn and 
Tanaka were awarded the Nobel Prize in Chemistry for their role in the development 
of these two ionisation methods. 222-224  These techniques are increasingly important in 
proteomics - allowing protein identification and quantification, protein profiling and 
protein interactions analysis .221-22'  The initial role of proteomic mass spectrometry 
was to characterise the molecular masses of proteins according to their primary 
sequences. However, the recent advances in the field have allowed mass 
spectrometry to become an essential complementary tool in structural biology for the 
investigation of secondary, tertiary and quaternary structures of large protein 
complexes. 228-230 
The principle of mass spectrometry MS is to generate ions in the gas phase, 
separate them according to their mass-to-charge ratio (m/z) and detect them 
qualitatively and quantitatively according to their respective m/z. 231 In order to study 
large unstable protein complexes, the generation of gas phase ions for MS analysis 
must occur directly from the protein in solution in a manner that avoids 
fragmentation or other undesirable alteration of the target proteins. 223;232  Although 
MALDI is also applied to study these assemblies, analyses of the stability of intact 
protein complexes with ESI and the derived applications to study their overall 
structure far outnumber analyses using MALDL 233235 This is primarily due to the 
sample-preparation requirements for MALDI studies which typically involve 
evaporation of solvent in highly acidic conditions that will undoubtedly perturb 
protein-protein interactions present in solution. 224  Additionally, MALDI mass spectra 
often yield intense signals for protein aggregates which may be artefacts of the laser 
desorption/ionisation process. 230 ' 232 
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A typical electrospray setup involves passing a sample through a metallic 
capillary held at high electrical potential (1-4 kV) making the tip enriched in ions 
usually in the positive mode.236 The applied potential causes the charges to gather 
preferentially at the tip of the capillary with an elongated meniscus forming a 
"Taylor cone". At the tip of the cone, the stream of solvent is drawn out into highly 
charged droplets of several micrometers in diameter. This ionisation process takes 
place at atmospheric pressure and is, therefore, very gentle. 236 Emerging droplets are 
subsequently guided by a potential and pressure gradient toward the mass analyser. 
Aided by flows of nebulizing gas, evaporation of solvent from the droplets decreases 
its radius and since the charge is conserved, at some critical radius (the "Rayleigh 
limit"), Coulombic forces overcome the surface tension of the liquid and lead to 
fission of the droplets into even smaller droplets. Subsequent depletion of solvent by 
further evaporation results in several generations of unequal droplet fission, until 
ultimately gas phase ions are produced. 236 
A conventional electrospray apparatus uses a spray capillary of 
approximately 0.5 mm in diameter and requires flow rates of several microliters per 
minute to maintain the Taylor cone stable. 236 In 1994, Wilm and Mann introduced an 
important variant of conventional ESI, termed nanoelectrospray (nESI). 237238 nEsI is 
typically performed using glass or quartz capillaries which have been pulled to a fine 
tip (1 jim inner diameter) and given a metallic (usually gold) coating to hold the 
electric potential in place. The sample is electrosprayed at flow rates in the range of 
1-10 nllmin driven primarily by the 0.5-2 kV potential applied to the capillary and an 
auxiliary backing gas pressure to maintain a steady stream of the solution through the 
tip.239 nESI desolvation process has been shown to be a gentler, more reliable, 
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method of introducing extremely labile protein assemblies into the gas phase intact. 
It is generally accepted that the smaller initial droplet sizes produced by the nESI 
source (100 to 500 nm) reduce the number and the energy of the collisions required 
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Figure 1.14 - Scheme of the nanoelectrospray ionisation process. (Robinson et 
al.) 
Although a wide range of mass analysers has been developed for the analysis 
of protein molecules, only a small subset of these has been successfully applied to 
the study of large protein complexes. 232  Typically, large protein ions appear at high 
m/z which considerably limits the use of typical mass spectrometers. Time-of-flight 
(T0F) analysers have been the preferred tool for the study of large protein complexes 
The principal advantage of the ToF spectrometer is the theoretically unlimited m/z 
range which is essential to study macromolecular assemblies. 140  Hybrid instruments 
have been developed using quadrupole (Q-ToF) or/and hexapole filters used in 
radiofrequency-only mode which transmit and focus the ion beam as well as acting 
as an interface and are orthogonally coupled to the TOF tube. 241  In tandem MS the 
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quadrupole and ToF analysers arranged in series are separated by a collision cell and 
ions of interest can be selected according to their m/z ratios in the quadrupole. 
analyser, subsequently activated in the collision cell, with their products being 
analysed in the ToF analyser. 241 In most commercial instruments the quadrupole 
mass range is limited to mlz 3,000-4,000 and in order to be able to select ions at high 
m/z ratios, quadrupoles operating at low frequency have been implemented in Q-T0F 
instruments by several groups 242-244 
The oligomeric state of protein complexes is often preserved during transfer 
from solution to the gas phase and thus, mass spectrometry provides an ideal 
approach to investigate such protein-protein interactions as the measured molecular 
mass of the oligomer directly reveals the number of subunits in the quarternary 
structure .230  The ESI mass spectrometry analysis carried out by Fitzgerald et al. in 
1996 on the quaternary structure of 4-oxalocrotonate tautomerase is one of the 
classical studies in which the oligomeric state of a protein was probed. 245 
Additionally, mass spectrometry can also provide information on aspects such as the 
dynamics of assembly, cooperativity, and ligand binding of intact protein complexes 
in solution phase .230  Elegant studies revealing the ability of mass spectrometry to 
investigate cooperativity were carried on the transthyretin system by McCammon et 
al.246 Their observation of the multifaceted ten-component complex containing six 
protein subunits (four transthyretin and two retinol binding proteins), two retinol 
molecules, and two synthetic ligands allowed them to conclude that inhibitor binding 
does not inhibit association of transthyretin with retinol bound retinol binding 
protein .246  Most MS studies show correlation of the structural and thermodynamical 
properties between the solution phase and gas the phase. However, quartemary 
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structures may be altered since water molecules cannot longer assist in stabilising the 
molecular structures in the gas phase. 230 
Activation and dissociation of non-covalent protein complexes in the gas 
phase can also afford further compositional information. 247  Analysis by MS of a 
multi-subunit protein and its sub-complexes can generate a three-dimensional 
interaction map of the different components within the overall complex. 248  The 
majority of the studies in which a non covalent protein complex is disassembled in 
the gas phase have employed collision induced dissociation (CID).232 249  This is 
performed using tandem MS where ions of large protein assemblies are mass 
selected and activated via collisions with neutral gas atoms or molecules. 249 
Activation occurs as a portion of the kinetic energy of an ion is converted into 
internal energy during each collision event and this may lead to dissociation if 
sufficient internal energy is accumulated . 2 ' 0 The CID technique can be used on 
homologous protein complexes as well as heterogeneous assemblies, often oligomers 
of different protein subunits. 230  The nESI mass spectrometric structural analysis by 
the group of Robinson of intact 70S ribosome complexes consisting of proteins and 
RNA is one of the first examples in which such a heterogeneous assembly has been 
characterised. 25 ' While dissociation studies of protein complexes in the gas phase 
have mostly used CID, blackbody infrared radiative dissociation (BIRD) and, more 
recently, electron-capture dissociation (ECD) and surfaceinduced dissociation (SID) 
have also been employed. 252-254 
Large multi-protein complexes show a tendency to decompose by CID via a 
similar pathway consisting in the expulsion of a small monomeric subunit.230 243  Gas 
phase dissociation of the streptavidin tetramer (S4) follows the typical monomer- 
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trimer decomposition pattern with the resulting monomer fragment moiety carrying a 
disproportionately large fraction of the charge (S 7 and S3 7 ).255 A model explaining 
this anomalous charge distribution observed in the dissociation of numerous large 
protein complexes suggested that the asymmetric dissociation process is analogous to 
the fission of charged droplets in the electrospray process in which the smaller 
offspring droplets are believed to form with much higher m/z than the parent 
droplet. 255  However, in the recent years, gas phase dissociation pathways have been 
observed in which the loss of a highly charged monomer ion is not the principal 
decay pathway. 244 In these cases, non-covalently bound tetrameric proteins were 
found to undergo symmetric dissociation into dimers. Such exceptions provide the 
opportunity to manipulate the dissociation of protein complexes in the gas phase. As 
more information on the mechanism of dissociation comes to light, it is becoming 
clear that considerable structural information can be obtained for protein complexes 
following such dissociative approaches. 247  Information can be generated regarding 
the nature of intra- and inter-subunit interactions, on both global and local levels, as 
well as details of the overall organization of subunits within an oligomer. 249 
1.5 Aims 
To understand the chemistry of the biotinylation reaction catalysed by biotin 
protein ligase, it was important to characterise the protein-protein interactions that 
control biotin transfer onto the substrate apo-BCCP. Preliminary studies on the class 
I biotin protein ligase from the hyperthermophilic organism Aqufex aeolicus 
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(AaBPL) carried out at the University of Edinburgh showed that the enzyme was 
functional and isolation of a chemically cross-linked AaBPL:BCCPA67 complex was 
reported for the first time. However, in the absence of a crystalline complex, site 
directed mutagenesis of the residues suspected to be involved in the cross-linking 
appeared necessary in order to gain an insight into the geometry of the structural 
interactions between AaBPL and BCCPA67. Furthermore, the enzyme mechanisms 
leading to the formation of the intermediate biotinyl-5'-AMP remained unclear in the 
monofunctional AaBPL and the binding order of the substrates biotin and ATP 
needed to be explored. Indeed, in contrast to E co/i BirA, previous limited 
proteolysis experiments of AaBPL revealed only one single protease-sensitive site 
adjacent to the predicted substrate-binding pocket. The task here was to determine 
the crystal structure of AaBPL and further characterise the interactions made with 
biotin and ATP which govern the extreme specificity of the biotinylation reaction. 
Isolation of the E. co/i multi-subunit ACC has yet not been achieved due to 
its high tendency to aggregate. Although the components biotin carboxylase and 
carboxyltransferase have been well characterized, the stoichiometry of the full length 
E. co/i biotin carrier EcBCCP remains unknown. Prof. Carol Robinson from the 
University of Cambridge has been specialised in determining the intact assemblies 
and the structural organization of large, unstable protein complexes by mass 
spectrometry. Therefore, in collaboration with her laboratory, analyses of the ACC 
subunits using mass spectrometry would constitute a novel approach towards the 
characterization of the assembly state of the full E. co/i ACC complex. 
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2.1 Analysis of the A. aeolicus bpi and accB Genes 
Aqu/'ex aeoiicus is a hyperthermophilic bacteria found near underwater 
volcanoes and hot springs which grows optimally at 95°C.' The complete genome 
sequence was successfully mapped by Deckert et al. in 1998 and consists of 1512 
predicted open reading frames.' The A. aeoiicus genome is only about a third of the 
length of the E. coil genome and 16% of its genes originate from the archaea domain. 
A BLAST search identified two ORFs of 233 and 154 amino acids with high 
sequence homologies to E. coil BirA (20.9% identity, 35.2% similarity) and BCCP 
(33.8% identity, 46.9% similarity) respectively. 2 The pairwise sequence alignments 
for BPL and BCCP from E. coil and A. aeolicus are shown in figure 2.1 and 2.2. 
Initial analysis of A. aeoiicus BPL (AaBPL) indicated that the ligase belongs 
to the class I of BPLs and lacks the N-terminal DNA-binding domain characterized 
in E. coil BirA (Fig 2. 1).3  AaBPL is a mono-functional enzyme which acts solely as a 
ligase. The amino acid sequence of AaBPL shows that the enzyme contains the 
conserved glycine rich motif 37GRGRLG42. Limited proteolysis experiments of 
AaBPL previously carried out by Clarke et ai. have shown that cleavage had 
occurred at the adjacent Arg43 and Lys44 and was sensibly decreased in the presence 
of substrates. 2 In E. coli BirA, the equivalent residues are contained in the biotin 
binding loop located in proximity of the binding site. 4 
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1 	 50 
BirAEC (1) MKDNTPLKLIALLANGEFHSGEQLGETLISRAAINKHIQTLRDWGVDV 
BPL_AA 	(1) -------------------------------------------------- 
51 	 100 
BjrAEC (51) FTVPGKGYSLPEPIQLLNAKQILGQLDGGSVAV. 	'?LDRIGE 
EPL_AA 	(1) -------------------------- GFLIWFL..'ERWN-- 
101 	 -------- 	 ------ 	150 
BirA_EC (101) 
BPL_AA 	(23) VSYI2LVDRTK 
151 	 200 
BirA_EC (151) 
BPL_AA 	(71) 	SVSAEEITEI 	 ----- IK 
201 	 250 
BirAEC (201) IVIAW.RVESVVNQGWI TLQF.ININTLAAMLIRELRAA 
BPL_AA (116) LI VIVNE I PEIKDRATTLYE I 	 WL-hCEVLLKVLKRISENE 
251 	 300 
BirA_EC (251) ELOEQEGLAPYLSRWOKLDNFINRP M IIGDKF2ISREIDKLL 
BPL_AA (166) KEKSFKEFXGKISKLYLG 	G-EGKIZKL1LSEKGAI 
301 
BirAEC (301) EQDGI PWM I 	SAEK (321) 
BPL_AA (215) LTEE 	IL 	S-- (233) 
Figure 2.1 - Sequence alignments of E. coli BirA and A. aeolicus AaBPL. The 
pairwise alignment was prepared using CLUSTAL W. 5 The black (-j) indicate the 
disordered surface loops in the apo-structure of E. co/i BirA and the red (-) indicate 
the residues forming the glycine-rich motif with the Argi 18 of BirA and the 
equivalent Arg40 of AaBPL highlighted in red. The residues corresponding to the 
trypsin cleavage sites in AaBPL are indicated in blue. 
In E. co/i BCCP, a sequence rich in proline and alanine residues is found 
between the amino acids 34 and 101 while the rest of the N-terminus has a large 
proportion of charged residues and displays little sequence similarity to any other 
BCCPs (Fig 2.2).6  In contrast, this pro/ala-rich sequence is absent between residues 
28 and 89 of the N-terminal domain from A. aeo/icus BCCP (BCCP154) which 
consists mainly of charged residues such as glutamic acids and lysines. In A. 
aeolicus, deletion of 67 residues of the N-terminal domain results in a truncated 
BCCP containing 87 amino acids (BCCPA67). 2 The homology scores between the A. 
VLSI 
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aeolicus BCCPA67 and E. co/i BCCP87 domains are 51.9% identity and 69.6% 
similarity. 7 Interestingly, although the sequence identities and similarities between 
the two biotinyl domains are significantly high, the canonical biotinylated lysine 
(Lys 117) of A. aeoiicus BCCPA67 is flanked by aliphatic residues (AVKL motif) 
instead of the conserved methionines of the E. co/i AMKIvI biotinylation motif. 8 
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Figure 2.2 - Sequence alignments of E. coli and A. aeolicus BCCP. The pairwise 
alignment was prepared using CLUSTAL W. 5 The (4.) shows the start residue of the 
E. co/i BCCP87 domain used in previous studies and the (1') shows the start residue 
of the A. aeolicus BCCPA67 domain. The biotinylated lysine residues are highlighted 
in red. Residues highlighted in blue were suspected cross-linking residues (See 
section 2.6). Secondary structural elements of the BCCP87 domain are indicated. 
2.2 Expression and Purification of A. aeolicus AaBPL 
The A. aeo/icus bpl gene had been previously cloned into the kanamycin-
resistant pET28a expression vector using the restriction enzymes NcoI and BarnHI 
(Fig. 2.3).2  The gene encoding AaBPL was expressed in E. co/i BL2I (DE3) 
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competent cells (Novagen) at 37 °C and induction was performed with 1 mM 
isopropyl- I -thio--D-ga1actopyranoside (IPTG). The amino acid sequence of A aB PL 
has shown that the enzyme consists of a high proportion of positively charged 
residues and the predicted isoelectric point of 9.1 for AaBPL is unusually high. 





















Figure 2.3 - Expression vector pET28a/AaBPL. The Aqufex aeolicus bpl gene was 
cloned using the NcoI and BamHI restriction sites. 
Initially, the crude lysate was incubated at 60 °C and this resulted in 
precipitation of a large number of E. co/i proteins which were subsequently removed 
by ultra-centrifugation. The sample was then dialysed overnight at room temperature 
against 10 mM HEPES (pH 7.5) as immediate loading of an untreated extract onto a 
ResourceS column (Amersham) resulted in very poor binding. It is unclear why this 
step was necessary, but after dialysis the enzyme eluted from the column with 200 
mM NaCl with a purity greater than 95%•2 
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Another purification method of AaBPL was established to avoid the heat-
shock and dialysis steps for further crystallisation studies of the enzyme. This 
consisted in directly loading the cell-free extract onto a 10 ml column HR 10/100 
containing high resolution cationic 15S beads (GE Healthcare). AaBPL eluted from 
the column with 200 mM NaCl with a purity of approximately 95% as determined by 
SDS-PAGE (Fig. 2.4). The protein was then dialysed overnight at 4 °C against 10 
mM HEPES (pH 7.5) and the final yield of AaBPL using this method was> 5mg per 
litre of cell culture. This protein was used for all subsequent activity assays, 
thermodynamic analyses, cross-linking studies and crystallisation. 
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Figure 2.4 - Purification and SDS-PAGE analysis of AaBPL. (a): chromatogram 
of AaBPL purification on a HR 10/100 column loaded with 15S beads. The protein 
eluted with 200 mM NaCl. (b): protein purification was analysed by SDS-PAGE 
under reducing conditions. Lane 1, low molecular weight marker (Amersham), lane 
2, AaBPL flow-through, lane 3, wash fraction, lane 4-9, fractions 6 to 12 eluted with 
NaCl (collected fractions are indicated in brackets). 
Liquid chromatography coupled to electrospray mass spectrometry (LC-ESI-
MS) analysis of purified AaBPL revealed the presence of a single species with a 
measured mass of 26,636 ± 2 Da, consistent with the post-translational removal of 
the N-terminal methionine residue and within experimental error of the predicted 
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molecular weight for AaBPL (26,634.57 Da). The protein was subjected to rigorous 
gel filtration analysis on a 120 ml HiLoad 16/60 Superdex75 column. In absence or 
presence of excess of biotin or/and MgATP, the elution profile of the protein 
corresponded to a molecular mass of approximately 26,600 Da indicating that 
AaBPL is monomeric (Fig. 2.5 & 2.6). 
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Figure 2.5 — Gel filtration analysis of AaBPL on a HiLoad 16/60 Superdex75 
column. The enzyme eluted from the 120 ml column in presence or absence of 
substrates at 65 ml indicating that AaBPL is monomeric. 
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Figure 2.6 - Calibration graph for the HiLoad 16/60 Superdex75 column. Ve 
corresponds to the elution volume and 40 ml corresponds to the void volume of the 
120 ml column. 
2.3 The Full-Length and Truncated A. aeolicus BCCP 
2.3.1 Cloning, Expression and Purification of BCCP154 
The full-length A. aeolicus BCCP containing 154 amino acids (BCCPI54) 
was initially cloned in a pET6H vector and expressed in E. co/i BL2 I (DE3) cells at 
37 °C. The resulting N-terminal hexahistidine tagged BCCP 154 failed to be purified 
by nickel affinity chromatography from the cell lysate. The N-terminal sequence 
which is rich in proline and alanine results in a very flexible structure in the E. co/i 
protein. In A. aeolicus BCCP154, the conformation of the N-terminal domain 
appears to have blocked binding of the hexahistidine tag to the nickel column. To 
avoid complications, BCCPI54 was cloned into an ampicillin-resistant pET16b 
expression vector using the restriction enzymes NcoI and BamHJ (Fig. 2.7). 
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pET 16b/Aa-BCCP154 
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Figure 2.7 - Expression vector pET16b/BCCP154. The Aqufex accB gene was 
cloned using the NcoI and BamHI restriction sites. 
The resulting plasmid pET16b/BCCPI54 was expressed in E. coil BL2I 
(DE3) cells at 37 °C and the protein concentrated by two successive anion exchange 
chromatography steps (Fig 2.8, A & B). A final gel filtration chromatography step 
yielded BCCP 154 which by SDS-PAGE analysis appeared to be > 90% pure (Fig 
2.8, Q. LC-ESI-MS indicated a molecular weight for BCCPI54 of 17,331 ± 6 
(Predicted mass: 17,303.88 Da). The mass difference between the experimental and 
calculated values is due to the poor desolvation of BCCP 154 and to the presence of 
salt adducts. The mass spectrum of the +9 to +15 ion series also revealed that 
BCCP 154 is heterogenous. Streptavidin western blot analysis was carried out with 
purified BCCPI54 and showed that the A. aeolicus biotinyl domain was recognized 
and biotinylated by the host BirA in vivo suggesting that it was correctly folded (Fig 
2.8, D). 
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Figure 2.8 - Purification and analysis of BCCPI54. A, B, C: purification of 
BCCP 154 was analysed by SDS-PAGE under reducing conditions. The collected 
fractions are indicated in brackets. Gel A. purification on a 55 ml Q-sepharose XL 
column. Gel B: purification on 1 ml MonoQ HR 515 column. Gel C: purification on 
120 ml HiLoad 16/60 Superdex75 column D: streptavidin western blot of BCCP 154 
indicates that the protein is biotinylated by its host in vivo. Holo-BCCPA67 is used as 
a standard. E: separation of BCCP154 under non-reducing conditions with a Tris-
Glycine protein gel (Invitrogen), lane 1, pre-stained SeeBlue® Plus2 molecular 
weight marker (Invitrogen), lane 2, non-reducing Tris-Glycine loading buffer, lane 3, 
tricine loading buffer. 
The stoichiometry of BCCP154 was analysed by gel filtration on a 320 ml 
Sephacryl S-200 HR column (Fig 2.9 & 2.10). Although different reducing 
conditions as well as a wide range of pH and salt concentrations were used, 
BCCP154 eluted from the column in the void volume and at 120 ml indicating 
molecular weights greater than 195 kDa. Non-reducing analysis with Tris-Glycine 
protein gels also showed that BCCP154 formed aggregates corresponding to 
molecular masses ~ 200 kDa (Fig 2.8, E). 
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Figure 2.9 - Gel filtration analysis of BCCPI54 on a Sephacryl S-200 HR. The 
protein eluted from the 320 ml column in presence of 2 mM DTT and 150 mM NaCl 
at 95 ml and 120 ml indicating that BCCP 154 forms aggregates of molecular masses 
> 195 kDa. 
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Figure 2.10 - Calibration graph for the Sephacryl S-200 HR column. Ve 
corresponds to the elution volume and 95 ml corresponds to the void volume of the 
320 ml column. 
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2.3.2 Expression and Purification of BCCPA67 and Mutant 
BCCPA67 K1 17L 
The full-length BCCPI54 was shown to be difficult to purify, manipulate but 
also to analyse by mass spectrometry due to its high tendency to aggregate. Previous 
studies by Clarke el al. have been using the truncated domain BCCPA67 for activity 
assays and cross-linking experiments with AaBPL. 2 The A. aeo/icus accB gene 
missing the first 201 base pairs which encode the C-terminal 87 amino acids of 
BCCP154 (BCCPA67) was previously cloned into the ampicillin-resistant pET6H 
vector using the restriction enzymes NcoJ and BamHI (Fig 2.11). 2  BCCPA67 is 
expressed from this construction with an N-terminal six histidine-tag (total length 96 
aa) by BL21(DE3) cells. 
cII (5q30) 
















Figure 2.11 - Expression vector pET6H/BCCPM7. The Aqufex accbzl67 gene 
was cloned using the IVcoI and BamHl restriction sites. The resulting construct 
encodes an N-terminal hexahistidine tag. 
N. 
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The hexahistidme-tagged BCCPA67 was concentrated from the cell lysate by 
nickel affinity chromatography on a 5 ml HisTrapTM HP column. His 6-BCCPA67 
eluted with 100 mM imidazole and was immediately diluted and dialysed against 10 
mM HEPES (pH 7•5)•2  SDS-PAGE indicated the protein to have a purity greater than 
90% (Fig. 2.12, A). LC-ESI-MS analysis revealed the presence of two distinct 
species corresponding to the apo- and holo- (biotinylated) forms of BCCPA67. The 
predominant species, of molecular weight 10,739 ± 1 Da, corresponds within 
experimental error to the predicted mass of the apo-His 6-BCCPA67 (10,739.63 Da) 
while the second species corresponds to the holo-protein with a measured mass of 
10,966 ± 1 Da (predicted mass of holo-BCCPi67: 10,965.94 Da). The mass 
difference of 227 ± 2 is equivalent within experimental error to the covalent 
attachment of one biotin (226.31 Da). The presence of holo-BCCPA67 confirmed 
that the biotinyl domain was recognised and biotinylated by the host BirA. 
The apo- and holo-forms of BCCPA67 were separated by anion exchange 
chromatography as previously described for E. coli BCCP87.7 A shallow NaC1 
gradient was run over 35 column volumes on a 1 ml MonoQ HR 515 column and LC-
ESI-MS analysis of the isolated protein fractions indicated that apo-BCCPA67 eluted 
at a lower salt concentration (200 mM NaCl) than the biotinylated form (300 mM 
NaCl). Approximately 80% of the apo-BCCPA67 was completely resolved from the 
holo-form by collecting only the leading fractions of the protein peak (Fig. 2.12, B). 
The final yield of apo-BCCP67 was approximately 3 mg per litre of cell culture and 
that of holo-form was less than 1 mg per litre. 
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Figure 2.12 - SDS-PAGE analysis of A. aeolicus BCCPA67 after (A) nickel 
affinity and (B) anion exchange chromatography. Protein purification was 
analysed under reducing conditions. Gel A: lane 1, low molecular weight marker, 
lane 2, flow-trough, lane 3, wash fraction, lane 4, BCCPA67. Gel B: lane 1, SeeBlue 
Plus2 molecular weight marker, lane 2, apo-BCCPA67. 
The hexahistidine-tagged mutant BCCPA67 K1 17L lacking the target 
biotinylated lysine, previously cloned in the same pET6H vector construction as 
BCCPL\67, was expressed and purified by a similar method. 2 As the mutant protein 
lacks the lysine biotinylation site, purification was simplified by the absence of apo-
and bob-forms. The cell lysate was fractionated by nickel affinity chromatography 
and the bound protein eluted from the HisTrap column with 200 mM imidazole. 
BCCPA67 Kl 17L was further purified by a single anion exchange chromatography 
step on a MonoQ HR 5/5 column. Analysis of the fractions by SDS-PAGE showed 
BCCPA67 KI 17L was greater than 95% pure and LC-ESI-MS revealed the presence 
of a single species with a measured mass of 10,725 ± 1 Da consistent with the 
predicted molecular weight of the hexahistidine-tagged BCCPA67 K 11 7L (10,724.62 
Da). 
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2.4 Activity Assay of AaBPL 
In vitro biotinylation assays were carried out to determine if AaBPL was 
biologically active and if the enzyme could modify apo-BCCPA67 in presence of 
biotin and Mg 2+-ATP. The reaction was performed at 65 °C and at pH 7.5 for 1 hour 
as previously described by Clarke et al.2 Analyses of the reaction mixture over the 
course of the reaction by LC-ESI-MS indicated the appearance of a new species with 
a molecular weight of 10,967 ± 1 Da (Fig. 2.13). The mass increase (227 Da) of 
approximately one biotin is consistent with the formation of holo-BCCPA67 and only 
the singly biotinylated BCCPA67 could be identified by electrospray mass 
spectrometry. In vitro biotinylation assays carried out with BCCPA67 Ki 17L as the 
biotin acceptor indicated that the BCCP mutant was not modified by AaBPL, 




Chapter 2: Aquifex aeolicus AaBPL 
8CCPD€7 cn. Sm. stLcm 	 AI07405456 
.48. 1344 
100 	
AID AD 	.47,1535 
	









All 1015 1194 .161791 
977 
S.r ... 	 . 
61:: 	 A 10740 SW 48 
100 	
.48. 344 
AID A9 	 1 
.47 
535 
All 1015 5194 
977 	 A6 . 17QI 
C. 
A8 1344 	A1 	A 0!4 54±1)58 10 	 AID '' 	 1535 
All 1075 1194 
977 	 *1791 
mass C.ts&., 	 mhz 
600 	800 	1000 	1200 	1400 	16130 	1805 
0CCPD67-L Cn,Sm,58,Cm 	 A MTN 9-911 21, 
25 	
.48, 1344 	 5''. log 	 A1;1 
.49 	 871558 




100 	 .47,1536 














0. lrr.'. .!l13141514tr.11 . ilL I 
981344 
100 	 1535 	Al 72598l 25 
.413 	1194 	I 	.---, 
All 1575 58 	 961791 
835977 I I 
mass . 	 58± 
600 	800 1000 	1200 	1400 	1600 	1800 
Figure 2.13 - LC-ESI-MS analysis of apo-BCCP67 biotinylated with AaBPL. 
The right panels show the charge state distribution after smoothing and the left panel 
show the charge deconvoluted mass spectra. The reaction was carried out at 65 °C in 
presence of MgATP. A: apo-BCCPi67 after incubation with AaBPL in the absence 
of biotin. B: apo-BCCPM7 after incubation with AaBPL for 10 n -fin in the presence 
of biotin and termination with ice-cold tri-fluoro acetic acid. The mass spectrum 
indicates the formation of holo-BCCPA67. 
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2.5 Isothermal Titration Calorimetry Analysis of AaBPL 
The first step in the enzymatic biotinylation catalyzed by BPLs involves the 
synthesis of the intermediate biotinyl-5'-AMP from biotin and ATP in the presence 
of Mg2 ions within the active site and the formation of inorganic pyrophosphate 
(PPi). In E. coli BirA, binding of biotin and ATP has been established to be a 
sequential ordered addition mechanism. In this system, the binding of biotin precedes 
that of ATP, and the biotin-induced ordering of the biotin binding loop is required for 
subsequent nucleotide binding.9 10  To determine the thermodynamic parameters for 
binding of biotin and ATP in the AaBPL system, isothermal titration calorimetry 
(ITC) was used. Since the formation of biotinyl-5'-AMP is Mg 2 - dependent, the 
binding of the ligands prior to reaction was studied in the presence of 4 mM EDTA. 1 ' 
This proved to be a valid simplification since crystallographic studies of AaBPL 
complexed with biotin and ATP subsequently showed that Mg 2 ions are not required 
for binding of the substrates (See chapter 3). 
The ITC results shown in figure 2.14 indicate that AaBPL binds both biotin 
and ATP in exothermic processes. The thermodynamic parameters calculated from 
these titrations suggest relatively weak protein-ligand interactions for both substrates 
under these conditions with KD = 3.5 M and KD = 7.2 tM for biotin and ATP 
respectively (Table 2.1). Biotin and ATP binding to AaBPL are both enthalpy-driven 
with favourable entropy changes. Since BirA is unable to bind ATP in the absence of 
biotin, only the dissociation constant of biotin was determined for BirA and this is in 
the nanomolar range (KD = 45 nM) indicating a much stronger protein-ligand 
interaction, some 1000-fold tighter than that for AaBPL and biotin.4 12 
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Figure 2.14 - ITC measurements of AaBPL with (A) biotin and (B) ATP. The 
upper panels show the raw data of heat changes upon addition of ligand. The lower 
panels show the processed data corresponding to the heat of each injection plotted 
against the molar ratio of ligand to enzyme after subtraction of the heat of ligand 
dilution. All buffers contained 10 mM HEPES pH 7.5 and 4 mM EDTA. . The 









 AaBPL + biotin 3.5 ± 0.2 -26.8 ± 0.8 4.6 ± 1.3 -31.4 ± 0.4 
 AaBPL + ATP 7.2 ± 1.3 -15.1 ± 3.3 -14.2 ± 3.8 -29.3 ± 3.3 
(lii) AaBPL:biotin + ATP 4.6 ± 0.5 -25.1 ± 2.1 -5.4 ± 2.5 -30.5 :k 2.1 
(iv) AaBPL:ATP ± biotin 0.7± 0.1 43.5± 0.8 8.4 ± 0.8 -35.1 ± 0.8 
BirA ± biotin (4.5 ±0.2)x10 2 -39.3 ± 1.3 -2.1 ± 1.3 -41.4 1 0. 4  
Table 2.1 - Thermodynamic parameters of biotin and ATP binding to AaBPL. 
The data are derived from the ITC measurement of AaBPL with biotin and ATP 
before and after formation of the binary complexes AaBPL:biotin and AaBPL:ATP. 
The error in AH is ± 5% and is mainly due to the differences in enzyme and ligand 
concentrations. AG' is calculated from the binding constant determined by ITC: AG' 
= -RT 1nKA = All - T.AS° . The thermodynamic parameters of BirA binding to biotin 
are also reported for comparison.'; 12 
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The small difference (a factor of 2) between the KD values of AaBPL 
determined for biotin and ATP suggests that ligand binding to AaBPL occurs via a 
random process. However, binding of ATP to AaBPL could have been an artefact 
caused by the presence of biotin inside the active site of the enzyme during the ITC 
experiments. The AaBPL preparation was therefore titrated with streptavidin (Sigma, 
KD for biotin = 10 13 M) and the occupancy value of biotin shown to be 0.0372, 
which corresponds to less than 4% of ligand-bound enzyme, indicated that the 
amount of biotin initially present in the active site of AaBPL could essentially be 
ignored (Fig 2.15).h1 
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Figure 2.15 - ITC measurements of AaBPL with streptavidin. The titration of 16 
pM AaBPL (cell) with 19.5 pM streptavidin (syringe) finished after the initial 
injection of 1 pJ and only four injections of 10 p1. KD = 1.4 ± 0.6 nM, AH = -92.0 kJ 
moi1 , -ThS = 42.3 ki moF 1 , AGO = -49.8 kJ moF 1 , N = 0.0372 ± 5.71 10. 
For an ordered mechanism to occur, binding of one ligand would be 
prerequisite for binding of the other but, the ITC results suggest that in contrast to the 
mechanism of BirA, biotin is not required for ATP binding to AaBPL. The 
cooperativity of the binding events after formation of the binary complexes 
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AaBPL:biotin and AaBPL:ATP was further investigated by titration with ATP and 
biotin, respectively. The ITC results and the thermodynamic parameters reveal that 
binding of both biotin and ATP to AaBPL is enhanced by prior occupancy by the 
second substrate (Fig 2.16). The affinity (KA) of biotin for the AaBPL:ATP binary 
complex is five times greater than for AaBPL alone, while the KA of ATP for AaBPL 
doubles for the AaBPL:biotin complex (Table 2.1). 
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Figure 2.16 - ITC measurements of the binary complexes (A) AaBPL:ATP with 
biotin and (B) AaBPL:biotin with ATP. All buffers contained 10 mM HEPES pH 
7.5, 4 mM EDTA. The derived thermodynamic parameters are listed in table 2.1. 
The enthalpy and entropy changes measured for the two pathways involving 
the formation of the binary complexes AaBPL:biotin and AaBPL:ATP leading to the 
formation of the AaBPL:biotin:ATP ternary complex - pathway (i) and (iii) and 
pathway (ii) and (iv) - correspond within experimental error and indicate 
cooperativity between biotin and ATP binding (Table 2.1, figure 2.17). It is worth 
noting that, despite quite large variations in apparent enthalpy and entropy changes 
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for the different AaBPL binary and ternary complexes, the changes in binding free 
energies are comparatively much smaller. This appears to be yet another example of 
the ubiquitous enthalpy-entropy compensation commonly observed in biomolecular 
systems. 14 
KA = (2.9 ± 0.2) x10 5 M 1 
	
AaBPL 	 AaBPL:biotin 
I 
KA = (1.4 ± 0.3) x105 M 1 ii 	 iii KA = (2.2 ± 0.3) x10 5 M 1 
iv 
AaBPL:ATP 	 o AaBPL:biotin:ATP 
KA = (1.4 ± 0.2) xl 06  M 1 
Figure 2.17 - Formation of the ternary complex AaBPL:biotin:ATP. The 
AaBPL:biotin:ATP complex can be formed via the formation of the binary complex 
AaBPL:biotin (pathway i and iii) or via the formation of the binary complex 
AaBPL:ATP (pathway ii and iv). In AaBPL, all the four reactions for the pathways i 
to iv take place. KA = association constant (lII(D) 
2.6 The AaBPL:BCCPA67 Cross-Linked complex 
The specificity of the biotinylation catalyzed by BPLs is well established in 
many organisms and has been demonstrated in A. aeolicus with the sole biotinylation 
of the target Lys 117 on the carrier BCCPA67 which was described earlier. However, 
the nature of protein-protein recognition between the enzyme BPL and the substrate 
BCCP remain unclear. Clarke et al. have previously characterized by SDS-PAGE a 
chemically cross-linked AaBPL:BCCPA67 complex trapped using 1-ethyl-
3(dimethylamino-propyl)-cabodiimide (EDC) and subsequently purified by gel 
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filtration .2  To increase the yield of AaBPL:BCCPA67 cross-linked complex for 
further biochemical and structural studies aimed at gaining an insight in the residues 
involved in the formation of the complex, an alternative cross-linking strategy 
involving the coupling reagent N-hydrosuccinimide (NHS) combined with EDC was 
investigated. NHS is similar to EDC in that it will activate acidic residues affording 
succinimidyl esters for further nucleophilic attack by neighbouring amino side 
chains and subsequent formation of an AaBPL-BCCPA67 amide linkage (Fig 2.18). 
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Figure 2.18 —Cross-linked AaBPL:BCCPA67 complex with EDC and NHS. 
Activation of acidic residues on BCCPA67 with EDC and NHS leads to the 
formation of succinimidyl esters that will further react with amino groups ofAaBPL. 
Chemical cross-linking experiments were carried out by activating AaBPL 
and apo-BCCPA67 at 60 °C with 5 mM EDC and 5 mM NHS before quenching the 
reagent with f-mercaptoethanol (n-ME). The reaction mixture was incubated for 
various period of time and termination of the cross-linking was carried out with 
hydroxylamine to regenerate acidic residues that had been activated but did not 
95 
Chapter 2: Aquifex aeolicus AaBPL 
cross-link. The time course of production of cross-linked AaBPL:apo-BCCPA67 
complex was analysed by SDS-PAGE and electrospray mass spectrometry. EDC and 
NHS were more reactive than EDC alone and SDS-PAGE indicated the formation of 
two new species (Fig 2.19, A). The first major band with a molecular weight of 
approximately 37 kDa corresponds to the AaBPL:apo-BCCPA67 complex while the 
second species has a mass of 47 kDa and could correspond to a cross-linked 
complex formed by one AaBPL and two apo-BCCPA67 molecules. Holo-BCCP67 
and BCCPLt67 K1 17L were cross-linked to AaBPL using the same method. 
Interestingly, the proportion of complex observed by SDS-PAGE was significantly 
reduced when AaBPL was cross-linked with holo-BCCPA67 suggesting that 
conformational changes in BCCPA67 upon biotinylation alter its ability to form the 
complex.2  The amount of generated cross-linked species with AaBPL and the 
BCCPA67 K! 17L mutant was similar to that with apo-BCCPA67 indicating that the 
active Lys 117 is not involved in the cross-linking reaction. 2 
Analysis of the cross-linked complexes was carried out by electrospray mass 
spectrometry. The AaBPL:apo-BCCPA67 complex was ionized with difficulty and 
eluted at the same time as AaBPL during LC-ESI-MS analyses. Direct injection after 
transfer in ammonium acetate buffer (pH  6.8) using a vivaspin concentrator 20,000 
MWCO (Vivasciences) allowed the identification of the complex using Electrospray 
Maximum Entropy (MassLynx software, Waters Micromass, U. K). The 
AaBPL:apo-BCCPA67 complex was observed at a molecular mass of 37,363 Da 
suggesting the formation of a single protein-protein amide linkage (predicted mass of 
non cross-linked and single cross-linked AaBPL:apo-BCCPA67 complex: 37,374.4 
Da and 37,358.4 Da respectively). 
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Figure 2.19 - SDS-PAGE of a cross-linked AaBPL:BCCPA67 complex. The 
formation of the cross-linked complex was analysed by SDS-PAGE under reducing 
conditions. All gels lane 1: low molecular weight marker. A: activation of AaBPL 
and apo-BCCPA67 together for 5 minutes. Lanes 2-6: assay after 1, 5, 15, 30 and 60 
minutes respectively. B: activation of apo-BCCPA67 alone for 2 minutes. Lane 2, 3. 
assay before addition of AaBPL after 1 and 3 min respectively, lane 3-7: assay after 
1, 5, 15,30 mm. 
In a separate experiment aimed at determining which protein possessed the 
activated carboxylate residue, AaBPL and apo-BCCPA67 were activated separately 
with EDC and NHS and the second protein was added to the reaction mixture after 
quenching the reagents with n-ME. SDS-PAGE analysis of the reaction after 
hydroxylamine termination showed that activation of apo-BCCPA67 allowed the 
formation of BCCPA67 dimers and other higher aggregates immediately after 
incubation with EDC and NHS (Fig 2.19, B). However, after addition of AaBPL, 
apo-BCCPA67 appeared to stop aggregating and reacted with AaBPL to generate the 
cross-linked AaBPL:apo-BCCPM7 complex. Holo-BCCPA67 did not form 
aggregates when incubated with EDC and NHS, presumably because the biotinylated 
form is more structured. Activated AaBPL even for long periods of incubation did 
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not react with apo-BCCPi67 suggesting that the chemical reaction between the two 
proteins is ordered with an amino side chain of AaBPL reacting with an activated 
succinimidyl ester located on the surface of BCCPA67. 
The model of the E. coli complex assembled by Weaver et al. with the crystal 
structures of BirA and BCCP87 suggests that the complex is formed by hydrogen 
bonding of 13-strands from each protein, creating an extended 13-sheet (Fig 2.2O).' 
The 3D model of the E. co/i BirA:BCCP87 complex showed several pairs of charged 
residues (Arg or Lys and Asp or Glu) located between -P2 to 5 A apart that 
constitute candidate residues for cross-linking in the AaBPL:BCCPA67 complex. In 
parallel with this work, cross-linking experiments were also carried out by Clarke 
with four mutated ion pairs on AaBPL and BCCPA67, including three conserved in 
BirA and BCCP87, to identify their role in mediating protein cross-linking (Fig 
2.20). The four single-site mutants of the BCCPA67 domain were assayed by SDS-
PAGE for their ability to cross-link with AaBPL and only the mutant BCCPA67 
E121A showed significant reduction of generated cross-linked complex. Based on 
the E. co/i model of the complex, the Lys 19 of AaBPL lies in close proximity to the 
Glu 121 and subsequent mutation of the lysine also showed a considerable reduction 
of complex formed. 
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Figure 2.20 - Model of the E. coli BirA:BCCP87 complex. The BirA moiety is 
coloured in violet and the BCCP87 domain in blue. The biotin is drawn in sticks with 
white carbons. Four amino-acid pairs at the protein:protein interface are drawn in 
sticks and correspond to potential cross-linking sites. The pair Leu95-G1n126 which 
corresponds to Lys19 and G1u121 on AaBPL and BCCPA67 respectively has been 
identified as the cross-linked salt bridge in A. aeolicus. (PDB entry I K67) 
2.7 Discussion 
The recombinant forms of the enzyme AaBPL, the full-length biotin carrier 
BCCP 154 as well as the biotinylation domain BCCPA67 from the hyperthermophile 
A. aeolicus have been characterised. AaBPL was shown to be monomeric and the 
homodimenzation interactions found in E. coil BirA are not present. 16  Dimenzation 
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in BirA is necessary for regulation of biotin biosynthesis by binding of the N-
terminal domains to the bidirectional 0/P region of the biotin operon.17 18 This dual 
role is absent in AaBPL which belongs to the class I BPL and lacks the N-terminal 
DNA-binding domain. AaBPL acts solely as a ligase and consequently remains 
monomeric even in presence of excess of substrates. 
The E. coli full-length BCCP has been proven to be a particularly recalcitrant 
protein due of its strong tendency to aggregate which has been attributed to the 
presence of the flexible Pro/Ala-rich sequence between amino acids 34 and 101.19; 20; 
21 
This Pro/Ala-rich sequence is absent in the N-terminal domain of A. aeoiicus 
BCCP154. Recent studies on another full-length BCCP from the thermophilic 
archaeon Suifolobus tokodaii which does not contain the Pro/Ala-rich sequence of E. 
coli BCCP indicated that the protein exists as a monomer. 22 Thermophilic bacteria 
are characterized by a higher number of ionic interactions which play a role in the 
thermostability of the proteins and these interactions could stabilize the N-terminal 
domains of S. tokodaii BCCP and A. aeoiicus BCCP154.2324  BCCP154 was initially 
cloned with an N-terminal His-tag and the recombinant protein expressed in E. coli. 
Although the N-terminal domain consists of a significant proportion of charged 
residues, the His-tagged BCCP 154 could not be separated from the lysate by nickel 
affinity chromatography suggesting that the N-terminus may be unfolded. Thus, 
BCCP154 was cloned without tag in a pET16b vector and purified by anion 
exchange chromatography. 
The protein was isolated as a mixture of apo- and bob-forms and it seems 
likely that the A. aeolicus biotinyl domain was correctly folded and was a substrate 
for E. coil BirA in vivo. However, like its E. coli homobog, BCCP 154 was shown to 
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form undecamers and higher oligomers in solution. Moreover, analysis by mass 
spectrometry was shown to be particularly difficult due to the heterogeneity of 
purified BCCP 154. Consequently, a truncated C-terminal 87 amino acids A. aeolicus 
BCCPL67 lacking 67 residues from the N-terminus which was previously shown to 
be a substrate for biotinylation with AaBPL was expressed and purified in both the 
apo- and holo-forms. 2 LC-ESI-MS analysis of in vitro biotinylation assays indicated 
that the isolated AaBPL enzyme was active and could biotinylate apo-BCCPA67 at 
elevated temperatures in the presence of biotin. Similar experiments carried out with 
the mutant BCCPA67 K! 17L, where the target Lysi 17 was mutated to a leucine, 
confirmed the extreme specificity of AaBPL for a single lysine. 
Isothermal titration calorimetry (ITC) experiments have been carried out with 
AaBPL to determine the thermodynamic parameters for binding of biotin and ATP 
and to investigate if the binding events occur via the ordered sequential mechanism 
previously characterized in E. coli BirA.' ° The ITC results indicated that AaBPL 
binds biotin and ATP randomly but substrate binding was also shown to be a 
cooperative process. This contrasts with BirA, where formation of the BirA:biotin 
complex is a prerequisite for ATP binding. The ordering of the binding events 
exhibited by BirA appears necessary in view of its dual role as a repressor and ligase 
and therefore, recruitment of ATP should be the second step.25 26  In contrast, for a 
monofuctional BPL such as AaBPL, which lacks a regulatory role, the binding order 
is not crucial. 
The kinetic constants of AaBPL for biotin and MgATP have been previously 
characterized by Clarke et al. using steady-state kinetics and are consistent with ATP 
binding to unliganded AaBPL (Table 2.2).2 The K m of AaBPL for biotin was 
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determined to be 439.6 ± 69.2 nM, a value similar to that reported of E. coli BirA for 
biotin (K=300 nM) 27 However, the Km of AaBPL for MgATP was measured to be 
15.14 ± 1.52 gM while the reported Km value of BirA is much higher (K m=300 
f)•2;27 The KmS of AaBPL for MgATP is similar to that of yeast BPL: K m=67 ± 11 
nM and Km 20.9 ± 3.0 jiM for biotin and ATP respectively (Table 2.2).28  Yeast BPL 
belongs to the class IV BPL and pyrophosphate inhibition studies carried out with S. 
cerevisiae BPL have shown that the order of binding is inverted in yeast, with ATP 
binding prior to biotin .28  The order of binding of the co-factor and ATP in the 
adenylate synthesising enzyme family appears to be peculiarly enzyme-specific since 
in class I and II tRNA synthetases, amino acid and ATP binding has been shown to 
be a random process. 2930 
Km Biotin (nM) Km MgATP (jtM) 
AaBPL 439 ±69 15±2 
BirA 300± 100 200±30 
ScBPL 67±11 21±3 
Table 2.2 - Michaelis constants of the A. aeolicus, E. coil and S. cerevisae BPLs.2 
27 
The second part of the post-translational biotinylation process is thought to be 
mediated through a network of interactions between BPL and the substrate BCCP. 15 
A recent combined mutagenesis/biological selection approach identified two single 
glutamate residues Glul 19 and G1u147 of E. co/i BCCP87 which appear to interact 
with BirA. BCCP87 El 19K was shown to be inactive as a substrate for BirA, 
whereas the E147K mutant protein could be biotinylated, albeit poorly. 3 ' It is 
presumed that these acidic BCCP87 residues interact with basic BirA counterparts 
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and the mutant BirA in which Lys277 was substituted with a Glu residue had a 
significantly higher activity with BCCP87 El 19K than wild-type BirA. Those results 
suggest that ion pair networks are important for the protein recognition of BCCP by 
BirA in E. coil. 27  Ion pair networks are a common feature in heat-resistant proteins 
and are believed to play important roles in their increased thermal stability. 23  Since 
both A. aeolicus AaBPL and BCCP contain a large number of charged residues and 
inhibition of biotinylation was observed at high salt concentrations, specific ionic 
interactions are presumably involved in the formation of the hyperthermophilic 
AaBPL:BCCPA67 complex. 2 
To investigate the formation of the AaBPL:BCCPA67 heterodimer for 
biochemical and structural studies, EDC and NHS were used as chemical cross-
linking reagents. SDS-PAGE analysis of apo-BCCPA67 incubated with AaBPL in 
the presence of EDC/N}zIS led to the time-dependent appearance of a species with a 
molecular weight of -P37 kDa which is in agreement with the predicted mass of a 1:1 
complex. A species with a mass of -P48 kDa which could correspond to a complex 
formed by two BCCPs and one AaBPL molecules was also observed by SDS-PAGE. 
Incubation of apo-BCCPA67 alone in the presence of EDC/NHS resulted in the 
formation of dimers and other higher aggregates stable under the SDS-PAGE 
reducing conditions which confirmed this hypothesis. Further cross-linking 
experiments with AaBPL and apo-BCCPA67 indicated that the reaction was ordered 
and involved activated acidic residues on apo-BCCPit67 which reacted with an 
amino side chain on AaBPL. The 3D model of the E. coli BirA:BCCP87 complex 
and the AaBPL/BirA sequence alignments were used to identify potential cross-
linked residues in the corresponding AaBPL:BCCPA67 complex. 15  Based on SDS- 
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PAGE results of cross-linking experiments with AaBPL and BCCPA67 single 
mutants, it appears that the salt bridge leading to the formation of a AaBPL-
BCCPA67 amide bond is due to the two non-conserved residues Lys 19 on AaBPL 
and G1u121 on B CCPA67. (Clarke, unpublished results) 
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3.1 Crystallization of A. aeolicus AaBPL 
The class I A. aeolicus AaBPL studied in this project was initially crystallized 
prior to the publication at the end of 2005 of the BPL structure from P. horikoshii. 12 
PhBPL also belongs to the class I BPL and possesses significant sequence homology 
with AaBPL (30.6 % sequence identity and 47.1 % sequence similarity). The 
sequence homologies displayed by the C-terminal of BirA and PhBPL remain similar 
to those measured for AaBPL (32.9% similarity for PhBPL and BirA, 20.9% 
identity, 35.2% similarity for AaBPL and BirA and 22.0% identity). Although the 
structures of PhBPL in complex with biotin, ADP and biotinyl-5'-AMP shed light on 
the residues important for catalytic activity, the exact position and orientation of ATP 
within the active site remained unclear. Mutation of the Argi 18 in BirA has been 
shown to dramatically affect the affinity of the enzyme for the different substrates. In 
P/iBPL, the equivalent conserved Arg48 plays only a minor role in binding biotin.' 
Important sequence differences are displayed within the biotin binding loop glycine-
rich motifs of the P. horikoshii, A. aeolicus and the E. coli enzymes (PhBPL: 
45GHGRLN50) while the 37GRGRLG50 motif of AaBPL is similar to that of BirA (See 
chapter 2, figure 2.1). 
Crystallographic studies of AaBPL were carried out in collaboration with 
Prof. Malcom Walkinshaw at the University of Edinburgh. The enzyme was 
crystallized by vapor diffusion and the 24 well plates were stored at 17 °C. An initial 
screening was performed with the Structure Screen 2 Kit (Molecular Dimension). 
Forty eight different trial conditions containing sterile filtered reagent combinations 
incorporating precipitants across a pH range of 4 to 9 were tested with a standard 
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AaBPL concentration of 6 mg. ml -1 . Diamond-shaped microcrystals of 0.05 mm grew 
in two weeks under three different trial conditions (Fig. 3.1, A). Two crystals from 
different plates were soaked into an equivalent reservoir solution supplemented with 
20% v/v sterile glycerol and frozen in liquid nitrogen. X-ray diffraction 
measurements at the European Synchrotron Radiation Facility (ESRF) in Grenoble 
(France) allowed data collection to a resolution of 2.8 A for both crystals. The 
sequence similarities displayed by AaBPL and BirA allowed the modeling of an 
initial structure of AaBPL by molecular replacement using the polyalanine backbone 
of the E. coil enzyme. The preliminary structure of AaBPL was solved by Dr. lain 
McNae using the programs MOSFLM and SCALA in the CCP4 suite and the 
coordinates were refined to a crystallographic residual RCRYST = 31% and RFREE = 
41% at 2.8 A resolution. 
To obtain better diffracting crystals, optimization was carried out for the three 
conditions in which crystals were previously obtained, at varying enzyme and 
precipitant concentrations, pH, temperature and ratios of enzyme / reservoir solution 
within the drops. The crystals grew overnight with different shapes and dimensions 
varying from microcrystals to needles of approximately 1 mm length (Fig. 3.1, B). 
The size of the needles reached 1.5 mm when crystallization was carried out at 4 °C 
(data not shown). A large number of crystals were generated in a more or less 
random process within the different drops of the optimization screens. However, 
preliminary X-ray diffraction at the home-beam in Edinburgh indicated that the 
crystals were disordered and the resolution of the data collected ranged from 3.5 to 7 
A. Further X-ray screening of the crystals was performed on the Edinburgh beam and 
at the ESRF and the Synchrotron Radiation Source (SRS) in Daresbury (U.K) on 
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crystals grown under more than twenty different conditions. The resolutions of the 
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Figure 3.1 - Crystals of apo-AaBPL The crystals were grown at 17 °C with the 
following precipitants. A: 0.2 M ammonium sulfate, 0.1 M MES pH 6.5, 30 % w/v 
PEG monoethylether 5,000. B: 0.1 M MES pH 7, 12% w/v PEG 20,000. C: 0.2 M 
ammonium sulfate, 0.1 M MES pH 6.5, 20% w/v PEG 5,000 monoethylether; D: 0.2 
M ammonium sulphate, 0.1 M MES pH 6.5, 14% wlv PEG 5,000 monoethylether. 
The conditions in which the crystals of AaBPL diffracted to the greatest 
resolution were chosen for further optimization. AaBPL was crystallized at a 
concentration of 5 mg.ml' and the drops contained 2 tl enzyme / 1 J.Ll reservoir 
solution. The wells contained 0.1 M MES, 0.2 M ammonium sulfate, 20% w/v PEG 
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5,000 monoethyl ether with a final pH range of 6 to 7. The crystals grew non-
reproducibly with a rectangular shape in few hours to a size of approximately 0.4 
mm (Fig. 3.1, C). X-ray diffraction of the crystals indicated resolutions lower than 
2.7 A. The immediate and promiscuous crystallization of AaBPL under such 
conditions appeared to contribute to the significant disorder observed within the 
crystals generated. To limit the nucleation sites due to impurities, the enzyme was 
centrifuged for 30 min at 4 °C prior to the crystallization setup. Lower PEG and 
enzyme (4.5 mg.mF') concentrations were also found to slow down the nucleation 
process and led to the formation of crystals which diffracted to a resolution of 2.3 A 
(Fig. 3.1, D). Data for the apo-crystals of AaBPL were collected at BM14 at the 
ESRF Grenoble and processed by Dr. lain W. McNae. The structure of AaBPL in the 
unbound form (apo-AaBPL) was solved by molecular replacement using the newly 
released structure of apo-PhBPL and the coordinates were refined to a 
crystallographic residual RCRYST = 21.39% and RFREE = 28.38% at 2.3 A resolution 
(Table 3.1). 
Many attempts were carried out to co-crystallize biotin with AaBPL under 
similar conditions as used for the apo-enzyme at different biotin concentrations 
ranging across 200 p.M to 2 mM (pH 12). Co-crystals with biotin grew overnight 
with a different hexagonal shape. However, these hexagonal crystals were disordered 
and destroyed within three days. Rectangular crystals which grew more slowly were 
chosen for X-ray diffraction at the synchrotron but the resolution of the data proved 
to be lower than 3 A. 
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Data collection and 
Processing.  
Apo ATP, biotin R40G, biotin 
Space group P2 1 P2 1 2 1 21 P2 1 2 1 21 






























Observations [high shell] 92480 [8941] 76866 [11290] 63143 [8673] 
Unique observations [high 
shell]  
20745 [2066] 21993 [3166] 13851 [1869] 
Multiplicity [high shell] 4.5 [4.3] 3.5 [3.6] 4.6 [4.6] 
Completeness (%) [high 
shell]  
92.4 [64.6] 98.9 [99.0] 88.1 [83.9] 
Mean IIa(I) [high shell] 22.4 [5.0] 10.4 [2.5] 12.6 [2.2] 
R merge (%) [high shell] 3.5 [30.8] 9.7 [42.3] 9.7 [63.9] 
Refinement 
Total atoms 3648 4071 3903 
Solvent atoms 87 181 131 
Resolution range (A) 31.47-2.30 39.62-2.30 28.84-2.55 
Rcryst(%) 21.39 20.86 20.00 
Rfree (%) 28.38 28.92 29.31 
R.M.S.D from ideal 
Bond lengths (A) 0.005 0.006 0.007 
Bond angles (deg) 0.695 0.902 0.932 
Ramachandran plot statistics 
Residues in most 
favoured regions (%)  
86.8 87.0 84 
Residues in additionally 
allowed regions (%)  
11.1 11.0 13.3 
Residues in generously 
allowed regions (%)  
1.6 0.5 1.5 
Residues in disallowed 
regions (%) 	 I  
0.5 1.5 1.2 
Table 3.1 - X-ray Data collection, Processing and Refinement Statistics. 
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Similarly, AaBPL was co-crystallized with 1 mM biotin and 5 mM ATP in 
the absence of MgCl2- Crystals grew within two to three days and these appeared 
more ordered than the AaBPL:biotin co-crystals. X-ray diffraction at SRS Daresbury 
station 10.1 allowed data collection to a resolution of 2.3 A. The structure was solved 
by molecular replacement using the structures of apo-AaBPL and PhBPL and the 
coordinates were refined to a crystallographic residual RCRYST = 20.86% and RFREE = 
28.92% (Table 3.1). 
3.2 Crystal Structure of AaBPL 
AaBPL displays linear sequence similarities with E. coli BirA and PhBPL 
and analysis of the crystal structures from the three different enzymes reveals that 
these similarities are also conserved in their overall folds and secondary structures 
(Fig. 3.2 & 3.3). 1; 4; 5 In the structure of apo-AaBPL, the first 186 residues of the 26 
kDa protein folds into a large N-terminal catalytic domain which adopts the 
conserved RRM fold containing seven 13-strands and five (x-helices (Fig. 3.2).6 In the 
catalytic domain, the two N-terminal parallel 13-strands are inaccessible to solvent 
while the remainder of the mixed 13-sheet has one face which is largely solvent- 
exposed and forms the active site (strands 03, 136 and 13). The Lys19 which was 
shown to interact with apo-BCCP67 by chemical cross-linking with EDC/NHS is 
located on the a1-helix which constitutes the bottom of the catalytic pocket. The 
smaller C-terminal domain (47 aa) contains a mixed 13-sheet of five strands and 
forms a 13-barrel similar to a SH3-module. 
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Figure 3.2 - Monomer structure of apo-AaBPL. Secondary structure elements CC-
helices (coloured red) and n-strands (coloured yellow) are numbered according to 
their position in the protein sequence. The disordered loop (residues 37 to 47) is 
represented by a green dashed line. 
The biotin binding loop, encompassing residues 37 to 47 (loop 02 - P3) 
containing the 37GRGRLG42 motif, is disordered in the structure of apo-AaBPL. The 
equivalent adenylate-binding loop, which only becomes organized upon ATP 
binding in BirA, is ordered in the structure of apo-AaBPL and the ATP binding site 
is consequently more structured (Fig. 3.2).' This observation supports our previous 
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ITC binding studies which showed that in contrast to apo-BirA, apo-AaBPL is 
capable of binding ATP in the absence of biotin (See section 2.5). Additionally, 
compared to other BPL structures, the surface loop connecting the J36  and 137  strands 
of the active site is shifted towards the catalytic pocket in AaBPL (Fig. 3.3). 
I 
Figure 3.3 - Dimer comparison of PhBPL and AaBPL. Left image: PhBPL dimer, 
monomers A and B from the crystal asymmetric unit are coloured blue and green 
respectively. Right image: AaBPL monomers A and B are coloured red and yellow 
respectively. Central image: overlay of chains A from PhBPL and AaBPL dimers in 
the crystal asymmetric unit. Colouring is as for individual images. 
Unlike AaBPL, PhBPL has been shown to be dimeric in solution by dynamic 
light-scattering experiment and this dimer is also observed in the crystal form (See 
section 2.2)) There are no structural similarities between the homodimers formed by 
PhBPL and BirA. While in the crystal structure of dimeric BirA the 13-strands of the 
catalytic domains form a seamless 13-sheet interface, the structure of P/IBPL indicates 
that the two subunits of the homodimer are associated via a 13-sheet formed by the 13'- 
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strands of each monomer (Fig. 3.3). The crystals of apo-AaBPL are monoclinic 
and belong to the space group P2 1 , while the crystals of AaBPL in complex with, 
biotin and ATP belong to the orthorhombic system and possess a P2 1 2 1 2 1 symmetry 
(Table 3.1). Similarly to the P. horikoshii structure, the asymmetric unit of AaBPL 
consists of two monomers related by a pseudo-two fold axis.' However, in the 
structure of apo-AaBPL, the 13 1 -strands are located in close proximity but do not form 
the inter-subunit 13-sheet observed in PhBPL (Fig. 3.3). Thus, in contrast to the P. 
horikoshii enzyme, AaBPL does not constitute a functional homodimer. 
3.3 The AaBPL:Biotin:ATP Complex 
3.3.1 The Biotin and ATP Binding Sites of AaBPL 
In the structure of AaBPL in complex with biotin and ATP 
(AaBPL:biotin:ATP), the two ligands are fully ordered as are residues 37-47 which 
form the biotin binding loop (Fig. 3.4 & 3.5, a). The peptide segment stabilizes the 
biotin and ATP moieties inside the active site with strong hydrophobic and 
hydrophilic interactions. Biotin is shown to interact with the biotin binding loop as 
well as the solvent exposed 136  and 3' strands and a 1 -helix. The tetrahydrothiophene 
ring of the biotin is accommodated in the interior of the binding pocket formed by 
residues Glyl 19 and G1y121 of the 137-strand. The nitrogen atoms of the ureido group 
hydrogen-bond with the side chain of Gln34 and the backbone carbonyl of Arg38 
from the biotin binding loop and with the side chain of Thr14 from the a 1 -helix. In 
addition, the ureido carbonyl forms hydrogen-bonds with the hydroxyl group of 
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Serl3 from the 0 1 -a 1 loop and the backbone NH of Arg38 (Fig. 3.5, b). The aliphatic 
tail of the biotin is held by a sandwich of two hydrophobic walls formed by the 
residues G1y106, Va1107, and LeulO8 from the p 6-strand on one side, and on the 
other side, the residues G1y37, Gly39, Trp45, and Leu46 from the biotin binding 
loop. 
Figure 3.4 - Stereo view of AaBPL bound to biotin and ATP. Cartoon 
representation of AaBPL monomer A; the ligands ATP, biotin and the Arg40 residue 
are represented as sticks with grey carbons. 
The biotin carboxylate is adjacent to the turn of the biotin binding loop and is 
strongly stabilised by hydrogen-bonds with the side chain of the Arg40 from the 
37GRGRLG 50 motif (Fig. 3.4 & Fig. 3.5). Additionally, the carboxyl group interacts 
weakly with the Arg40 backbone NH and the side chain of Lys 103 from the 36-
strand. The biotin carboxylate lies toward the outside of the active site, near the ATP 
binding pocket. We find that the oxygen atoms of the carboxyl group of the biotin 
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and the a-phosphate of ATP are located in close proximity (approximately 3.5 A; 
figure 3.5, b). Therefore, the nucleophilic attack of the carboxylate anion at the a-
phosphate of ATP, resulting in the formation of the phosphoanhydride bond of 
biotinyl-5'-AMP, induces only minor conformational changes to the active site. 
Comparison of the structures of the AaBPL:biotin:ATP and PhBPL:biotinyl-5'-AMP 
complexes shows that the orientation of the biotin and the adenine ring and sugar 
moiety of ATP within the active sites are similar in the two complexes.' In the 
structure of PhBPL bound to biotinyl-5'-AMP, the intermediate adopts a U-shaped 
conformation allowing the phosphoanhydride bond to protrude from the adenylate 
binding site. This conformation exposes it for subsequent reaction with the lysine of 
Polar and electrostatic interactions with residues Asn123, 1le133 and Arg136 
from the adenylate-binding loop and residues Trp45, Leu46 and Ser47 from the 
biotin binding loop contribute to the correct positioning of the adenine ring of ATP 
in the active site. The a-phosphate of ATP is stabilised via a network of hydrogen-
bonding interactions with the side chains of Arg40, Arg43 and Lys 103. In addition to 
these interactions, the crystal packing allows the formation of hydrogen-bonds 
between the oxygen atoms of the cc-phosphate of ATP and the side chain of Lys 192 
from the second monomer of the asymmetric unit (Fig. 3.5, b). 
118 


















Figure 3.5 —Stereo views of the active site of the AaBPL:biotin:ATP complex. (a) 
Active site of AaBPL monomer A with the electron density shown around the ligand 
biotin and ATP and the Arg40 (Blue coloured chickenwire). Final 2IF0I-IFI  map is 
contoured at la. (b) Binding interactions of ATP and biotin within the AaBPL 
monomer A active site. ATP and biotin are coloured with green carbons, H-bonds are 
shown as dashed red lines. Lys 192 is from the B monomer. 
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The structure of the AaBPL:biotin:ATP complex reveals that the 3- and y-
phosphates are solvent-exposed and protrude from the adenylate binding site 
delineated by the 135  and 136 strands on one side and the turns of the biotin and 
adenylate binding loops on the other, and point into the inter-subunit cavity formed 
by the N- and C-terminal domains (Fig. 3.4). In the crystal, the P-phosphate is 
stabilised by the hydrophilic environment formed by Asp96 from the 13 5-strand and 
the side chains of Arg40, Lys92 and Lys 103. The y-phosphate interacts weakly with 
the hydroxyl group of Tyr98 and the side chain of Lys92 from the 04 and 05 strands 
respectively. Interestingly, the structure of the biotin-ATP complex reveals that the 
hydroxyl group of Ser229 from the 13 1 2-strand located on the C-terminal domain also 
form hydrogen-bonds with the oxygen atoms of the y-phosphate (Fig. 3.5, b). 
Although Mg2  can not be visualised, the terminal diphosphate is in a position which 
allows binding of divalent metal ions. This is presumably a prerequisite for 
elimination of the pyrophosphate and formation of biotinyl-5'-AMP. 
3.3.2 Capture of the Biotin-ATP Intermediate Complex of AaBPL: 
The Role of the Arginine 40. 
The orientation of the side chain of Arg40 and the interactions made by this 
conserved residue in the structure of the AaBPL:biotin:ATP complex are of 
particular note. These differ significantly from those of the equivalent Argi 18 in 
BirA and Arg48 in P/iBPL.' In the biotin-ATP ternary AaBPL complex, Arg40 
plays an essential role in stabilising the biotin and ATP ligands within the active site 
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(Fig. 3.5). The structure of the AaBPL complex reveals that the side chain of Arg40 
interacts with the carboxyl group of the biotin and forms direct hydrogen-bonds with 
the oxygens of the a- and 3-phosphates of ATP. The backbone NH of the Arg40 
residue also interacts with the carboxyl group of the biotin. This orientation of the 
conserved arginine side chain has not been observed in other ligand-bound BPL 
structures. 
In the structure of the BirA:biotin complex, the backbone NH of Argi 18 
forms hydrogen-bonds with the carboxyl group of the biotin and in the complex with 
biotinol-5'-AMP, the backbone NH interacts with the oxygen atoms of the phosphate 
group of the analogue. 4 Thus, in the BirA complexes, the side chain of the 
conserved Arg 118 appears to play mainly a structural role by closing the active site 
and sequestering the ligands via weak hydrophilic interactions. 
The structure of PhBPL bound to biotin and ATP was recently solved by 
Bagautdinov et al. and the coordinates of the complex have been deposited in the 
protein databank (PDB entry: 213TO). In the directly comparable structure of the 
PhBPL:biotin:ATP complex, the equivalent Arg48 stabilises the a-phosphate of ATP 
by strong hydrogen-bonding. While in the structure of AaBPL:biotin:ATP, the side 
chain of the Arg40 adopts a bent conformation in order to interact with the biotin 
carboxylate, in the PhBPL:biotin:ATP complex, the side chain of the Arg48 points 
towards the 7-phosphate and has a similar orientation with respect to the triphosphate 
chain (Fig. 3.6). The conformation of the Ar948 allows the side chain to form a 
network of weak hydrogen-bonds with the oxygen atoms from the three phosphate 
groups of ATP. However, neither the backbone NH nor the side chain of the Arg48 
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Figure 3.6 - Stereo view of the overlay of the AaBPL and PISBPL biotin-ATP 
complexes binding sites. AaBPL colouring: red cartoon, ATP, biotin and Arg40 
shown as sticks with pink carbons. PhBPL colouring: blue cartoon, ATP, biotin and 
Arg48 shown as sticks with light blue carbons. The equivalent arginines and ATP are 
seen to be significantly different in their positions. 
In the P. horikoshii enzyme, LysI 11 from the p 6-strand has been proposed to 
be involved in the formation of biotinyl-5'-AMP by stabilising the a-phosphate upon 
formation of the phosphoanhydride bond. In the structure of the AaBPL:biotin:ATP 
complex, the equivalent conserved Lys 103 adopts a similar conformation but here 
forms weak interactions with the biotin carboxylate and the a-phosphate of ATP 
which is shifted towards the Arg40.' The phosphate chain of bound ATP adopts a 
slightly different orientation in the active sites of AaBPL and PhBPL while the 
position of biotin is similar in the two complexes. The main structural differences 
observed between the AaBPL and PhBPL biotin-ATP complexes are located on the 
biotin binding loops (Fig. 3.6). The two loops adopt different conformations which 
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are a result of the sequence differences between their glycine-rich motifs. In 
comparison to the AaBPL:biotm:ATP structure, in the PhBPL complex, the loop is 
displaced and the side chain of the Asn50 is solvent-exposed and interacts weakly 
with His46. 
3.4 Discussion 
The crystal structures of AaBPL have been determined in the apo-form and in 
complex with biotin and ATP. The geometry of this complex is revealing and seems 
similar to that of the intermediate state which is expected to immediately precede 
biotinyl-5'-AMP formation. In the structure of the AaBPL:biotin:ATP complex, the 
bulk of both the biotin and the AMP moiety of ATP are buried and the biotin 
carboxylate and the a-phosphate are located in close proximity to each other at the 
entrance of the active site. The binding of Mg 2 and subsequent nucleophilic attack 
of the carboxylate anion on the a-phosphate, leading to the formation of the 
phosphoanhydride bond of the product, would induce only minor changes to the 
conformation of the active site. 
AaBPL displays high structural similarities with BirA and the P. horikoshii 
BPL enzyme." 4  Similarly to PhBPL, the structure of apo-AaBPL reveals only one 
disordered surface loop.' In AaBPL, the peptide segment encompassing residues 37-
47 which forms the biotin binding loop becomes organized upon ligand binding and 
largely encloses the biotin and ATP moieties. The loop appears to act as a partial lid 
to the active site and protects the ligands from the solvent. On one side of the loop, 
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G1y37, G1y39 and the aliphatic chain of Arg38 stabilize the hydrophobic tail of the 
biotin. On the other side, Trp45, Leu46 and Ser47 play important roles in the correct 
positioning of the adenine ring of ATP in the active site. The Arg40 from the 
glycine-rich motif 37GRGRLG42 is located at the turn of the loop. The side chain of 
the conserved arginine interacts with the biotin carboxyl group and together with the 
Arg42 forms a network of hydrogen-bonds with the cc-phosphate of ATP. Arg40 
appears to play an important role in positioning the biotin carboxylate in proximity to 
the cc-phosphate and in the neutralisation of the negative charges of the phosphate 
chain of ATP. 
In the structure of the AaBPL:biotin:ATP complex, the P and 7 phosphates of 
ATP are solvent-exposed and pointing towards the cavity formed by the N- and C-
terminal domains. The inter-subunit domain can readily accommodate the Mg 2+  ion 
required for stabilization and elimination of the diphosphate chain. The oxygen 
atoms of the ATP y-phosphate are shown to form long range hydrogen-bonds with 
the backbone NH of residues Ser229 and Leu230 located on the 012  strand of the C-
terminal domain and this remains the first direct demonstration that interactions 
between the C-terminus and ATP occur. Mutagenesis analyses previously carried out 
on BirA support the interactions between ATP and the C-terminus observed in the 
AaBPL structure. Single-site mutations within the C-terminal domain of BirA 
revealed that residues located at some distance from the active site directly affected 
Mg2tATP binding.8 For example, the affinity of the mutant BirA R3 1 7E for MgATP 
was determined to be 25-fold lower than wild-type BirA. In the structure of the 
AaBPL:biotin:ATP complex, this conserved arginine, equivalent to the Arg231, is 
adjacent to Leu230 and the side chain is located in the vicinity of the 7-phosphate. 
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In the model of the E. coli BirA:BCCP87 complex, the turn of the loop of 
BCCP87 containing the biotinylated Lys 122 and the conserved AMKM biotinylation 
motif is located at the entrance of the inter-subunit cavity formed by the central and 
C-teminal domains of BirA (See chapter 2, figure 2.20). The side chain of Lys 122 
from BCCP87 is adjacent to the Argl 18 of BirA, while the Metl2l and Met123 
interacts respectively with the corresponding 135  and 1312  strands of AaBPL. In the E. 
co/i complex, the interior of the inter-subunit cavity of BirA is free from side chain 
interactions with BCCP87. Therefore, the presence of the terminal diphosphate and 
Mg 2+  ion within the cavity would not interfere with the formation of a BPL:BCCP 
complex. In AaBPL, the Lys19 shown to interact with G1u121 of apo-BCCPA67 by 
chemical cross-linking with EDC and NHS is located on the a 1 -helix and is solvent-
exposed. Hydrophilic interactions formed by Lys19 and Glul2l of BCCPM7 would 
protect the bottom of the interface of the AaBPL:BCCPA67 complex. The catalytic 
pocket and the ligands appear to be enclosed in the core of the complex which limits 
loss of biotinyl-5'-AMP by diffusion into the media ensuring that the adenylate is 
specifically transferred to the target lysine of BCCP. 
Additionally, mutation of Lys 277 in BirA, which is spatially in proximity of 
the Arg3 17, to a glutamic acid residue was demonstrated to restore the activity of the 
mutant apo-BCCP87 El 19K which was previously shown to be poorly biotinylated 
by the wild-type enzyme. 8 On the basis of this result, the C-terminal domain of BirA, 
which had been ascribed no biochemical function, has been proposed to play a role in 
protein-protein recognition and in mediating the formation of a BirA:BCCP complex. 
In the structures of the BPLs, the C-terminal domain adopts a Src-homology 3-like 
fold (SH3) which was also found in the structural homolog phenylalanine tRNA 
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synthetase (PheRS).10 ' The SH3 fold consists of two antiparallel n-sheets, packed 
against each other at an approximate right angle. Eukaryotic Src homology regions 2 
and 3 domains are conserved protein modules of 50-70 amino acids long found in a 
variety of proteins with important roles in signal transduction pathways. 12 ; 13 These 
non-catalytic domains are conserved among a series of cytoplasmic signaling 
proteins regulated by receptor protein-tyrosine kinases, including phospholipase C-
gamma, Ras GTPase (guanosine triphosphatase)-activating protein, and Src-like 
tyrosine kinases, whereas the SH3 domains of AaBPL, BirA, P/IBPL and PheRS are 
essential constituents of prokaryotic ligases and synthetases. In the structure of 
Thermus thermophilus PheRS, the enzyme undergoes disorder-to-order transition 
upon aminoacyl and ATP binding similar to that observed in AaBPL and BirA.' 47 
In presence of phenylanyl-AMP, PheRS adopts a closed conformation and the SH3 
module is shifted towards the active site. Those concerted conformational changes 
have been shown to be necessary for the correct order of substrate binding in the 
overall phenylalanylation reaction. 17 Although the SH3 C-terminal domain ofAaBPL 
appears to undergo only minor conformational changes upon ligand binding, those 
differences may be sufficient to play a role in the formation of the AaBPL:BCCP 
complex. 
Interestingly, the orientations of the substrates and the triphosphate chain of 
ATP characterized within the active site of AaBPL are not conserved in the 
structurally homologous class II tRNA synthetases. In the structures of class II 
aaRSs, ATP adopts a U-shaped conformation and the 3 and y phosphates are solvent-
exposed. 18  Investigation of the structures of T. thermophilus glycyl-tRNA synthetase 
bound to ATP and glycyl-AMP showed that the ATP phosphate chain, located at the 
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entrance of the active site, is bent away from the binding site of the glycyl moiety. 18 
The resultant aminoacyl-adenylate adopts an extended conformation which has also 
been characterized in PheRS complexed with phenylalanyl-AMP. 17 Analyses of the 
structures of Staphylococcus aureus threonyl-tRNA synthetase bound to ATP and 
Zn2 and to an adenylate analog (threonyl-AMS) as well as the MgATP and alamne 
complexes of A. aeolicus alanyl-tRNA synthetase suggest that this binding mode is 
common in class II tRNA synthetases! 920 
The U-shaped conformation of ATP has also been demonstrated in the 
structures of Thermoplasma acidophilum LpIA (TaLp1A). 21 In the complex of 
TaLpIA bound to MgATP, the phosphate chain of the ATP moiety points inward 
towards the bifurcated lipoyl-AMP binding pocket which is only accessible through a 
tunnel-like entrance. 21  The n-phosphate occupies roughly the same position as the 
carboxyl group of lipoic acid inside the cavity. The structure of TaLpIA reveals a 
peptide segment similar to the biotin binding loop which contains a conserved 
sequence motif 71 RRkXGGGXV(FfY)HD82. The bent conformation of the 
triphosphate group is maintained through strong interactions with the side chain of 
the conserved Arg72 inside the lipoic acid binding pocket.22 23  The structure of 
TaLp1A bound to lipoic acid suggests that the Arg72 stabilizes the negative charge of 
the co-factor carboxylate during ATP binding and formation of the 
phosphoanhydride bond.22 23  If ATP were to bind prior to lipoic acid, the 0 and y-
phosphate groups of ATP would have to be released from the binding pocket when 
lipoic acid enters the binding site. The environment surrounding the diphosphate 
chain in the TaLp1A:ATP complex is highly hydrophobic, and thus it would 
preferentially bind lipoic acid .21  In TaLpIA, the intermediate lipoyl-AMP has been 
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shown to adopt a bent conformation identical to that described in the 
PhBPL:biotinyl-5 '-AMP and BirA:biotinol-5 '-AMP complexes. 1; 7 
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4.1 Cloning, Expression and Purification of Mutant AaBPL 
R406 
The structure of AaBPL in complex with biotin and ATP has allowed 
characterization of the residues important for substrate binding. It is now clear that 
Arg40 plays a key role in stabilizing and positioning the biotin and ATP moiety 
within the active site. The equivalent Argi 18 in E. coli BirA is important for 
substrate specificity and the BirA RI 18G mutant was recently demonstrated to 
biotinylate promiscuously in vivo and in vitro non-cognate proteins.' On the basis of 
the fact that BirA R1 18G binds biotinyl-5'-AMP less tightly than wild-type BirA 
(KD =20 nM and KD =45 pM respectively), it has been suggested that this could be a 
direct consequence of non-specific solution reactions of free biotinyl-5 '-AMP with 
exposed lysine residues.' 2  However, the mechanism involved in this promiscuous 
biotinylation is not clearly understood and despite the crystallographic data obtained 
for the different BirA complexes, the role of the conserved arginine from the glycine 
motif in the normal catalytic process remains unclear. 
Similarly to the E. coli mutant BirA RI 18G, the Arg40 residue of AaBPL was 
mutated to a glycine to explore the functional role of the interactions made by the 
side chain of the conserved arginine residue. The A. aeolicus bpl R40G gene was 
produced by site directed mutagenesis and the PCR product was cloned into a 
pGEM-T easy vector (Promega). The mutation was confirmed by DNA sequencing 
and the mutated A. aeolicus bpl R40G gene was subsequently cloned into the pET28a 
expression vector using the restriction enzymes NcoI and BamHI (Fig. 4.1). 
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Figure 4.1 - Expression vector pET28a/AaBPL R40G. The mutated Aqufex bpl 
R40G gene was cloned using the NcoI and BarnHJ restriction sites. 
The resulting construct was then transformed into E. co/i BL2 1 (DE3) cells at 
37 °C and induction was performed with 1 mM IPTG. The expressed protein was 
purified by cation exchange chromatography in an identical manner to wild-type 
AaBPL. The mutant enzyme eluted with 150 mM NaCl on the HR 10/100 15S 
column with a purity of more than 95% as determined by SDS-PAGE (Fig. 4.2). The 
resulting yield of pure AaBPL R40G was greater than that of the wild-type enzyme 
(- 10 mg / litre of cell culture). Gel filtration analysis of AaBPL R40G carried out on 
a HiLoad 16/60 Superdex75 column indicated that like the wild-type enzyme, the 
mutant R40G is monomeric in the apo-form and in the presence of substrates. 
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Figure 4.2 - Purification and SDS-PAGE analysis AaBPL R40G. (a): 
Chromatogram of AaBPL R40G purification on a HR 10/100 15S column. The 
protein eluted with 150 mM NaCl. (b): Protein purification was analysed by SDS-
PAGE under reducing conditions. Lane 1, low molecular weight marker 
(Amersham), lane 2, AaBPL R40G flow-through, lane 3, wash fraction, lane 4-8, 
eluted fractions 5 to 9. 
Analysis by LC-ESI-MS confirmed the purity of the protein as a single 
species with a measured mass of 26,542 ± 3 Da, which is in agreement with the 
predicted molecular weight of 26,535.43 Da. Western blotting analyses with 
streptavidin showed that purified AaBPL R40G was not biotmylated even after 
incubation with biotin at 60 °C. However, addition of ATP and Mg 2 to the 
incubation mixture resulted in hyper-biotinylation of the mutant indicating that 
AaBPL R40G remained capable of catalyzing the formation of biotinyl-5'-AMP and 
had modified itself (Fig. 4.3). In contrast, previous streptavidin western blotting 
studies had shown that the equivalent E. co/i mutant BirA RI 18G was self-
biotinylated in vivo. The fact that AaBPL R40G remained unbiotinylated when 
expressed in E. coli could be attributed to the temperature dependence of the 
biotinylation reaction in A. aeolicus.' Activity assays performed by Clarke et al. with 
native AaBPL at varying temperatures indicated that the optimal activity at 70 °C 
133 
Chapter 4: The Mutant AaBPL R40G 
decreased by roughly 50% for every 10 °C drop in temperature with almost no 
activity detected at 37 °C. 3 Increasing the temperature above 70 °C resulted in 
enzyme precipitation with a dramatic loss in activity. 
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Figure 4.3 - Streptavidin western blot analysis of wild-type AaBPL and mutant 
AaBPL R40C. Left panel (lane 1-6): SDS-PAGE; right panel (lane 7-12): 
streptavidin western blot. Lane 1-3 & 7-9, AaBPL; lane 4-6 & 10-12, AaBPL R40G; 
lane 2, 4, 8, 11, incubation in presence of biotin at 60 °C; lane 3, 6, 9, 12, incubation 
in presence of biotin, ATP, MgCl 2 at 65 °C. 
For comparison by mass spectrometry, E. coil BirA RI 18G was also 
expressed in an ampicillin-resistant pBTac vector in E. coil JM109 competent cells. 
Induction of the birA R118G gene was carried out with 0.4 mM IPTG at 30 °C and 
the resulting C-terminal hexahistidine-tagged soluble protein was purified by nickel 
affinity chromatography. LC-ESI-MS analysis of BirA RI 18G indicated that the 
purified enzyme mixture was highly heterogeneous (Fig. 4.4). A number of different 
species with different elution times on the CS column could be identified with 
molecular masses ranging from 36,078 ± 11 Da (predicted molecular weight of His 6-
BirA RI 18G = 36,133.02 Da) to approximately 37,500 Da which corresponds to the 
addition of up to seven biotin molecules. ESI-MS analysis by direct infusion revealed 
a series of species with increasing molecular weight and intensities confirming that, 
in contrast to AaBPL R400, BirA RI 18G was biotinylated in vivo. 
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Figure 4.4 - LC-ESI mass spectrum of BirA R118G. The mixture is heterogenous 
indicating the presence of non-modified and of biotinylated species (predicted mass 
ofBirARll8G= 36,133.02 Da). 
4.2 Crystal Structure of AaBPL R400 in Complex with Biotin 
4.2.1 Crystallization of AaBPL R40G 
The mutant AaBPL R40G was initially crystallized under similar conditions 
as the native enzyme and optimization was carried out by varying the PEG 
concentrations across a pH range of 5.5 to 6.5. Crystallization of the mutant was 
performed at a concentration of 6 mg. ml -1 and the mutation was shown to have a 
dramatic impact on the growth of the crystals. The rapid and extensive nucleation 
observed with native AaBPL was significantly reduced and it took 4 days to two 
weeks for the crystals to grow reproducibly with a rectangular shape to a size of 
approximately 0.5 mm (Fig. 4.5). X-ray diffraction at BM14 at the ESRF Grenoble 
allowed data for the crystals of apo-AaBPL R40G to be collected to a resolution of 
2.3 A. The structure of the apo-R40G mutant indicated that the mutated biotin 
binding loop was disordered and thus the mutation itself could not be visualised in 
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the electron density. The apo-structures of both the native and mutant enzymes are 
consequently equivalent. 
1mm 
Fig.4.5 —Crystal of mutant AaBPL R40G. The mutation R40G was found to have a 
dramatic impact on the nucleation process. 
AaBPL R40G was also co-crystallized with biotin (2 mM) and ATP (5 mM). 
The structure of the mutant co-crystallized with ATP indicated no electron density 
for the nucleotide or for the biotin binding loop suggesting that the mutation might 
have affected ATP binding. Using a single co-crystal with biotin which diffracted to 
2.55 A at the BM 14 at the ESRF Grenoble, the structure of the mutant bound to the 
ligand was solved. This revealed a clear electron density for the R40G containing 
loop and for the bound biotin. The crystals of the AaBPL R40G:biotin complex are 
orthorhombic and belong to the space-group P2 3 2 1 2 1 . The coordinates of this mutant 
structure were refined to a crystallographic residual RCRYST = 20.00% and RFREE = 
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29.3 1% at 2.55 A resolution (See chapter 3, table 3.1). Co-crystallization with both 
biotin and ATP gave very fragile crystals with different shapes and sizes and X-ray 
diffraction measurements indicated that they were disordered. Optimization of the 
co-crystals screens at different pH and temperature was unsuccessful. 
4.2.2 Crystal Structure of AaBPL R40G in complex with biotin 
In the crystal structure of the mutant AaBPL R40G determined in complex 
with biotin, the clear density for the R40G containing loop and biotin indicates that 
biotin binding stabilises the loop (Fig. 4.6, a). The main conformational differences 
observed between the structures of the mutant and the wild-type enzymes are located 
within the active site. The biotin binding mode of the AaBPL R40G:biotin complex 
closely resembles that of the ATP-biotin complex of the wild type enzyme. While the 
ureido group and thiophene ring show near identical interactions with the wall 
formed by the 136  and  07 strands in both structure, in the mutant the carboxylate group 
of biotin is shifted towards the side chains of Lys 103 and Asp96 on the 136  and 07 












Figure 4.6 - Stereo views of the mutant AaBPL R40G:biotin complex binding 
site. (a) Electron density is shown around the R40G containing loop (blue coloured 
chickenwire) and the biotin ligand (green coloured chickenwire). Final 2F0 I-IFI map 
contoured at 1 a is shown. (b) Comparison of the loop positions between the mutant 
AaBPL R40G:biotin complex and native AaBPL:biotin:ATP complex. ATP, biotin 
and Arg40 are shown as sticks in the native structure with grey coloured carbons. 
The mutant loop and complexed biotin are coloured green. The loop position of 
AaBPL R40G can be clearly seen to preclude ATP binding. 
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The biotin binding loop (residues 37-47) containing the R40G mutation 
adopts a dramatically different conformation to the one observed in the 
AaBPL:biotin:ATP wild-type complex structure (Fig. 4.6, b). As a result, the 
interactions with the glycine-rich motif 37GRGGLG42 have changed significantly and 
the ATP binding site is now blocked by side chain interactions. In the structure of the 
mutant, the side chain of Arg38 adopts a different orientation and points towards the 
oxygen atoms of the ureido group. The carboxylate group of the biotin interacts via 
hydrogen-bonds with the backbone NH of the mutated G1y40, which occupies the 
binding site of the cc-phosphate of ATP. The backbone and side chain of Leu4 1 have 
shifted towards the active site and now blocks ribose sugar binding. 
The strong hydrogen bond formed between the backbone NH of the G1y42 
and the backbone carbonyl of the G1y39 stabilises the turn of the loop formed by the 
aliphatic mutated GRGGLG motif. While in the structure of the native complex the 
side chain of the Arg43 interacts with the cc-phosphate of ATP, in the structure of the 
mutant complex the side chain of this residue points towards the solvent. The loop is 
bent at the location of the Arg43 and the side chain of the Trp45 interferes with the 
positioning of the adenine ring of ATP. Furthermore, the side chain of Leu46, which 
contributes to the stabilisation of ATP in the native AaBPL complex, interacts with 
the aliphatic chain of the biotin in the structure of the mutant complex and hinders 
the binding of the adenine ring of ATP in the active site. 
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4.3 Binding Studies of AaBPL R40G 
To investigate the role of Arg40 in the ligand binding process, isothermal 
titration calorimetry experiments were also carried out with AaBPL R40G. Titrations 
of the mutant under the same experimental conditions as used for wild-type AaBPL 
indicated that AaBPL R40G binds biotin in an exothermic process (Fig. 4.7, A). The 
affmity for biotin was determined to be only 2.5-fold lower than that observed for the 
native enzyme suggesting that, in contrast to the E. co/i mutant BirA RI 18G, the R to 
G mutation has little effect on biotin binding in AaBPL (Table 4.1). 
Thus, while the affinity of BirA for biotin is approximately a hundred-fold 
greater than that of AaBPL, the dissociation constants for the biotin complexes of the 
two mutants BirA RI 18G and AaBPL R40G are similar (KD = 1.8 tM and KD = 8.3 
.tM respectively) .2  Biotin was also shown to bind to AaBPL R40G with a KD = 15.4 
tM when the mutant was titrated in the presence of ATP (Fig. 4.7, B). This small 
difference, a factor of ca 1.9, between the two measured dissociation constants for 
AaBPL R40G indicates that the presence of ATP does not significantly alter biotin 
binding. The thermodynamic parameters derived from the titrations shows that both 
apparent enthalpy and entropy changes are favourable for biotin binding to the 
mutant and remain similar in the presence of ATP. 
In contrast to the biotin data, titrations of the mutant enzyme with ATP 
showed only small signals, principally due to heat of dilution, indicating that binding 
of ATP to AaBPL R40G is negligible (KD > 200 jiM) under these conditions (Fig. 
4.7, Q. Thus, the side chain of the Arg40 appears to be necessary for ATP binding in 
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the absence of Mg2 . Titration of biotin-bound mutant with ATP also showed very 
weak binding (KD > 200 tM; figure 4.7, D). 
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Fig.4.7 - Isothermal titration calorimetry data of AaBPL R40G. Titration (A) 
with biotin (B) in presence of ATP and (C) with ATP (D) in presence of the binary 




















AaBPL R40G + biotin 83:k 2.1 -23.4 ± 6.3 -5.4 ± 15.9 -28.9 ± 9.7 
AaBPLR40G:biotin + ATP >200 Nd Nd Nd 
AaBPLR4OG+ATP >200 Nd Nd Nd 
AaBPL R40G:ATP + biotin 15.4 ± 3.7 -24.7 ± 10.0 -2.5 ± 18.8 -27.2 ± 8.8 
BirA R118G ± biotin 1.810.4 -39.3 ±1.3 -7.1±1.3 -32.2 ± 0.4 
Table 4.1: Thermodynamic parameters of biotin and ATP binding to AaBPL 
R40G. The data are derived from the ITC measurements of AaBPL R40G with biotin 
and ATP in the absence and in the presence of the second ligand. The error in AH is 
± 5% and is mainly due to the differences in enzyme and ligand concentrations. AG O  
is calculated from the binding determined by ITC: AGO = -RT InKA = AH - T.AS ° . 
The thermodynamic parameters of E. coli BirA RI 18G binding to biotin are also 
reported for comparison. 24 
4.4 Substrate Biotinylation with AaBPL R40G 
It has been shown that the C-terminal domain of A. aeolicus BCCP 
(BCCPA67) is a substrate for biotinylation with AaBPL. Streptavidin western blot 
studies indicated that incubation of apo-BCCPA67 with AaBPL or with the mutant 
AaBPL R40G in presence of biotin, ATP and MgCl2 for 20 min at 65 °C led to the 
formation of biotinylated-BCCPA67 (Fig. 4.8). On the basis of the western blots of 
the reactions, the R40G mutant appears to be a poorer catalyst than the wild type 
enzyme (Fig. 4.8, lanes 9 & 10). Western blot analysis also revealed that the mutant 
substrate BCCPA67 K! 17L, which lacks the target Lys i 17, is not biotinylated by 
AaBPL or AaBPL R40G showing that none of the remaining four lysine residues 
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Figure 4.8 - Streptavidin western blot of apo-BCCPA67 and BCCPA67 K1 17L 
biotinylated with AaBPL and AaBPL R40G. Left panel (lane 1-7): SDS-PAGE; 
right panel (lane 8-14): western blot. Lane 1 & 8, apo-BCCPz67; lane 2 & 9, apo-
BCCPA67 incubated with AaBPL in presence of biotin, ATP, M902  at 65 °C for 20 
mm; lane 3 & 10, apo-BCCPA67 incubated with AaBPL R40G in the same 
conditions; lane 4 & 11, BCCPA67 K117L; lane 5 & 12, BCCPt67 K1I7L 
incubated with AaBPL in presence of biotin, ATP, M902 at 65 °C; lane 6 & 13, 
BCCPA67 KII7L incubated with AaBPL R40G in the same conditions; lane 7 & 14, 
BCCPA67 K  17L incubated with AaBPL R40G in presence of 100 l.IM biotin, ATP, 
MgC12 at 65 °C. 
Biotinylation of apo-BCCPA67 with AaBPL R40G was also monitored by 
mass spectrometry (Fig. 4.9). LC-ESI-MS analysis of the biotinylated BCCPt67 
from the R40G catalysed reaction revealed the formation of only one species with a 
measured mass of 10,967 ± 2 Da which is in agreement with the predicted molecular 
weight of holo-BCCPA67 (10,965.94 Da). The increased mass of approximately one 
biotin (+227 Da) confirmed the formation of only single-biotinylated BCCPL\67 
species. 
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Figure 4.9 - LC-ESI mass spectra of apo-BCCP67 biotinylated with AaBPL 
and AaBPL R40G. The mass spectra show the +6 to +11 charge states and the 
charge deconvoluted masses. (a): apo-BCCPA67 incubated in presence of biotin, 
ATP, MgCl2 at 65°C for 15 mm. (b): apo-BCCPA67 incubated with AaBPL in the 
same conditions. (C): apo-BCCPA67 incubated with AaBPL R40G in the same 
conditions. Predicted mass for apo-BCCPA67: 10,739.63 Da; predicted mass for 
holo-BCCPA67: 10,965.94 Da 
However, while the wild-type AaBPL was shown to be stable during the 
biotinylation assays, the mutant AaBPL R40G was highly modified in presence of 
biotin and MgATP at a temperature above 45 °C. Western blots of these reactions 
revealed that, in contrast to the wild-type enzyme, the mutant AaBPL R40G self-
biotinylates (Fig. 4.8). This was confirmed by matrix assisted laser desorption-
ionization mass spectrometry (MALDI-MS) analysis of the R40G species which 
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showed mass increases after incubation ranging from '-200 to —2000 Da indicating 
that the mutant, which has 29 lysine residues, undergoes multiple biotinylation (Fig. 
4.10). The extent of auto-biotinylation observed by MALDI-MS was directly 
affected by the concentration of biotin and the incubation time as well as 
temperature. Furthermore, the intensity of the AaBPL R40G blot, given that the 
protein concentrations of R40G and BCCPL67 were 10/1 in this experiment, 
supports the multiple nature of R40G self-biotinylation (Fig. 4.8, lane 10). 
'ii 
Figure 4.10 - MALDI mass spectra of self- biotinylated AaBPL R40G. A: AaBPL 
R40G, predicted mass = 26,535.43 Da. B: AaBPL R40G incubated with 100 AM 
biotin, ATP, MgCl 2 at 65 °C for 15 mm. The observed molecular weight of 27,290 
Da corresponds to a mass increase of 757 Da (approximately 3 biotin molecules). 
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The fact that BCCPA67 and BCCPA67 Ki 17L are not multiply biotinylated is 
supported by chemical biotinylation studies with free biotinyl-5'-AMP. Chemical 
biotinylation of E. co/i BCCP87 with synthetic biotinyl-5'-AMP has been previously 
demonstrated and MALDI-MS analysis of the digested fragments of biotmylated 
BCCP87 indicated that only the target Lys122 had been modified. 5 The five lysines 
of BCCP are all relatively solvent-accessible and therefore, the specific biotinylation 
of BCCP87 with free adenylate has been claimed to be due to the intrinsic reactivity 
of the target lysine to nucleophilic attack. The residue has been suggested to have a 
lower pKa although it has not, apparently, been measured. 5 The interactions of the 
ureido ring of the biotin moiety covalently attached to Lys 122 with residues of the 
"thumb" region present in both E. coli and A. aeolicus BCCP may contribute to the 
stability of the BCCP:biotin complex. 3 ; 5 6 
To determine whether AaBPL and AaBPL R40G could carry out non-specific 
biotinylation, the enzymes were incubated with biotin, ATP and MgCl 2 in the 
presence of bovine serum albumin (Pierce) at 65 °C. Western blot analysis of the 
products revealed that, while biotinylation of BSA did not occur in the presence of 
substrates alone or at low concentration of wild-type AaBPL, the mutant AaBPL 
R40G biotinylated itself and BSA in a manner similar to BirA RI 18G (Fig. 4.11).' 
However at high enzyme concentrations, the wild-type AaBPL also carried out self-
biotinylation and non-specific biotinylation of BSA, albeit less effectively. The fact 
that AaBPL R40G appears to self-biotinylate preferentially rather than derivatise the 
substrates BSA or BCCPA67 is likely to be a consequence of the elevated 
temperature of the reaction with thermostable enzymes (See figures 4.8 and 4.11). 
Since chemical biotinylation with biotinyl-5'-AMP is proximity dependent and the 
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lifetime of AMP mixed anhydrides in aqueous solution (typically t112 - 1 min at pH 
7, 25 °C) will be significantly shorter at 65 °C, the amount of reagent surviving to 
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Figure 4.11 - Streptavidin western blot of BSA biotinylated with AaBPL and 
AaBPL R40G. Left panel (lane 1-7): SDS-PAGE, right panel (lane 8-14): 
streptavidin western blot. BSA (2 1iM) incubated in presence of biotin, ATP, MgCl2 
at 65 °C for 20 mm; lane 1 & 8, BSA; lane 2 & 9, BSA with 50 nM AaBPL; lane 3 
& 10, BSA with 50 nM AaBPL R40G; lane 4 & 11, BSA with 200 nM AaBPL; lane 
5 & 12, BSA with 200 nM AaBPL R40G; lane 6 & 13, BSA with 500 nM AaBPL; 
lane 7 & 14, BSA with 500 nM AaBPL R40G. 
4.5 Discussion 
The conserved Arg40 of AaBPL has been mutated to a glycine and the 
resulting mutant enzyme AaBPL R40G characterized. The crystal structures of 
AaBPL R40G in both the apo- and biotin-bound forms have been determined. The 
mutated loop is ordered upon biotin binding but is shown to adopt a dramatically 
different conformation to that observed in the wild-type AaBPL:biotin:ATP complex. 
In the structure of the mutant in complex with biotin, the R40G containing loop has 
shifted towards the active site in order for the backbone NH of G1y40 to stabilize the 
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biotin carboxylate. The collapse of the biotin binding loop results in side chain 
interactions from residues located on the loop, which block the ATP binding pocket. 
To investigate the effects of the R40G mutation on substrate binding in 
solution, ITC measurements were carried out with AaBPL R40G to determine the 
thermodynamic parameters for binding biotin and ATP. The ITC results revealed that 
the affinity for biotin is relatively unaffected by the R40G mutation. In contrast, the 
thermodynamic data indicate that binding of ATP to AaBPL R40G is very weak in 
the absence or presence of biotin (KD > 200 p.M) and the free enthalpy and entropy 
changes measured during the ATP titrations are too high to be considered. The R40G 
mutant appears to have lost its ability to sequester ATP within the catalytic pocket. 
Moreover, in the structure of the mutant co-crystallized with ATP, the biotin binding 
loop and the nucleotide could not be visualized in the electron density. Thus, the side 
chain of the Arg40 is essential in order for the active site binding loop to adopt the 
correct conformation for substrate binding and stabilization of the ATP moiety inside 
the binding pocket. 
The equivalent E. coli mutant BirA RI 18G was recently shown to biotinylate 
itself as well as a number of cellular proteins in vivo but also to modify non-cognate 
proteins in vitro.' The promiscuous biotinylation observed with BirA RI 18G was 
suggested to arise as a result of dissociation of the BirA Ri 18G:biotinyl-5'-AMP 
complex to give free adenylate which reacts with available amino groups. 
Interestingly, purified AaBPL R40G was not biotinylated in vivo but was shown to 
biotinylate extensively itself by streptavidin western blot and mass spectrometry 
when incubated in presence of biotin and MgATP at temperatures above 50 °C. 
Although structural and thermodynamic studies of AaBPL R40G have shown that the 
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mutation directly affects ATP binding and the subsequent formation of the AaBPL 
R40G:biotin:ATP ternary complex, the R40G mutant remains catalytically active. In 
the presence of high concentrations of ATP, its reaction with bound biotin, which is 
correctly positioned for attack, can be envisaged as a result of conformational flux of 
the active site. The resulting AaBPL R40G:biotinyl-5'-AMP binary complex 
dissociates prematurely and the reactive adenylate is released from the active site of 
the mutant. 
AaBPL R40G was also shown to biotinylate the non-cognate protein BSA 
which suggests diffusion of biotinyl-5'-AMP in the media. However, the extent of 
self-biotinylation are significantly greater that the non-specific biotinylation of BSA. 
Biotinyl-5'-AMP is a mixed anhydride that readily hydrolyses in solution at neutral 
pH and elevated temperatures and AaBPL R40G has an unusually high proportion of 
lysine residues (12.5% frequency). The reactive biotinyl-5 '-AMP released from the 
active site of AaBPL R40G after its formation will therefore preferably biotinylate 
one of the mutant's own solvent exposed lysine side chains located in the vicinity of 
the biotin binding pocket. ]  
Because of the high reactivity of anhydrides towards primary amines, similar 
modifications have also been characterised with aminoacyl-adenylates in the native 
E. coli methionyl-tRNA synthetase (MetRS) and valyl-tRNA synthetase (Va1RS). 
Analysis of the modified peptide fragments of MetRS by MALDI-MS indicated that 
the lysines covalently attached to [ 14C]methionine are distributed at the surface of the 
binding site regions of the three substrates, methionine, ATP, and tRNA. 8 Several 
different aminoacyl groups have been used to modify Va1RS and determine the 
residues involved in substrate binding. 9  The activity of the enzymes MetRS and 
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VaIRS were shown to be directly affected by these modifications being decreased 
significantly upon methionylation and valylation respectively. 8 Only the putative 
editing site of Va1RS was modified with [ 14C]Thr and [ 14C]Met and the enzyme 
activity stayed unchanged. 9 
Substrate biotinylation with AaBPL R40G was also carried out with apo-
BCCPA67 and BCCPA67 Ki 17L. The mutant was shown to biotmylate only the 
target Lysi 17 in a manner similar to the wild-type enzyme. The specific biotinylation 
of BCCPA67 is supported by biotinylation studies with E. co/i BCCP87 which 
showed that only the conserved lysine was modified in presence of free biotinyl-5'-
AMP, albeit less effectively than in the enzymatic reaction catalysed by BirA. 5 The 
unusual reactivity of the target lysine of BCCP has been attributed to intrinsic 
properties of the residue which, together with the self-biotinylation of the mutant, 
appears to prevent most of the chemical biotinylation with non-specific acceptors 
generated upon dissociation of the AaBPL R40G:biotinyl-5'-AMP complex. The 
extent of self-biotinylation observed with the A. aeo/icus mutant remains very high 
however and chemical biotmylation was observed at temperatures below 4 °C when 
the concentration of mutant and biotin was adjusted. Thus, using AaBPL R40G in 
order to generate active biotinyl-5 '-AMP and biotinylate target peptides and proteins 
in a proximity dependant process could be envisaged. 10 
This study sheds more light on the effects of mutation within the biotin 
binding loop on substrate specificity of the bacterial BPLs and provides some insight 
into the molecular basis of human multiple carboxylase deficiency syndrome (MCD). 
MCD is a rare autosomal recessive disease characterized by a combination of severe 
biochemical and clinical disorders which can lead to coma and death if not treated 
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with a pharmaceutical dose of biotin." This disease is linked to mutations in the 
human holocarboxylase synthetase enzyme (HCS), a class IV BPL, and is 
characterized by a decrease in activity of all four human biotin-dependent 
carboxylases (acetyl-00A carboxylase, pyruvate carboxylase, propionyl-CoA 
carboxylase and -methylcrotonyl-CoA carboxylase) which, in turn, affects 
gluconeogenesis, fatty acid metabolism and ammo acid catabolism." 
It has been demonstrated that from the 726 amino acid sequence, the 
minimum functional HCS protein is retained in the C-terminal 349 amino acids 
which show a striking sequence similarity with the biotin binding domain of bacterial 
BPLs. 12 Further deletion of the N-terminus of human HCS to map the 276 amino 
acids of AaBPL resulted in 33.3 % sequence similarity and 19.2 % sequence identity 
between the human and A. aeolicus enzymes (c.f. a 21.7 % sequence identity with 
the catalytic and C-terminal domains of BirA). The most recurrent HCS mutations 
leading to MCD is R508W located in the 505GKGRGG 510 motif, which maps to 
Arg40 of AaBPL.13 '' The HCS R508W mutant expressed in a cellular environment 
has been shown to have low activity in the cells but to remain responsive to biotin in 
vitro and the missense R508W mutation (Exoni 1, 1522C—+T) can be treated 
clinically with additional doses of the vitamin. 14 ;  15 Adjacent mutations G518E, 
V550M and D571M have been shown to affect biotin binding and catalytic activity 
while other recurrent mutations leading to MCD have also been characterized in the 
C-terminal as well as the N-terminal domain of the HCS enzyme. 15 It seems likely 
that further studies on the bacterial proteins may uncover details of enzyme action 
relevant to human biochemistry.' 3 ; 14; 16 
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5.1 Stoichiometry of the E. coil Full-Length BCCP (EcBCCP) 
5.1.1 Purification and Characterization of EcBCCP 
Studies with the full-length E. coli biotin carboxyl carrier protein (EcBCCP) 
have been limited by the presence of the conserved N-terminal proline and alanine-
rich linker sequence between residues 34 and 101 (See chapter II, figure 2.2).' 
This N-terminal linker segment located outside the biotinyl domain is though to be 
highly flexible and extremely sensitive to proteolytic cleavage and most studies have 
been carried out with truncated C-terminal fragments of EcBCCP.2 The full-
length biotin carrier was shown to be a better substrate for the partial ACC-catalysed 
reactions than the truncated biotinyl domain BCCP87 and deletion of 30 amino acids 
of the N-terminal linker residues resulted in a EcBCCP mutant which could be 
biotinylated but was defective in function in vivo.'' 7 Therefore, the N-terminus has 
been suggested to be important not only for dimerisation of EcBCCP but also to 
interact with the other subunits of the ACC complex. 8 EcBCCP was previously 
purified and found to be a heterogeneous mixture of dimers plus higher order 
aggregates but the exact assembly state of EcBCCP remains unknown 1 7 Since the 
subunits of E. co/i ACC are required in a defined stoichiometry, the aim of this study 
is to shed light on the exact assembly of E. co/i ACC. In collaboration with Prof. 
Carol Robinson from the University of Cambridge, analysis of the oligomeric states 
of EcBCCP and BC and of the interactions formed by the biotin carrier and the BC 
subunit within the E. co/i ACC complex have been carried out using non denaturing 
mass spectrometry. 
In the recent study by Soriano et al., the production of large amounts of 
recombinant forms of the E. co/i ACC subunits (EcBCCP, BC and CT) is reported.' ° 
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The EcBCCP gene, accB, had been previously cloned into the pET29a vector with a 
C-terminal hexahistidine-tag by using the restrictions sites NdeI and XhoJ and was a 
kind gift from Dr. Aileen Soriano at Schering-Plough. The plasmid pET29aJEcBCCP 
was expressed in E. co/i BL21 (DE3) cells and induction was carried out with 1 mM 
IPTG for 5 hours at 37 °C. Because biotin biosynthesis is strictly regulated by BirA 
and apo-BCCP in E. co/i, the pET29a!EcBCCP vector was transformed in presence 
of a second plasmid, pBirAcm Avidity (AviTagTM), which overproduces BirA in 











Figure 5.1 — Expression vectors pBirAcm. pBirAcm is a low copy number plasmid 
which is commercially available (Avidity). 
The cell-free extract was ultracentrifugated for 1 hour at 30,000 rpm prior to 
purification by Ni-NTA agarose chromatography (Qiagen) at 4 °C. Elution with 170 
mM followed by 250 mM imidazole of the soluble His 6-EcBCCP protein was 
monitored using the Bradford reagent (Fig. 5.2, a). EcBCCP was further purified by 
anion exchange chromatography on a 1 ml MonoQ HR 5/5 column and the protein 
which eluted at 420 mM NaCl was judged to be 90% pure as deduced from SDS-
PAGE analysis (Fig. 5.2, b & c). Purified EcBCCP was extensively dialyzed in the 
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presence of 20% glycerol, n-ME (20 mM) or DTT (1 mM) and 300 mM NaCl at pH 
8, and the final yield of the protein was >10 mg per litre of cell culture. 
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Figure 5.2 - EcBCCP purification (a) by nickel-NTA affinity chromatography 
and (b & c) anion exchange chromatography. (a): SDS-PAGE under reducing 
conditions of His 6-tagged EcBCCP purification with NI-NTA agarose; lane 1, low 
molecular weight marker (Amersham), lane 2, flow-through, lanes 1-8, fractions 
eluted with 170 m imidazole, lanes 9-18, fractions eluted with 250 mm imidazole. 
(b): chromatogram of EcBCCP purification on a I ml MonoQ HR 515 column. The 
protein eluted at 420 mM NaCl. (c): Protein purification on the MonoQ HR 5/5 
column was analysed by SDS-PAGE under reducing conditions. Lane 1, low 
molecular weight marker, lanes 2, flow-through, lanes 3-10, fractions 13 to 21 eluted 
with MCI. 
Initial mass spectrometry analysis was carried out to confirm the mass of the 
purified His 6-tagged EcBCCP. LC-ESI-MS revealed the presence of apo- and 
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biotinylated forms of EcBCCP with measured masses of 17,754 ± 3 Da and 17,981 ± 
4 Da (Predicted masses = 17,751.40 Da and 17,977.71 Da for apo- and holo-
EcBCCP respectively). The molecular weight of EcBCCP determined by SDS-
PAGE is approximately 6 kDa greater than the mass determined by electrospray 
mass spectrometry. This anomalous migration has been previously observed and has 
been attributed to the high Pro/Ala-rich sequence of the full-length EcBCCP.7 10  The 
stoichiometry of EcBCCP was initially studied by gel filtration. Analysis of EcBCCP 
on a Sephacryl S-200 HR column (320 ml) was carried out at protein concentrations 
of 1 1.M, 5tM and 20iM under reducing conditions and in presence of glycerol. The 
protein eluted in the void volume indicating a molecular weight above 200 kDa (Fig. 
5.3, see figure 2.10). Concomitant with the mass of the holo-EcBCCP monomer, this 
result suggests that the protein forms decamers and other higher aggregates. 
4 	- 	 __4 
- - 	 - 	
- 	 •I4• 
Figure 5.3 - Gel filtration analysis of EcBCCP. The protein eluted from the 320 ml 
Sephacryl S-200 HR column at 95 ml in the void volume indicating the formation of 
oligomers of mass > 200 kDa. The calibration graph for the Sephacryl S-200 HR 
column is shown in chapter 2, figure 2.10. 
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The stoichiometry of EcBCCP was also analysed by non-reducing protein 
gels. Tricine and Tris-Glycine gels ran under non-denaturing conditions with their 
respective buffers indicated clearly that the protein formed a dimer (Fig. 5.4). The 
assembly states of the full-length EcBCCP and BCCP87 (un-tagged) were previously 
analysed by equilibrium sedimentation. 7 While the results indicated that EcBCCP 
forms a number of large aggregates, BCCP87 remained monomeric. Further studies 
of BCCP87 indicated that the apo-form consisted of disulfide-linked dimer and it is 
tempting to assume that the non-reducing gels reveal the presence of a full-length 
EcBCCP dimer bonded via the equivalent Cys 116 residue." 
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Figure 5.4 - Protein gels of EcBCCP. Gels A, B, C: the pre-stained SeeBlue® 
Plus2 molecular weight marker is used. A: EcBCCP ran on SDS-PAGE under 
reducing conditions. B: EcBCCP separated on a Tricine gel with a Tncine non-
reducing loading and running buffer. C: EcBCCP separated on a Tns-Glycine gel 
with a Tris-Glycine non-reducing loading and running buffer. (Invitrogen) 
To determine if the biotinylation affected the oligomeric state of the biotin 
carrier in solution, EcBCCP was further purified by monomeric avidin 
chromatography. The unbound protein was washed with phosphate buffer while the 
biotinylated EcBCCP eluted with 2 mM biotin. Interestingly, the wash fractions 
'4 
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indicated that the protein eluted slowly from the column and were found by LC-ESI- 
MS to consist of a mixture of apo- and holo- forms (Fig. 5.5, A). EcBCCP was 
shown to elute rapidly in presence of biotin. However, despite a significant increase 
in the proportion of biotinylated EcBCCP, LC-ESI-MS analysis revealed the 
presence of apo-protein which suggests that the EcBCCP oligomers are formed by a 
mixture of apo- and holo-EcBCCP monomers (Fig. 5.5, B). 
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Figure 5.5 - Purification of EcBCCP by monomeric avidin chromatography. A: 
analysis of the fractions washed with phosphate buffer. SDS-PAGE: lane 1, low 
molecular weight marker, lanes 2-10, fractions I to 9; LC-ESI-MS analysis: charge 
deconvoluted mass spectrum of apo- and holo-EcBCCP in the wash fraction 1. B: 
analysis of the bound fractions eluted with 2 mM biotin. SDS-PAGE: lane 11, low 
molecular weight marker, lane 12, wash fraction 10, lane 13-17, fractions 1 to 5 
eluted biotin; LC-ESI-MS: charge deconvoluted mass spectrum of apo- and holo-
EcBCCP of the bound fraction 1. 
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5.1.2 Analysis by Mass Spectrometry of the Assembly State of 
EcBCCP 
The structure of the N-terminal domain of EcBCCP could not be determined 
due to its high degree of mobility and there have been no reports of successful 
crystallisation of an isolated full-length bacterial BCCP subunit. The interesting 
oligomerisation properties of EcBCCP encouraged us to carry out further studies on 
this upstream linker segment by mass spectrometry (MS). EcBCCP was analysed by 
Laura Lane from the laboratory of Prof. Carol Robinson (University of Cambridge, 
UK) on a quadrupole time-of-flight (Q-ToF) mass spectrometer using 
nanoelectrospray ionization (nEST) in the positive mode. nESI results in the 
generation of intact, multiply charged ions of the form [M + nH]n+. While initial 
analysis by LC-ESI-MS on a standard analyser generated ion series of mass over 
charge (m/z) in a range across 500 to 2000 m/z, the instrumentation in Cambridge 
enables the study of ions of up to 30,000 m/z under non-dissociative conditions. This 
would allow the identification of ions from large stable EcBCCP oligomers with 
relatively low charge states. 12 
EcBCCP was buffer exchanged into 20 mM ammonium acetate (pH 6.8) at a 
concentration of 1 mg.mF' and 2 p.1 of the protein were injected into the borosilicate 
glass capillary and electrosprayed at a flow rate of approximately 5 nl.min' driven 
by a potential ranging from 1.2 kV to 1.8 kV with a backing gas pressure to ensure a 
stable flow. Preliminary analysis by nESI-MS on a modified Q-T0F II instrument 
(Waters Micromass, UK) indicated a series of low intensity peaks below 2,500 m/z, 
several of which can be attributed to monomeric EcBCCP proteins. 13 The mass 
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spectrum shows two ion envelopes (A and B) with ion peaks equivalent to the +7, +8 
and +9 charge states (Fig. 5.6). These two resolvable charge state distributions (CSD) 
series have masses of 17,924 ± 2 Da and 18,145 ± 1 Da respectively. The mass 
difference between the two species (221 ± 3 Da) corresponds to the covalent 
attachment of one biotin (226.31 Da). The discrepancies observed between the 
experimental values and the predicted molecular weights of monomeric apo- and 
holo-EcBCCP (predicted mass: 17,751.40 Da and 17,975.71 Da respectively) can be 
attributed to the conditions of ionization resulting in poor desolvation of EcBCCP as 
well as the addition of salt adducts NH 4 (+18 Da). 
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Figure 5.6 - nESI mass spectra of EcBCCP analysed on a modified Q-ToF LI 
instrument. Conditions: ISV 1.5 kV, SC 100 V, EC 0 V, CE 10. Pirani pressure, 
penning pressure and ToF penning pressure (mbar): 5.7e-3, 7.3e-5 and 9.1 e-7. A: 
mass spectrum in the 400 to 9000 ni/z range. B and C: enlargements of the two CSD 
of +7 to +9 charge states with measured masses of 17,924 ± 2 Da and 18,145 ± I 
which correspond to apo- and holo-EcBCCP respectively. 
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To obtain a more accurate mass of monomeric EcBCCP from a wider charge 
state distribution, EcBCCP was denatured and was buffer exchanged into water. 
Analysis was carried out by nESI-MS on a Q-star XL instrument (Concord, ON, 
Canada) and gave two extended CSD in the 500 to 2000 m/z range (Fig. 57)•14  In 
this case, the two ion series (A and F) were observed for the +8 to +19 charge states 
and could be resolved with masses equivalent to 17,759 ± 23 Da and 17,969 ± 1 Da 
which correspond to the apo- and holo-form of EcBCCP with a mass difference of 
210 ± 24 Da. The calculated errors between the experimental values of the two apo-
and holo- species and the predicted masses of EcBCCP correspond to less than 0.5%. 
In contrast to the analysis carried out in ammonium acetate buffer, the +7 charge 
state of monomeric EcBCCP in the m/z > 2000 is not apparent on this mass 
spectrum. The high charge states of the two CSD also suggests unfolding of the 
monomeric EcBCCP species in absence of salt. Structural and biochemical studies of 
the truncated biotinyl domain of BCCP87 have shown that biotinylation increases the 
side-chain packing within the core of the protein and reduces its sensitivity towards 
proteolysis. 11; 15  It is thus worth noting that the ratio of holo:apo EcBCCP decreases 
proportionally with the number of charges on the ion peaks. In the case of the low 
charge states (+8 to +15), the proportion of holo-EcBCCP is greater than the extent 
of apo-form (Fig. 5.7). 
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Figure 5.7 - nESI mass spectra of EcBCCP analysed in water on a Q-star XL 
instrument. Conditions: Isv 1.5 kV, DP 100, FP, 150, DP2 15, QO 20, CAD 3, IRD 
6, IRW 5. A: The two 8-19+ CSD (A and F) corresponding to apo- and holo-
EcBCCP are well resolved. The high charge state of the ion series suggests that the 
protein is unfolded. B: enlargement of the +15 charge state of apo- and holo-
EcBCCP 
Optimization consisted principally in decreasing the concentration of 
EcBCCP to a range across 5 .tM to 10 jiM. The reduction in protein concentration 
reduces the likelihood that there is more than one protein species in a single droplet, 
hence, decreasing the appearance of ESI artefacts. 12  The mass spectrum obtained 
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after analysis on a Q-star XL instrument indicates that the sample is heterogeneous 
(Fig. 5.8, A). Two well resolved CSD in the low m/z (A and C, +13 to +20 charge 
states) with measured masses of 17,762 ± 10 Da and 17,986 ± 9 Da correspond 
within experimental error to the molecular weights of apo- and holo-EcBCCP 
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Figure 5.8— nESI mass spectra of EcBCCP analysed on a Q-Star XL instrument 
after optimization. Conditions: Isv 1,8 kV, DP 100, FP 200, DP2 25, QO 20, CAD 
3, IRD 6, IRW 5 A: The mass spectrum indicates the presence of two different 
conformations in the low m/z (coloured green and red) and the presence of 
polydisperse EcBCCP species in the high m/z (coloured blue). B: enlargement of the 
mass spectrum in the 800 to 1500 m/z range showing the ion series A and C (charge 
states +13 to +19) corresponding to apo- and holo-EcBCCP. C: enlargement of the 
mass spectrum in the 1700 to 2700 m/z range showing the ion series B and D (charge 
states + 8 to + 10). D: polydisperse EcBCCP species observed at approximately 6000 
m/z. 
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The two ion series (B and D) for the charge states +8 to +10 in the higher m/z 
range which were previously observed are better resolved and the measured masses 
of 17,753 ± 3 Da and 17,986 ± 9 Da correspond within experimental error to the 
predicted molecular weights of monomeric apo- and holo-EcBCCP (Fig. 5.8, C; see 
figure 5.6). Optimisation of the 1750 to 3000 m/z range allowed the characterization 
of the two ion series of +6 to +10 charge states corresponding to molecular weights 
of 17,754 ± 1 Da and 17,982 + 3 Da (Fig. 5.9). The mass difference between the two 
species is equivalent to 228 + 4 Da and the error between the experimental values 
and the predicted masses of monomeric apo- and holo-EcBCCP is less than 0.5%. 
The presence of two different CSD pairs (+6 - +10 and +13 - +20 charge states) 
equivalent to monomeric EcBCCP indicate a different conformation for the protein 
which is more compact for the low charge states ions. 
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Figure 5.9 - nESt-MS analysis of EcBCCP in the 1,750 to 3,000 ln/z range. 
Conditions: Isv 1.2 kV, DP 180, FP 15, DP2 15, QO 20, CAD 3, IRD 6, IRW 5.The 
different charge series suggest that EcBCCP adopts a more compact conformation in 
the high m/z. 
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The polydisperse peaks observed at approximately 6,000 m/z appears 
occasionally to be resolved (Fig. 5.8, D). MS-MS of one of these peaks indicated an 
average oligomeric state of ten. Although other oligomeric species appear to be 
present in this m/z region, their intensities and stoichiometries are often not apparent 
in the mass spectrum and after smoothing (Fig. 5.10). Further MS-MS analysis of 
these polydisperse species may reveal useful stoichiometric information. 
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Figure 5.10— nESt-MS analysis of EcBCCP in the the 4,000 to 7,000 m/z range. 
Conditions: ISV 1.2 kV, DP 180, FP 15, DP2 15, QO 20, CAD 3, IRD 6, IRW 5. A 
and B: Polydisperse BCCP peaks can be observed 
5.2 Assembly state of E. coil Biotin Carboxylase (BC) 
5.2.1 General Description of E. co/i BC 
The E. co/i biotin carboxylase gene (accC) encodes a protein of 449 residues 
which has a molecular weight of 49,387.20 Da.'6 17  The accC gene was previously 
cloned with an N-terminal histidine-tag into the ampicillin-resistant pET16b vector 
by using the restrictions sites NdeJ and XhoJ and was a kind gift from Dr. Aileen 
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Soriano from Schering-Plough. The resulting sequence of E. coil His 10-BC shown in 
figure 5.11 consists of 471 amino acids and has a formula weight of 51,908.94 Da. 
1 GHHHHHI-IHHH HSSGHIEGRH MLDKIVIANR GEIALRILRA CKELGIKTVA 
51 VI{SSADRDLK HVLLADETVC IGPAPSVKSY LNIPAIISAA EITGAVAIHP 
101 GYGFLSENAN FAEQVERSGF IFIGPKAETI RLMGDKVSAI AAMKKAGVPC 
151 VPGSDGPLGD DMDKNRAIAK RIGYPVIIKA SGGGGGRGMR VVRGDAELAQ 
201 SISMTRAEAK AAFSNDMVYN EKYLENPRHV EIQVLADGQG NAIYLAERDC 
251 SMQRRHQKVV EEAPAPGITP ELRRYIGERC AKACVDIGYR GAGTFEFLFE 
301 NGEFYFIEMN TRIQVEHPVT EF4ITGVDLIK EQLRIAAGQP LSIKQEEVHV 
351 RGHAVECRIN AEDPNTFLPS PGKITRFHAP GGFGVRWESH IYAGYTVPPY 
401 YDSMIGKLIC YGENRDVAIA RNKNALQELI IDGIKTNVDL QIRIMNDENF 
451 QHGGTNIHYL EKKLGLQEKS D 
Figure 5.11 - Amino acid sequence of H1s 10-BC. The accC gene was previously 
cloned in the pET 16b vector using the restrictions sites NdeI and XhoI. BC contains 
an N-terminal decahistidine tag and consists of 471 amino acids. 
5.2.2 Purification and Characterization of BC 
The plasmid pETl6b/BC was used to transform E. coli BL21 (DE3) cells and 
BC was induced with 1 mM IPTG for 5 hours at 37 °C. Purification of BC was 
carried out by nickel affinity chromatography on a 5 ml HisTrapTM HP column. The 
protein eluted with 250 mM imidazole and was extensively dialyzed in presence of 
0.1 mM EDTA (Fig 5.12). The isolated BC was further purified by gel filtration and 
eluted from the Sephacryl S-200 HR column (320 ml) at a volume of 120 ml which 
corresponds approximately to a mass of 101 kDa (Fig. 5.13, see figure 230; 
predicted molecular weight of BC dimer = 103.8 kDa). A portion of the protein 
eluted in the void volume but was not kept for further MS analysis. After the gel 
filtration purification step, BC was judged to have a purity greater than 95% as 
determined by SDS-PAGE and the yield of the protein was> 10 mg per litre of cell 
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culture (Fig 5.13, b). Initial mass spectrometry measurements carried out by LC-ESI- 
MS indicated a single species with a measured mass of 51,906.04 ± 27.75 which 
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Figure 5.12 - Purification and SDS-PAGE analysis of E. coli BC (a): 
Chromatogram of BC purification on a HisTrapTM HP nickel column. The peak 
corresponding to BC is indicated by an arrow (b): Protein purification was analysed 
by SDS-PAGE under reducing conditions. Lane 1, SeeBlue Plus2 molecular weight 
marker, lanes 2-9, eluted fractions 6 to 13 (collected fractions 8-13). 
(a) (b) 








Figure 5.13 - Gel filtration analysis of BC. (a): purification of BC on a Sephacryl 
S-200 HR column. The enzyme eluted at 120 ml indicating that BC is dimeric. A 
portion eluted at 85 ml in the void volume. The calibration graph for the column is 
shown in chapter 2, figure 2.10. (b): protein purification was analysed by SDS-
PAGE under reducing conditions. Lane 1, SeeBlue Plus2 molecular weight marker, 
lanes 2-10, eluted fractions 11 to 19 (collected fractions 13-17). 
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5.2.3 Mass Spectrometry Analysis of BC 
BC was nanoelectrosprayed out of 20 mM ammonium acetate buffer pH 6.8 
at a concentration of 2 mg.mF 1 and similarly to EcBCCP, the ions generated in 
positive mode were analysed on a modified Q-T0F II spectrometer (Waters 
Micromass, UK). Two different CSD observed in the mass spectrum were resolved 
indicating the presence of monomeric and dimeric BC (Fig. 5.14). The first charge 
state distribution (A) corresponds to a mass of 52,251 ± 44 which is close to the 
predicted mass of monomeric BC (51,908.94 Da). The second CSD (B) corresponds 
to dimeric BC with a measured mass of 104,587 ± 15 Da (predicted mass of BC 
dimer = 103,817.88 Da). Poor desolvation and addition of salt adducts may 
contribute to the discrepancy observed between the experimental value and the 
predicted molecular weight of monomeric and dimeric BC. This phenomenon is 
commonly observed when studying protein ions because increasing the activation of 
the ions leads to disruption of noncovalent interactions before full desolvation is 
reached. 18 
The results of this incomplete desolvation are broad peaks and mass 
measurements that are several percent larger than those predicted by the amino acid 
sequence. Therefore, despite the resolving power capabilities of the Q-ToF 
spectrometer, the peak width achieved for a protein is determined primarily by the 
sample homogeneity but also by the electrospray process and subsequent ion 
desolvation. However, it has been shown that the widths of the mass spectrum peaks 
are directly correlated with the excess mass observed due to adducts for large ions of 
known molecular weight. 19 On the spectrum A, the peak widths for the +14 charge 
states of the ion series A corresponds to approximately 700 Da, while the peak 
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widths for the +21 charge states of the ion series B corresponds to approximately 
1000 Da (Fig. 5.14). Those values are higher than the difference measured between 
the experimental and the predicted masses of the BC monomer and dimer. 
Figure 5.14 - nESI mass spectrum of BC analysed on a modified Q-ToF II 
instrument. Cap 1.7 kV, SC 150, EC 0 V, CE 1 0.Pirani pressure, penning pressure 
and ToF penning pressure (mbar): 7.70.e-4, 2.88.e-4 and 1.42.e-6. Two charge series 
A and B corresponding to monomeric and dimeric BC respectively are observed. 
5.3 Discussion 
Studies of the assembly states of the EcBCCP and BC subunits of E. co/i 
ACC were carried out on a modified Q-ToF II and a Q-star XL mass spectrometer in 
the laboratory of Prof Carol Robinson at the University of Cambridge. 13 ; 14 
Monomeric EcBCCP was initially analysed in water by nESI-MS on a Q-star XL 
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instrument in the positive mode. The derived mass spectra revealed the presence of 
charge series which correspond to monomeric forms of apo- and holo-EcBCCP. The 
+9 to +19 charge state series is well resolved and the sample appears relatively 
homogenous. However, the high charge states of the ion peaks in the two series 
indicate that the protein is unfolded. In solution phase, the energy that assists a 
protein in folding to a specific conformer can be attributed to the driving force to 
form the hydrophobic core while polar residues are oriented towards the solution and 
form a hydrophilic surface. 20 This model is consistent with the structure of the 
BCCP87 domain which forms a flattened -barrel stabilized by a core of 
hydrophobic residues and, therefore, the monomeric form of EcBCCP could be 
stable in solution. 
The full-length EcBCCP was similarly analysed in an ammonium acetate 
buffer (pH 6.8) by nESI-MS on a modified Q-ToF II instrument. 13  The mass 
spectrum revealed charge state distribution series of +7 to +9 charge states 
corresponding to apo- and holo-EcBCCP monomers. The charge differences of the 
ion peaks in the series obtained after nESI-MS analysis in water and in ammonium 
acetate buffer suggest that while the water condition appeared to be denaturing, the 
presence of salt seems to be required for the protein to maintain a compact structure. 
This observation is well described by the charged-residue model (CRM) of the 
highly charged microdroplets in the ionization source. 21  In the CRM model, complete 
desolvation of ions occur via successive loss of all solvent molecules. The protons of 
the ultimate droplet are then transferred onto the protein molecules and thus, the 
number of charges is directly related to the space that a molecule covers in the 
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microdroplets. Compact proteins exhibit lower charge state under identical nEST 
conditions than their unfolded conformations. 21 
Further analysis of EcBCCP in water but at lower protein concentrations 
(approximately 5 pM to 10 tM instead of 55 tM) confirmed the presence of a 
different, more compact conformation of monomeric EcBCCP in the high m/z region 
(+6 to +10 charge states). Interestingly, the extent of biotinylated EcBCCP is also 
higher in this m/z range. In the published X-ray and nmr structures of the biotinyl 
domains of BCCP, flexible regions (either not well resolved or disordered), are the 
N-terminus and the protruding thumb segment. 2224  In the nmr structure of holo-
BCCP87, the core of the protein is shown to have a more favourable side-chain 
packing than in the apo-structure and the interactions with the biotin moiety 
stabilizes the residues located on the flexible thumb region. 1 5; 24 To investigate the 
role of the N-terminus in the ionization process, BCCP87 was cloned with the C-
terminal His-tag for future studies (Fig. 5.15). Although the N-terminal domain 
consists principally of aliphatic residues, characterization of both the full-length 
BCCP and BCCP87 by nESI-MS under similar conditions may reveal the 
significance of the N-terminus interactions with the core of the protein. 
Polydisperse EcBCCP species in the range from 4,000 to 10,000 m/z were 
also observed on the mass spectrum after optimization and suggested the presence of 
at least EcBCCP decamers. The sample is highly heterogeneous in this m/z region 
and attempts to analyse these species by MS-MS were carried out. In tandem MS, 
single species of interest can be selected and activated according to their m/z ratios in 
the first analyser (quadrupole) and analysis to determine their stoichiometry is 
performed in the ToF analyser at the end. 25  However, the ion peaks corresponding to 
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EcBCCP decamers are not always evident and MS-MS analysis was difficult to 
perform. Previous studies of EcBCCP have demonstrated the formation of lower and 
higher assembly states than decamers. 7 Furthermore, purification of EcBCCP carried 
out by monomeric avidin chromatography revealed that the EcBCCP oligomers 
consist of a mixture of apo- and holo-forms which could not be separated using 
affinity chromatography. The formation of EcBCCP oligomers appears to occur in a 
more or less random process and therefore, the proportion of biotinylated monomers 
can vary significantly in the EcBCCP complexes which in turn, contributes to the 
heterogeneity of the ions generated from decamers and other oligomers in this m/z 
region. 
Figure 5.15 - DNA gels of EcBCCP and BCCP87. A: PCR amplification of the 
accB gene followed by digestion with NdeI / XhoI and NcoJ / XhoI yielded fragments 
of the size corresponding to EcBCCP and BCCP87 respectively B: restriction digest 
of the pET28aIBCCP87 vector obtained after DNA sequencing of BCCP87 and 
ligation into a pGEM vector (Promega) followed by cloning into a pET28a vector 
(Novagen) using the restriction sites NcoI and XhoI. Lanes 1, 3 and 5, undigested 
BCCP87, lanes 2, 4 and 6, BCCP87 digested with NcoI / XhoI 
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In E. coli, the EcBCCP and BC genes (accB and accC respectively) form an 
operon with the accB gene located upstream of accC and this arrangement is 
strikingly conserved among bacterial genomes.17 26; 27 Although transcription of the 
biotin biosynthetic operon (bioABFCD) in E. co/i is regulated by BirA as well as the 
presence of apo-EcBCCP protein, overproduction of accC was recently shown to 
disrupt regulation of biotin and fatty acid biosynthesis. 2829 It is thought that the accB 
and accC genes are co-transcribed to ensure stringent regulation of the ratio of the 
two proteins and the subsequent level of biotin biosynthesis. 28 Thus, to investigate 
the assembly state of EcBCCP by MS, analysis of BC and of the BC:EcBCCP sub-
complex appears necessary. 
BC has been shown to be a dimer in solution and this dimeric state assembly 
is conserved in the crystal structure. 30 ;  31 The recombinant form of E. co/i BC was 
purified to homogeneity and subsequent analysis by nESI-MS on a Q-ToF II 
instrument confirmed the dimeric nature of BC. The E. co/i BC and EcBCCP form 
an unstable complex with a stoichiometry that has been the subject of long-term 
debate. Preliminary studies in E. co/i together with the isolation and characterization 
of the BCCP2:BC2:CTa 2 :CT 2 multi-subunit ACC from Pseudomonas citrone/lolis 
suggested that a EcBCCP 2 :BC2 complex might be present in vivo. 2 ;  9; 32 A new model 
of the BC:EcBCCP complex was recently reported by Choi-Rhee and Cronan. Their 
analysis by SDS-PAGE of a [ 35S]methionine-labelled BC:EcBCCP complex 
indicated the ratio of BC per EcBCCP molecule to be 1 In the proposed ACC 
model, the BC2:BCCP4 complex is thought to bind the a2132  CT heterodimer in order 
to form the active ACC complex (BC2:BCCP4:CTa 22) which would have a 
combined mass of -304 kDa. With the aim to investigate in the future the ratio of BC 
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and EcBCCP molecules within the BC:EcBCCP sub-complex by nESI-MS analysis, 
the accBC operon was cloned from genomic E. coil DNA in a pGEM vector 
(Promega) to generate a similar clone to that used by Choi-Rhee and Cronan (data 
not shown). 
The structure of the complete biotin-dependant enzyme pyruvate carboxylase 
from Rhizobium etli (RePC) was recently determined at 2.0 A resolution and revealed 
the structure of a full-length BCCP for the first time (Fig. 5.16, a). 34 RePC consists of 
an N-terminal BC, a central CT, and a C-terminal BCCP domain. There are two 
monomers in the asymmetric unit and BCCP can be visualised only in one monomer. 
The structure of RePC shows that each monomer contains a central domain which 
has not been previously described and appears to serve as a mediator by connecting 
the BC to the CT domain and the BCCP to CT domain .34  PC is a tetramer in solution 
and the RePC crystal lattice also contains a tetramer composed of a dimer of dimers 
(Fig 5.16, b). 34 ' 35 The BC active site is located at -65 A from the CT active site from 
an opposing polypeptide chain, with the BCCP domain positioned equidistant 
between the two. Therefore, based on distances and orientation of the different active 
sites of RePC, the BCCP domain is predicted to swing between the BC and CT 
components from different polypeptide chains. 34  The structure also reveals that the 
global position of the BCCP is restrained by the arrangement of the remaining RePC 
enzyme. The 34 A proline/alanine-rich linker connecting BCCP to the allosteric 
domain is highly flexible and facilitates the moves of biotinylated BCCP between the 
active sites. 3 ; 36; 37 
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Figure 5.16 - Crystal structure of the R. etli PC complex. (a) The structure of the 
RePC dimer. The BC, CT, BCCP, and allosteric domains are colored blue, yellow, 
red, and green, respectively. The active sites are highlighted by the presence of 
ligand drawn in spheres: CoA in the linker domain, the ATP analog adenosine-5'-
diphosphate monothiophosphate SAP complexed with Mg 2+  in the BC active site, 
and Zn2 in the CT active site. (PBD code 2QF7) (b) Model of the RePC tetramer 
showing the movement of the BCCP domain between neighbouring active sites on 
opposing polypeptide chains. 34 
More recently, Tong et al. also reported the crystal structures at 2.8 A 
resolution of the full-length PC from S. aureus (SaPC) and the C-terminal region 
missing the BC domain of human PC. 38 The two structures show a PC tetramer and 
reveal a previously uncharacterized domain suggested to mediate teramerization. In 
SaPC, the biotinylated BCCP domain of monomer 4 is located in the active site of 
the CT domain of monomer 3 and a similar conformation for the BCCP domain is 
observed in the structure of human PC. In both structures, the biotin moiety is 
projected away from the BCCP and is located near the pyruvate substrate bound in 
the CT active site. Therefore, this conformation may represent that of BCCP during 
catalysis in the carboxyltransfer reaction and is the first observation of BCCP in a 
catalytically competent conformation. 38 Those PC structures provide the first glimpse 
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of the interactions made by BCCP with BC and CT. They provide an important 
insight into the functionality of biotin-dependent enzymes but also reveal the 
complexity of the assembly states of such protein complexes. A clone that expresses 
the complete CT enzyme of E. co/i ACC was generously supplied by Aileen Soriano 
and attempts to characterize the full ACC complex by MS analysis will continue in 
the future. 
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6.1 General Materials 
6.1.1 General Reagents 
Chemicals and solvents were of the appropriate quality and were purchased from GE 
Healthcare, Amersham Bioscience, Promega, Sigma-Aldrich, Pierce, Qiagen, 
Invitrogen, Bio-Rad, Vivascience, Roche and New England Biolabs unless otherwise 
stated. D-biotin was obtained from sigma. 
Aquifex 	aeolicus 	plasmids 	pET28a/BPL, 	pET6HIBCCP 154 
pET6HJBCCP67 and pET6HIBCCPM7 Ki 17L were obtained from David Clarke 
(University of Edinburgh). The pBtacfBirA RI 18G plasmid was a kind gift from 
John E. Cronan Jr (University of Illinois). The plasmids expressing the histidine-
tagged E. coli BCCP and BC were generously supplied by Aileen Soriano (Schering-
Plough-Hialeah). 
6.1.2 Media and Solutions. 
Sterilisation of media - All media were autoclaved at 121 °C for 20 minutes at 15 
psi prior to use. 
Luria Bertani (LB): tryptone (10 g.1 1 ), yeast extract (5 g11 ), sodium chloride (10 
g1 1 ); pH adjusted to 7.5 with sodium hydroxide. 
SOC: tryptone (20 g.1 -1 ), yeast extract (5 g.1 1 ), sodium chloride (0.5 gS 1 ), 
magnesium sulfate (5 g.1 11), glucose (3.2 g.1 -1 ); pH adjusted to 7.5 with sodium 
hydroxide. 
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Agar plates: bacto-agar (15 g.F') was added to the LB media. The specific antibiotic 
was added prior to making the plates. 
X-Gal plates: S-Ga.1TMILB Agar Blend from Sigma-Aldrich containing tryptone (10 
g.1 1 ), yeast extract (5 g.1 1 ), sodium chloride (10 g.1-1 ), agar (12 g.1-1 ), S-Gal (0.3 g.F 
1),  Ferric ammoniumcitrate (0.5 g.F'), TPTG (0.03 g.F') was dissolved in the 
appropriate amount of deionised water according to the manufacturer instructions. 
The specific antibiotic was added prior to making the plates. 
DNA-running buffer: TAE buffer - 40 mM Tris-HC1, 20 mM Acetic acid, 1 mM 
EDTA (pH 8.3). 
6.1.3 Purification Buffers 
Purification of A. acolicus AaBPL, AaBPL R40G, BCCP154, apo- and holo-
BCCPM7 and BCCPM7 K117L 
. Buffer A (binding buffer): 10 mM HEPES (pH 7.5). 
• Buffer B (elution buffer): 10 mM HEPES, 1 M NaCl (pH 7.5). 
• Buffer C (gel filtration buffer): 10 mM HEPES, 150 mM NaCl (pH 7.5). 
• Buffer D (binding buffer): 20 mM Tris-HC1, 0.5 M NaCl, 5 mM imidazole (pH 
7.5). 
• Buffer E (elution buffer): 20 mM Tris-HC1, 0.5 M NaCl, 100 mM imidazole (pH 
7.5). 
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Purification of E. coli BirA R118G 
• Buffer F (binding buffer): 50 mM Tris-HC1, 300 mM NaCl, 5 mM imidazole (pH 
7.8). 
• Buffer G (elution buffer): 50 mM Tris-HC1, 300 mM NaCl, 100 mM imidazole 
(pH 7.8). 
Purification of E. coli BCCP 
• Buffer H (lysis buffer): 50 mM HEPES, 300 mM NaCl, 10% glycerol, 20 mM 2-
mercaptoethanol (pH 8.0). 
• Buffer I (wash buffer 1): 50 mM HEPES, 300 mM NaCl, 10% glycerol, 20 mM 
2-mercaptoethanol, 20 mM imidazole (pH 8.0). 
• Buffer J: (wash buffer II): 50 mM HEPES, 300 mM NaCl, 10% glycerol, 20 mM 
2-mercaptoethanol, 50 mM imidazole (pH 8.0). 
• Buffer K (elution buffer I): 50 mM HEPES, 300 mM NaCl, 10% glycerol, 20 
mM 2-mercaptoethanol, 170 mM imidazole (pH 8.0). 
• Buffer L (elution buffer II): 50 mM HEPES, 300 mM NaCl, 10% glycerol, 20 
mM 2-mercaptoethanol, 250 mM imidazole (pH 8.0). 
• Buffer M (binding buffer): 50 mM HEPES, 50 mM Nacl, 10% glycerol, 1.0 mM 
DTT (pH 7.5) 
• Buffer N (elution buffer): 50 mM HEPES, 1 M NaCl, 10% glycerol, 1.0 mM 
DTT (pH 7.5) 
• Buffer 0 (gel filtration buffer): 50 mM HEPES, 150 mM Nacl, 10% glycerol, 1.0 
mM DTT (pH 7.5) 
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Purification of E. coli BC 
• Buffer P (binding buffer): 20mM HEPES, 150 mM NaCl, 5 mM imidazole, 1 
mM DTT, 0.1 mM EDTA, 10% glycerol (pH 7.5). 
• Buffer Q (elution buffer): 20 mM HEPES, 150mM NaCl, 1 M imidazole, 1 mM 
DTT, 0.1 mM EDTA, 10% glycerol (pH 7.5). 
• Buffer R (gel filtration buffer): 20 mM HEPES, 150 mM NaCl, 1 mM DTT, 0.1 
mM EDTA, 10% glycerol (pH 7.5). 
6.2 Molecular Biology 
6.2.1 Bacterial Cell Lines 
Strain Genotype Applications 
K-12 MG1655 F X ilvG rJb5O rphl DNA isolation. 
F mcrA A(mrr-hsdRMS-mcrIBC) 
Top 1OTM 4801acZbM15 AlacX74 deoR 
(Competent) recAl araD 139 IX(ara-leu)7697 
Cloning. 
galtJ galK X rpsL (Str') nupG 
F 4801acZAM 15 L(lacZYA-argF) 
DH5aTM U169 deoR recAl endAl hsdRl7 
(Competent) (rk-, mk+) phoA supE44A thi- 1 
Cloning. 
gyrA96 relAl 
endAl recAl gyrA96 thi hsdR17 
JM109 (rk-, mk +) relAl supE44, L(lac- Protein expression. 
(Competent) proAB), [F' traD36 proAB, Transformation of DNA 
laqIqZAM 15] ligations. 
BL21(DE3) 
(Competent) 
F ompT hsdSB (rB mn) gal dcm 
(DE3) Protein expression. 
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6.2.2 Oligonucleotide primers 
The following oligonucleotide primers were used this study. Restriction and 
mutation sites are underlined. 
Name Sequence (5'-3') 
AaBPL R40G For GGAAGGGGAGGACTCGAAGGAAGTGGCTC 
AaBPL R40G Rev GAGCCACTTCCTTCCGAGTCCTCCCCTTCC 
AccBC For GCTACAATCACTCTAGACAAA 
AccBC Rev CCTTATGGGGGTTCTCGAGCC 
pGEM For GAATACTCAAGCTATGC 
pGEM Rev AGTGAATTGTAATACGACT 
6.2.3 DNA Manipulation 
6.2.3.1 Purification of Plasmid DNA 
Plasmid DNA was prepared using QlAprep ® Spin Miniprep Kit (Qiagen) 
following the manufacturer's instructions. 
6.2.3.2 Isolation of E. coil Genomic DNA 
The cells from the E. coli K-12 MG1655 strain were spread on an agar plate 
and left at room temperature until sufficient colonies were obtained. Multiple 
colonies were resuspended in 20 p1 lysis buffer containing 0.25% w/v sodium 
dodecyl sulphate (SDS) and 0.05 M NaOH. The mixture was incubated for 15 min at 
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95 °C and centrifuged at 11,000 x g for 20 sec. Distilled water was added (180 ml) 
and the cell debris was harvested by centrifugation for 5 mm. 
6.2.3.3 Transformation E. coil Competent Cells with Recombinant DNA 
Competent cells were transformed according to the manufacturers' 
instructions. DNA (up to 40 ng) was added to an aliquot of competent cells and 
gently mixed. This was left on ice for 30 minutes before the cells were heat shocked 
(42 °C, 40 sec). The cells were then grown in 250 j.tl SOC medium at 37 °C for 1 hr. 
Finally, the cells were spread to dryness on selective agar plates and incubated at 37 
°C overnight. 
6.2.3.4 Electrophoresis of DNA 
The required amount of agarose was added to TAE buffer (typically 1.2 g / 
100 nil) and heated at 100 °C until dissolved. The solution was allowed to cool to 55 
°C and ethidium bromide was added to a final concentration of 0.5 i.g.ml 1 . The gel 
was then poured into the casting mould and allowed to set at room temperature. 
Loading dye (Promega) was added to the sample prior to loading and the DNA 
migrated using a potential difference of 100 V for an adequate time to achieve 
separation. The gels were viewed and photographed under UV-light. HyperLadder I 
and TV (Bioline) were used for quantitation of the DNA. 
6.2.3.5 Digestion of DNA with Restriction Endonucleases 
The required amount of DNA (0.5 - 1 jig) was treated with the appropriate 
amount of endonuclease and buffer and incubated for at least 3 hours at 37 °C before 
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analysis by electrophoresis on agarose. The restriction enzyme EcoRI was used as a 
control for the digestion of pGEM-T easy plasmids. 
6.2.3.6 Gel-Extraction of DNA 
DNA was purified from agarose using QlAquick® Gel Extraction Kit 
(Qiagen) following the manufacturer's instructions. 
6.2.3.7 Direct Cloning of PCR Products 
All PCR products were cloned into the pGEM-T easy vector (Promega) using 
the manufacturer's guidelines. 2x rapid T4 DNA ligase buffer (2 pJ), pGEM-T easy 
vector (1 j.tJ), PCR product (3 p1) and T4 DNA ligase from Promega (1 p1) were 
gently mixed and incubated for one hour at room temperature. 2 p1 of the reaction 
mixture was used to transform JM 109 competent cells. 
6.2.3.8 Cloning into Plasmid Vectors 
The DNA fragment cut with suitable restriction enzymes (8 tl), the host 
vector cut with suitable restriction enzymes (2 p1), 2x Quick ligation buffer (2 p1), 
and Quick T4 DNA ligase from New England Biolabs (1 pJ)  were gently mixed and 
incubated for 10 min at room temperature. The reaction mixture (3 p1) was used to 
transform JM 109 competent cells. 
6.2.3.9 Storage of Bacterial Stocks 
LB medium containing the appropriate antibiotics were used for the short 
term storage of E. coli. Colonies of bacteria were stored on inverted agar plates at 4 
p-tsIsJ 
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°C for up to 28 days. For long term storage, strains were frozen (-80 °C) in LB media 
containing 20% glycerol. Purified plasmids DNA were stored at -20 °C for up to one 
year. 
6.2.4 Polymerase chain reactions 
Polymerase chain reactions (PCRs) were performed using a Perkin Elmer 480 
thermal cycler and the reactions were overlayed with —30 tl oil. PCR sequencing 
reactions were performed on an Eppendorf Mastercycler Personal which has a hot-
top assembly and does not require the addition of oil. 
6.2.4.1 Amplification of DNA 
A typical amplification PCR contained 2 Ready to Go PCR rm beads 
(Amersham Biosciences), DNA template (2 i1), primer-forward 10 .iM (5 tl,), 
primer-reverse 10 iM (5 p1), and distilled water (final volume of 50 p1). The cycling 
parameters of the PCR are listed bellow. The PCR product was then subjected to 
agarose gel electrophoresis and the required band was excised and the DNA purified 
as described in section 6.2.3.6. 
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PCR steps Temperature (°C) Time (mm) Number of cycles 
Initial denaturation 95 2 1 
Denaturation 95 1 25 
Annealing 55 1 25 
Extension 72 2 25 
Termination 72 10 1 
6.2.4.2 PCR Megaprimer Mutagenesis 
Mutations were performed by using the Stratagene site-directed mutagenesis 
kit. Each reaction contained plasmid DNA (5 l), lOx reaction buffer (5 pJ), primer-
forward 10 pM (1 l), primer-reverse 10 pM (1 p1), dNTP mix (1 j.tl), distilled water 
(final volume 50 p1) and Pfu DNA polymerase 2.5 ulj.il (1 pJ). The cycling 
parameters of the PCR are listed bellow 
PCR steps Temperature (°C) Time Number of cycles 
Initial denaturation 95 2 min 1 
Denaturation 95 50 sec 18 
Annealing 60 50 sec 18 
Extension 68 1 mm I 1000 bp 18 
Termination 68 7 min 1 
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6.2.4.3 DNA sequencing 
The sequencing reactions were performed using the BigDye® Terminator 
v3.1 Cycle sequencing kit (PE Applied Biosystems). The PCR mixture contained 
DNA template -.5 pmol (5 pJ), 5x reaction buffer (2 tl), primer 10 tM (1 pJ) and 
Big Dye 3.1 (2iJ). Sequencing of the 5'-end of the DNA template was carried out 
with the primer pGEM-forward while the sequencing of the 3'-end was carried out 
with the primer pGEM-reverse. The cycling parameters of the PCR are listed bellow. 
PCR steps Temperature (°C) Time Number of cycles 
Denaturation 95 30 sec 30 
Annealing 60 20 sec 30 
Extension 68 4 min 30 
Automated DNA sequencing was performed on an ABI prism 377 DNA 
sequencer using the Sanger dideoxy chain termination method. Sequence data were 
analysed using Contig Express within the Vector NTI Advance Tm V9 software 
package. 
6.3 Protein Expression and Purification 
6.3.1 Polyacrylamide Gel Electrophoresis (PAGE) 
SDS-PAGE was used to analyse proteins on the basis of their molecular mass 
with a Tris-Glycine or "Laemnili" discontinuous buffering system.' Alternatively, 
proteins were analysed on precast 12% Bis-Tris Nu-PAGE gels (Invitrogen) 
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according to manufacturer's instructions. Proteins were analysed in their native form 
by non-denaturing gel electrophoresis using Novex® 12% Tricine or 12% Novex® 
Tris-Glycine precast gels (Invitrogen). Gels were visualised using Comassie blue. 
6.3.2 Expression and Purification of AaBPL and Mutant AaBPL 
R4OG 
6.3.2.1 Large Scale Expression of AaBPL and AaBPL R40G 
AaBPL was expressed and purified as described previously by Clarke et al 
with the following modifications. 2 Overexpression of A. aeolicus AaBPL and mutant 
AaBPL R40G was achieved by transforming E. coli BL21(DE3) (Novagen) cells 
with the vectors pET28a/AaBPL and pET28a/AaBPL R40G respectively. A single 
colony was added to 250 nil LB supplemented with kanamycin (30 jig.m1 1 ) and 
grown overnight at 37 °C and 200 rpm. This seed culture was then used to inoculate 
4 litres of fresh LB medium and grown under similar conditions to OD 600 = 1.0 
before induction with isopropyl-1-thio--D-galactopyranoside (JTPG) to a final 
concentration of 1.0 mM. After a further 3 hours, the cells were harvested by 
centrifugation (5,000 x g for 15 minutes at 4 °C), washed with buffer A, and stored at 
-20 °C. 
6.3.2.2 Purification of AaBPL and AaBPL R40G 
Cells overexpressing AaBPL were resuspended in buffer A (5 ml per gram of 
wet cell paste) with one tablet of Complete m Proteinase Inhibitor Cocktail (Roche) 
and disrupted by sonication (15 pulses of 30 seconds at 30 second intervals) at 4 °C. 
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The cell debris was removed by centrifugation two times for 15 minutes at 27,000 x 
g and at 4 °C in presence of 1 jiJ DNase 10 u/pi (Roche). The supernatant was 
filtered through a 0.45 .tM membrane before being loaded on a cation exchange 10 
ml Tricorn HR 10/100 column containing 15S beads (GE Healthcare) pre-
equilibrated with buffer A. The column was then washed with 5 column volumes of 
buffer A and the protein was eluted with a linear salt gradient (0-100% buffer B) 
over 20 column volumes at 4 °C. Fractions containing AaBPL were run on either 
SDS-PAGE or Nu-PAGE gels and those fractions judged to be 95% pure were 
dialysed overnight against buffer A at 4 °C. Protein concentration was determined 
with the Bradford protein assay (Bio-Rad) and by measuring the absorbance at 280 
nm using the molar extinction coefficient 34,850 M' cm-1 which was calculated 
using the Vector NTI Advance'rm V9 software. AaBPL was concentrated to 1 mg.mf 
1  using a Vivaspin concentrator 20,000 MWCO (Vivascience) and stored in buffer A 
containing 20% glycerol (v/v) at —20°C. The mutant AaBPL R40G mutant was 
purified in a similar manner. 
6.3.3 Expression and Purification of A. aeolicus Full-Length 
BCCP: BCCP154 
6.3.3.1 Large Scale Expression of BCCP154 
Overexpression of A. aeolicus His6-Tagged BCCP 154 and untagged 
BCCP154 was carried out by transforming E. coli BL21(DE3) cells with the 
pET6HJBCCP154 and pET16bIBCCP154 vectors respectively. A single colony was 
added to 250 ml LB supplemented with ampicillin (100 j.ig.m1 4) and grown 
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overnight at 37 °C and 200 rpm. This seed culture was then used to inoculate 4 litres 
of fresh LB medium and grown to 0D 600 = 0.6 before induction with 1TPG (1.0 mM 
final concentration) for 3 hours at 37 °C and 200 rpm. The cells were then harvested 
by centrifugation (5,000 x g for 15 minutes at 4 °C), washed with buffer A and stored 
at -20 °C. 
6.3.3.2 Purification of N-terminal His6-Tagged BCCP154 
Initial purification of A. aeolicus full length BCCP 154 carried out with the N-
terminal His6-Tagged protein by nickel affinity chromatography was shown to be 
unsuccessful. Cells overexpressing His6-BCCP154 were resuspended in binding 
buffer D (5 nil per gram of wet cell paste) with one tablet of Complete' rm Proteinase 
Inhibitor Cocktail and disrupted by sonication (15 pulses of 30 seconds at 30 second 
intervals) at 4 °C. The cell debris was removed by centrifugation at 27,000 x g for 20 
minutes at 4 °C in presence of 1 j.tl DNase 10 u/pd. The supernatant was filtered 
through a 0.45 pm membrane prior to chromatography at 4 °C. The cell lysate was 
loaded onto a 5 ml HisTrapTM HP column (GE Healthcare) previously equilibrated 
with binding buffer D. The column was then washed with 5 column volumes of 
buffer D before elution using a linear gradient of imidazole (0-100% buffer E). 
Fractions were analysed by SDS-PAGE and the His-tagged protein which did not 
bind to the nickel column, was shown to be in the flow-through fraction with the rest 
of the unbound material. 
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6.3.3.3 Purification of Untagged BCCP154 
After being cloned into a pET 16b vector, A. aeolicus BCCP 154 was purified 
by cation exchange chromatography. Cells overexpressing BCCP 154 were 
resuspended in binding buffer A (5 ml per gram of wet cell paste) with one tablet of 
CompleteTm Proteinase Inhibitor Cocktail and disrupted by sonication (15 pulses of 
30 seconds at 30 second intervals) at 4 °C. The cell debris was removed by 
centrifugation at 27,000 x g for 20 minutes at 4 °C in presence of 1 jil DNase 10 
u/pJ. The supernatant was filtered through a 0.45 gm membrane prior to 
chromatography at 4 °C. The cell lysate was first loaded on a 55 ml Q-Sepharose XL 
(Amersham) previously equilibrated with binding buffer A. The column was then 
washed with 5 column volumes of buffer A and the bound material eluted using a 
linear salt gradient of 0-100% buffer B over 15 column volumes. The fractions were 
analysed by SDS-PAGE and those containing a significant proportion of protein 
BCCP 154 were dialyzed overnight against buffer A at 4 °C. The protein mixture was 
filtered through a 0.45 gm membrane before being loaded on a 1 ml MonoQ HR 5/5 
(Amersham) column equilibrated with buffer A. The bound material eluted with a 
salt gradient (0-100% buffer B) over 20 column volumes and the fractions analysed 
be SDS-PAGE which contained BCCP 154 were dialyzed overnight against buffer A 
at 4 °C. The protein was concentrated to a volume of 4 ml using a Vivaspin 
concentrator 10,000 MWCO and, after filtration through a 0.45 gm membrane, was 
loaded on a 120 nil HiLoad 16/60 Superdex75 gel filtration column (Amersham) 
previously equilibrated with buffer C. The bound material eluted with buffer C at a 
flowrate of lml.min 1  and SDS-PAGE analysis of the fractions indicated BCCP 154 to 
be 95% pure. BCCP154 was dialysed overnight against buffer A at 4 °C. Due to the 
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low proportion of aromatic residues in BCCP 154, protein concentration was 
determined using the BCATM  protein assay kit (Pierce) and by measuring the 
absorbance at 280 nm (molar extinction coefficient 6,520 M 1 cm'). BCCP154 was 
concentrated to 1 mg.m1 1 using a 10,000 MWCO and stored in buffer A containing 
20% glycerol (v/v) at —20°C. 
6.3.4 Expression and purification of A. aeolicus BCCPi\67 and 
BCCPA67 Ki 17L 
6.3.4.1 Large scale expression of BCCPA67 and BCCPL67 Ki 17L 
The pET6HIBCCPA67 and pET6HJBCCPA67 K1 17L vectors were used to 
transform E. coli BL21(DE3). A single colony was added to 250m1 LB supplemented 
with ampicillin (100 g.ml-1 ) and grown overnight at 37 °C and 200 rpm. This seed 
culture was then used to inoculate 4 litres of fresh growth medium and grown under 
similar conditions to 0D6 00 = 1.0 before being induced with ITPG (1.0 mM final 
concentration). After a further 3 hours, the cells were harvested by centrifugation 
(5,000 x g for 15 minutes at 4 °C) and stored at -20 °C. 
6.3.4.2 Purification of BCCPA67 and BCCPA67 Ki 17L 
BCCPA67 and mutant BCCPL67 Ki 17L were expressed and purified as 
described previously by Clarke et al.2 Cells overexpressing His6-BCCPA67 were 
resuspended in binding buffer D (5 ml per gram of wet cell paste) with one tablet of 
CompleteTm Proteinase Inhibitor Cocktail and disrupted by sonication (15 pulses of 
30 seconds at 30 second intervals) at 4 °C. The cell debris was removed by 
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centrifugation at 27,000 x g for 20 minutes at 4 °C, after which the supernatant was 
filtered through a 0.45 gm membrane prior to chromatography. The cell lysate was 
loaded onto a 5 ml HisTrapTM HP column (GE Healthcare) previously equilibrated 
with binding buffer D. The column was then washed with 5 column volumes of 
buffer D before the bound material was eluted using a linear gradient of imidazole 
(0-100% buffer E) over 20 column volumes at 20 °C. Fractions were analysed by 
SDS-PAGE and those containing BCCPL67 were pooled and dialysed overnight 
against 4 litres of buffer A at 20 °C. The mutant BCCPA67 K! 17L was purified in a 
similar manner. 
Apo- and holo-BCCPA67 were separated by applying the BCCPi67-
containing fractions eluted from the nickel column onto a 1 ml MonoQ HR 5/5 
column (Arnersham) pre-equilibrated with buffer A The column was then washed 
with 10 column volumes of buffer A before the protein eluted with a linear salt 
gradient (0-100% buffer B) over 30 column volumes at 20 °C. The elution was 
monitored by SDS-PAGE and fractions containing apo- and holo-BCCPA67 were 
screened by LC-ESI-MS. The concentration of apo-BCCP67, holo-BCCPA67 and 
mutant BCCPA67 Ki 17L was determined by using the BCATM  protein assay kit and 
by measuring the absorbance at 280 nm (molar extinction coefficient 3,960 M 1 cm 
1)• The separated apo- and holo-proteins and the Ki 17L mutant BCCPA67 were 
concentrated to 1 mg.mf 1 using a Vivaspin concentrator 3,000 MWCO and stored in 
buffer A containing 20% glycerol (v/v) at -20°C. 
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6.3.5 Expression and Purification of E. co/i Mutant BirA Ri 18G 
6.3.5.1 Large Scale Expression of BirA R1 18G 
The E. coli BirA R  18G mutant was expressed according to the method 
described by Ting. 3  The pBTac vector containing the gene for the His-tagged E. coli 
mutant BirA R  18G was used to transform JM1O9 cells (Novagen). A single colony 
was added to 10 ml LB medium supplemented with ampicillin (100 g.ml - ') and 
grown overnight at 37°C and 200 rpm. This seed culture was used to inoculate 250 
ml LB supplemented with ampicillin (100 .tg.mf 1 ) and grown overnight under 
similar conditions. The overnight growth was then added to 4 litres of fresh LB 
medium and grown at 37 °C and 200 rpm to 0D600=0.9. Enzyme expression was 
induced with IPTG to a final concentration of 0.4 mM at 30 °C and 200 rpm. After a 
further 3 hours, the cells were harvested by centrifugation (5,000 x g for 15 minutes 
at 4 °C), washed with buffer F in presence of one tablet of CompleteTM Proteinase 
Inhibitor Cocktail and stored at -20 °C. 
6.3.5.2 Purification of BirA Ri 18G 
The cells overexpressing His6-BirA R  18G were resuspended in buffer F (5 
ml per gram of cell paste) and disrupted by sonication at 4 °C (three 10-second 
pulses with 1 minute interval between each pulse). The cell debris was removed by 
centrifugation (27,000 x g, 20 mm, 4 °C) and the supernatant kept at 4 °C, was 
filtered through a 0.45 pm membrane. The His6-tagged soluble protein was purified 
at 20°C from the lysate using a 5m1 HisTrapTM HP nickel column (GE Healthcare) 
pre-equilibrated with buffer F. The column was washed with 10 column volumes of 
binding buffer before bound material was eluted using a linear gradient of 0-100% of 
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buffer G over 25 column volumes. The fractions were analysed by SDS-PAGE and 
those fractions, judged to be 95% pure, were dialysed overnight against phosphate 
buffer saline (pH 7.4) at 4 °C. The concentration of BirA Ri 18G was determined 
using the Bio-Rad protein assay kit and by measuring the absorbance at 280 nrn 
(molar extinction coefficient 47,630 M 1 cm-1 ). The purified BirA R118G was 
concentrated to 1 mg.m1 1 using a Vivaspin concentrator 20,000 MWCO and stored 
in phosphate buffer saline containing 20% glycerol (v/v) at -80°C. 
6.3.6 Expression and Purification of E. co/i BCCP (EcBCCP) 
6.3.6.1 Large Scale Expression of EcBCCP 
Overexpression of the full length E. coli EcBCCP was achieved by 
transforming E. coli BL21(DE3) (Novagen) cells with the vectors pET29a/EcBCCP 
and pBirAcm Avidity (AviTagTM). A single colony was added to 250 ml LB 
supplemented with kanamycin (200 j.ig.m1 1 ) and chloramphenicol (20 pg.mf 1 ) and 
grown overnight at 37 °C and 200 rpm. This seed culture was then used to inoculate 
4 litres of fresh LB medium supplemented with kanamycin (200 pg.ml'), 
chloramphenicol (20 j.ig.mF 1 ) and biotin (30 tg.ml') and grown at 37 °C and 200 
rpm to 0D600 = 0.7. Overexpression was induced with ITPG to a final concentration 
of 1.0 mM for 5 hours. The cells were then harvested by centrifugation (5,000 x g for 
15 minutes at 4 °C), washed with buffer H, and stored at -20 °C. 
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6.3.6.2 Purification of ECBCCP 
The C-terminal His6-tagged BCCP was first purified with nickel affinity 
followed by anion exchange chromatography. Cells overexpressing EcBCCP were 
resuspended in buffer H (5 ml per gram of wet cell paste) with one tablet of 
Complete' Proteinase Inhibitor Cocktail. The resuspended cell paste was shaked at 
37 °C for 30 min and the cells were then disrupted by sonication (5 times 1 min at 30 
seconds interval) at 4 °C. The cell debris was removed by centrifugation two times 
for 15 minutes at 27,000 x g and at 4 °C in presence of 1 p1 DNase 10 u/p1 (Roche). 
The supernatant was then further clarified by ultracentrifugation at 120,000 x g and 
at 4 °C for 1 hour. 2 ml of Ni-NTA agarose (Qiagen) was washed with 10 ml of 
distilled water and equilibrated with 3 times 10 ml of buffer H. The Ni-NTA agarose 
was centrifuged at 1,000 x g and at 4 °C for 1 min and was then slowly mixed in a 
beaker with the lysate and left to set for 2 hours at 4 °C. The mixture was then loaded 
on a 5 ml disposable column (Pierce) washed with buffer I. The presence of protein 
in the washes was monitored by using the Bradford reagent from the Bio-Rad protein 
assay kit (1 drop of solution / 1 ml of Bradford reagent). The slurry was then washed 
with buffer J until no protein could be detected with the Bradford method. The slurry 
was further purified with 5 column volumes of buffer J before elution of the protein 
with buffer K (170 mM of imidazole) over 10 column volumes. The protein was 
collected in 1 ml fractions and was further eluted with buffer L (250 mM imidazole) 
until no more protein could be detected with the Bradford method. The flow-through 
and the 17 fractions were analysed by SDS-PAGE before being extensively dialysed 
against buffer M at 4 °C. 
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The protein was then filtered through a 0.45 tm membrane before being 
loaded on a 1 ml MonoQ HR 515 column (Amersham) pre-equilibrated with binding 
buffer M. Elution of the protein was performed with a linear gradient of salt 0-1 M 
NaCl (buffer N) over 20 column volumes. The fractions were analysed by SDS-
PAGE and judged to be 90% pure and the protein was then extensively dialysed 
against buffer 0 at 4 °C. Protein concentration was determined by measuring the 
absorbance at 280 nm (molar extinction coefficient 2,680 M 1 cm-1 ) and the fractions 
were concentrated to 4 ml using a Vivaspin concentrator 3,000 MWCO. After 
filtering through a 0.45 pM membrane, EcBCCP was loaded on a gel filtration 320 
nil Sephacryl S-200 HR column (Amersham) pre-equilibrated with buffer 0. The 
protein eluted with buffer 0 at a flowrate of lml.min 1 and SDS-PAGE analysis of 
the fractions showed EcBCCP to be 95% pure. EcBCCP was dialysed overnight 
against 4 L buffer 0 in presence of 20 % glycerol at 4 °C. Protein concentration was 
determined with the Bio-Rad protein assay and by measuring the absorbance at 280 
nm. EcBCCP was concentrated to 1 mg.m1 1 using a Vivaspin concentrator 3,000 
MWCO and stored in buffer 0 (20% glycerol v/v) at -20°C. 
6.3.7 Expression and Purification of E. co/i BC 
6.3.7.1 Large Scale Expression of BC 
The plasmid pET 16bJBC was used to transform E. coli BL21(DE3). A single 
colony was added to 250 nil LB supplemented with ampicillin (1 ig.mf 1 ) and grown 
overnight at 37 °C and 200 rpm. This seed culture was then used to inoculate 3 litres 
of fresh LB medium and grown subject to the same conditions to 0D6 00 = 0.6 before 
being induced with ITPG (1.0 mM final concentration). The overexpression was 
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allowed to proceed for 5 hours, and the cells were harvested by centrifugation (5,000 
x g, 15 mm, 4 °C), washed with buffer R and stored at -20 °C. 
6.3.7.2 Purification of BC 
Cells overexpressing BC were resuspended in buffer P (5 ml per gram of wet 
cell paste) with one tablet of Complete Proteinase Inhibitor Cocktail (Roche) and 
disrupted by sonication (5 times 1 min at 30 seconds intervals) at 4 °C. The cell 
debris was removed by centrifugation two times for 15 minutes at 27,000 x g and at 4 
°C in presence of 1 tl DNase 10 u/pJ (Roche). The supernatant was filtered through 
a 0.45 jiM membrane before being loaded on a HisTrapTM HP column (GE 
Healthcare) previously equilibrated with buffer P. The column was then washed with 
5 column volumes of buffer P and the BC protein eluted with a linear gradient of 
imidazole (0-100% buffer Q) over 20 column volumes at 4 °C. Fractions were 
analysed by SDS-PAGE and those containing BC were pooled and dialysed 
overnight against 4 litres of buffer R at 4 °C. Protein concentration was determined 
by measuring the absorbance at 280nm using (molar extinction coefficient 25,850 M -
I 
 cm') and the fractions were concentrated to 4 ml using a Vivaspin concentrator 
20,000 MWCO. After filtering through a 0.45 jiM membrane, BC was loaded on a 
gel filtration 320 ml Sephacryl S-200 HR column previously equilibrated with buffer 
R. The protein eluted with buffer R at a flowrate of lml.min' and SDS-PAGE 
analysis of the fractions indicated BC to be 95% pure. BC was dialysed overnight 
against 4 L buffer R at 4 °C. Protein concentration was determined with the Bio-Rad 
protein assay and by measuring the absorbance at 280 nm. BC was concentrated to 2 
mg.mF 1  and stored in buffer R containing 20% glycerol (v/v) at —20°C. 
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6.4 Protein Chemistry 
6.4.1 Protein Characterisation 
6.4.1.1 Liquid chromatography-mass spectrometry (LC-ESI-MS) 
LC-ESI-MS was performed on a MicroMass Platform II quadrupole mass 
spectrometer equipped with an electrospray ion source. The spectrometer cone 
voltage was ramped from 40 to 70 V and the source temperature set to 140 °C. 
Protein samples were separated on a Jupiter C5 reverse phase column (5 pm, 250 x 
4.6 mm, Phenomenex) with a Waters HPLC 2690 directly connected to the 
spectrometer. Proteins were eluted from the column with a 5-95% acetonitrile 
(containing 0.01% TFA) gradient at a flow rate of 0.1 ml.min 1 . The total ion count in 
the range 500-2000 m/z was scanned at 0.1 s intervals. The scans were accumulated, 
spectra combined and the molecular mass determined by the MaxEnt and Transform 
algorithms of the Mass Lynx software (Micromass, U. K.). 
6.4.1.2 Nano-electrospray mass spectrometry (nESI-MS) 
Nanoelectrospray MS data were acquired on a Q-T0F II instrument (Waters, 
Manchester, UK) and on a MDS Sciex Q-star XL (Concord, ON, Canada) in positive 
mode, under conditions optimised for the transmission and efficient desolvation of 
high-mass non-covalent complexes. Instrument parameters and pressures throughout 
the instruments were adjusted to enhance these processes. 4 Samples were introduced 
into the instruments via nanoflow-electrospray capillaries. These capillaries were 
prepared using a micropipette puller (Flaming/Brown P-97, Sutter Instruments, 
Novato, CA, USA) and glass capillary tubes of 1 mm outer-diameter and 0.78 mm 
inner-diameter (Harvard Apparatus, Holliston, MA, USA). A thin layer of gold 
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coating, to make the capillaries electrically conductive, was applied using a SEM 
sputter-coater (Polaron, Newhaven, UK). The pulled end of the capillaries were 
clipped under a stereomicroscope resulting in an inner tip diameter of 2-5 pm. 
Capillaries were loaded, using GEloader tips (Eppendorf), with 2 jil of aqueous 
protein solution. Proteins were sprayed from these capillaries with the aid of a 
backing pressure to initiate and maintain a steady spray. Prior to data collection the 
mass spectrometer was calibrated using caesium iodide (100 mg MI -1 ). Data were 
acquired and processed with MassLynx software 4.0 (Waters, Manchester, UK). All 
spectra are shown with minimal smoothing and without background subtraction. 
The Q-TOF II mass spectrometer is equipped with a Z-spray source in which 
the direction of the electrospray is orthogonal to the sample cone orifice. A radio 
frequency (RF) is applied to the first hexapole to direct and collimate the whole ion 
beam into the quadrupole analyser. The ion path is further focused by a second 
hexapole, before ions reach the ToF analyser which is orthogonal to the ion beam 
and where ion separation is achieved. A reflectron is used in the ToF analyser to 
reduce the kinetic energy spread of ions which would diminish spectral resolution. 
Ions are finally detected using a Microchannel Plate Detector (MCP) detector. Here, 
the incident ion signal results in an electron emission from a channel wall in the 
MCP which is then accelerated by a potential applied across the plate. The current 
which reaches the rear of the plate is then transformed into a mass spectrum using a 
time-to-digital converter. 
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Figure 6.1 - Schematic of a Q-ToF II mass spectrometer. 
In the MDS Sciex Q-star spectrometer, the pre-T0F ion path consists of three 
quadrupoles (ion guide QO, mass analyser ROl, collision cell R02). ROl is the 
mass-filtering device, whereas QO and R02 are operated in the RF-mode only and 
function as ion guide devices. In contrast with the Q-T0F II, the nanospray set-up of 
the Q-star spectrometer has a liner trajectory.5 
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Figure 6.2 - Schematic of the MDS Sciex Q-star XL. 
6.4.1.3 Streptavidin Western Blot 
Pure proteins were separated by SDS-PAGE on two identical gels. One gel 
was kept for control and analysis while the proteins from the second gel were 
transferred on a 0.2 m pore sized Hybond-ECL nitrocellulose membrane 
(Amersham) using a Trans blot Semi-Dry Transfer cell. The membrane was 
incubated overnight in the biotin-free SuperBlock solution at 4 °C. Excess blocking 
solution was then removed by washing with phosphate buffer containing 0.1 % 
Tween (Sigma) four times before being incubated in SuperBlock solution containing 
1150,000 Streptavidin HRP for one hour at room temperature. The membrane was 
washed and dried before immunolabelled proteins were detected using the ECL 
enhanced chemiluminescence detection system (Amersham) in accordance with the 
manufacturer's protocol. Proteins were visualised on a BioMax XAR film (Kodak). 
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6.4.2 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) was carried out in collaboration with 
Pr. Alan Cooper and the Glasgow Biological Microcalorimetry Facility. The ITC 
measurements were performed on a VP-ITC calorimeter (Microcal Inc Northampton, 
USA) at 25 °C. AaBPL and AaBPL R40G were exhaustively dialyzed against the 
buffer system containing 10 mM HEPES, 4 mM EDTA, pH 7.5. The final dialysis 
buffer was used to make up the ligand solution as well as for instrument equilibration 
and baseline controls. The concentrations of the wild-type AaBPL and mutant 
AaBPL R40G were determined by measuring the absorption at 280 nm (15.4 [IM 
AaBPL and 18 pM AaBPL R40G) and the concentrations of ligands were 
approximately 10 times higher (0.200 mM biotin, 0.204 mM ATP). 
The reactants AaBPL and AaBPL R40G were placed in the 2 ml sample 
chamber and the substrates biotin and ATP in the syringe. A typical ITC 
measurement consisted of a first control injection of 1 p1 followed by 29 successive 
injections of 10 .tl for 20s with a 3 min interval between each injection. AaBPL and 
AaBPL R40G were titrated with the first ligand biotin or ATP which was left in the 
cell in order to titrate the binary complexes with the second ligand. The 
concentrations of the proteins were adjusted in function of the volume added during 
the first titration. During the titration of AaBPL with streptavidin (Sigma, 0.198 mM 
in the syringe), the first 1 p1 injection was followed by only 12 injections of 10 p1. 
Control experiments in which the ligands were directly injected in the buffer were 
performed in order to evaluate the heat contributions due to coupled protonation 
events upon binding. The observed heat effects were identical to the heat signals 
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after complete saturation of the proteins. Therefore, the non-specific background was 
usually estimated by averaging the small heats at the end of the AaBPL and AaBPL 
R40G titrations. 
Raw data were collected, corrected for ligand heats dilution, and the peaks 
generated integrated using the ORIGIN software (Microcal Inc) by plotting the 
values in microcalories against the molar ratio of injectant to reactant within the cell. 
Data were fitted using the one single-site binding model. From the dissociation 
constant KD and the reaction enthalpy value MI, the change in free Gibbs energy 
(G°) and entropy change (S°) can be calculated using the equation AG' = -RT in 
(1/KD) = AH —TiS ° where R is the universal gas constant and T the absolute 
temperature. 
6.4.3 In vitro Biotinylation Assays 
6.4.3.1 Biotinylation of apo-BCCPA67 and BCCPL67 Ki 17L with AaBPL 
and AaBPL R40G 
In vitro biotinylation assays of the apo-form of BCCPA67 and mutant 
BCCPA67 K! 17L were carried out with AaBPL or AaBPL R40G and were analysed 
by LC-ESI-MS and streptavidin Western blot. All biotinylation experiments, except 
otherwise stated, were carried out in 10 mM HIEPES at pH 7.5. For LC-ESI-MS 
analysis, the reaction mixture contained 100 pM biotin, 1 mM ATP, 2 MM M902 
and 40 .iM substrate apo-BCCP67 or BCCPA67 Ki 17L. The reaction was initiated 
by the addition of purified AaBPL or AaBPL R40G to a final concentration of i IIM, 
and incubated at 65 °C for 30 mm. Aliquots of the incubation mixture were taken at 
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5 min and 10 min intervals and terminated by the addition of ice-cold trifluoroacetic 
acid (final concentration 25% w/v) and incubation on ice for 30 mm. For the 
streptavidin Western blot studies, the reaction contained 5 tM biotin, 100 jiM ATP, 
200 PM M902, 2 jtM of substrate apo-BCCPA67 or BCCPA67 Ki 17L and was 
incubated with 200 nM AaBPL or AaBPL R40G at 65 °C for 15 mm. The reactions 
were terminated by addition of SDS sample buffer prior to SDS-PAGE and western 
blotting. 
6.4.3.2 Biotinylation of BSA with AaBPL and AaBPL R40G 
Biotinylation of Bovine Serum Albumin (Pierce) was assayed with wild-type 
AaBPL and mutant AaBPL R40G at 3 different enzyme concentrations (50 nM, 200 
nM, and 500 nM). The reaction contained 2 M BSA, 5 jiM biotin, 1 mM ATP, 2 
MM M902 and was initiated by the addition of wild-type or mutant AaBPL. Because 
BSA aggregates at elevated temperatures, the reaction was incubated at 60 °C for 15 
min and was terminated by addition of SDS sample buffer prior to western blotting 
analysis. 
6.4.4 Chemical Crosslinking of A. aeolicus AaBPL and BCCPz67 
AaBPL was cross-linked chemically with apo-BCCPA67, holo-BCCPz67 and 
BCCPL67 K1 17L using the coupling reagents 1-ethyl-3(dimethylamino-propyl)-
carbodiimide (EDC) and N-hydrosuccinimide (NHS). All cross-linking experiments, 
except otherwise stated, were carried out with 30 jiM AaBPL and 50 jtM of substrate 
BCCPA67 and in presence of 5 mM EDC and 5 mM NHS in a MES buffer pH 6.0. 
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The reaction was incubated at 60 °C and the formation of activated succidinimidyl 
ester was quenched after 7 minutes with 10 mM 3-mercaptoethanoL The reaction 
mixture was set at 60°C for 2 hours and aliquots were withdrawn at different time 
intervals. Termination was carried out using 10 mM hydroxylamine to regenerate 
acidic residues that had been activated but did not crosslink. Analysis of the time-
dependent formation of cross-linked complex was carried out by SDS-PAGE. ESI-
MS was used to characterize the molecular mass of the cross-linked species. Prior to 
ESI-MS analysis, the AaBPL:BCCPA67 complex was transferred into 20 mM 
ammonium acetate pH 6.8 using Vivaspin concentrators of 10,000 and 20,000 
MWCO (Vivascience). 
To investigate further the cross-linking pathway, apo-BCCPA67 was 
incubated alone for 3 minutes with EDC and NHS at 60 °C and the reaction was 
quenched with 10 mM 3-mercaptoethanol before addition of the enzyme AaBPL. In 
a similar manner, AaBPL was activated alone for 15 minutes before quenching and 
addition of apo-BCCPA67. The formation of complex was analysed by SDS-PAGE. 
6.5 Crystallography 
6.5.1 Crystallization of AaBPL and Mutant AaBPL R40G 
Crystallization of wild-type AaBPL and mutant AaBPL R40G was carried 
out in collaboration with the Structural Biochemistry Group of Pr. Malcom 
Walkinshaw (University of Edinburgh). The purified AaBPL protein was 
concentrated to 6 mg-mi 1 using a Vivaspin concentrator 20,000 MWCO 
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(Vivascience). The enzyme concentration was verified using the Bio-Rad protein 
assay kit and by measuring the absorbance at 280 nm (molar extinction coefficient 
34,850 M 1  cm'). AaBPL was crystallized by the hanging drop vapour diffusion 
method on XRL 24 well crystallization plate (Molecular Dimension Ltd) at 17 °C. 
Initial crystal trials were set up using the Crystal Screen Kit - Structure Screen 2 
(Molecular Dimensions). The drops contained 1.3 .tl of AaBPL and 1.3 d of 
reservoir solution. The crystals obtained in two different screening conditions 
(condition 26: 0.2 M ammonium sulfate, 0.1 M MES pH 6.5, 30 % w/v PEG 
monoethylether 5,000 and condition 28: 0.1 M HEPES pH 7.5, 20 % w/v PEG 
10,000) were soaked in their respective reservoir solution supplemented with 20% 
sterile glycerol (v/v) before being frozen in liquid nitrogen and analysed by X-ray 
diffraction at the European Synchrotron Radiation Facility (ESRF) in Grenoble 
(France). 
During the optimization set up, each crystallization drop contained 2 jl of 
protein at a concentration of 5 mg.mf 1 and 1 l of the reservoir solution. The well 
buffer contained 0.1 M MES, 0.2 M ammonium sulfate over a pH ranging from 6 
to 7 and with a concentration of PEG 5,000 mono-ethyl ether varying from 5 % to 
25% w/v. AaBPL was centrifuged for 30 min at 11,000 x g and at 4 °C prior to 
crystallization. The crystals were soaked in a cryoprotectant solution (Non-drying 
immersion oil Type B Formula code 1248, Cargille Laboratories Inc) before being 
frozen in liquid nitrogen and screened by X-ray diffraction at the ESRF and at the 
Synchrotron Radiation Source (SRS) in Daresbury (U.K). Crystallization of the 
AaBPL:biotin:ATP complex was achieved by adding biotin (2 mM, 1 M NaOH) 
and ATP (5 mM, pH 7) to the enzyme prior to centrifugation and the AaBPL 
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complex was kept at 4 °C during the crystallization set up. The mutant AaBPL 
R40G was also crystallized by hanging drop vapour diffusion at 17 °C at a 
concentration of 6 mg-ml -1 . The mutant crystallized in similar conditions with 
wild-type AaBPL (0.2 M ammonium sulphate, 0.1 M HEPES pH 6.2 10 % w/v 
PEG 5,000 mono-ethyl ether) and co-crystals with biotin were obtained in 
presence of 2 mM biotin. 
6.5.2 Data collection and Structure Analysis 
Data collection and processing were carried out by Dr. lain McNae. Data 
were collected at station BM14 ESRF Grenoble and station 10.1 SRS Daresbury. 
Data were processed using the programs MOSFLM and SCALA as part of three 
CCP4 suite of programs and the structure solved using the program PHASER using 
the structure from Pyrococcus Horikoshii (pdb- 1WPY). 6  Initial refinement was 
performed using the program REFMAC and finished using the program 
phenix.refine as part of the PIIENIX package.8 9  Manual refinement was performed 
using the program COOT. 10 
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